id	sid	tid	token	lemma	pos
cord-327697-80msva10	1	1	key	key	JJ
cord-327697-80msva10	1	2	:	:	:
cord-327697-80msva10	1	3	cord-327697	cord-327697	VB
cord-327697-80msva10	1	4	-	-	HYPH
cord-327697-80msva10	1	5	80msva10	80msva10	CD
cord-327697-80msva10	1	6	authors	author	NNS
cord-327697-80msva10	1	7	:	:	:
cord-327697-80msva10	1	8	Sarı	Sarı	NNP
cord-327697-80msva10	1	9	,	,	,
cord-327697-80msva10	1	10	Cenk	Cenk	NNP
cord-327697-80msva10	1	11	;	;	:
cord-327697-80msva10	1	12	Şimşek	Şimşek	NNP
cord-327697-80msva10	1	13	,	,	,
cord-327697-80msva10	1	14	Ersin	Ersin	NNP
cord-327697-80msva10	1	15	Çağrı	Çağrı	NNP
cord-327697-80msva10	1	16	;	;	:
cord-327697-80msva10	1	17	Özdoğan	Özdoğan	NNP
cord-327697-80msva10	1	18	,	,	,
cord-327697-80msva10	1	19	Öner	Öner	NNP
cord-327697-80msva10	1	20	title	title	NN
cord-327697-80msva10	1	21	:	:	:
cord-327697-80msva10	1	22	The	the	DT
cord-327697-80msva10	1	23	outcomes	outcome	NNS
cord-327697-80msva10	1	24	of	of	IN
cord-327697-80msva10	1	25	the	the	DT
cord-327697-80msva10	1	26	postulated	postulate	VBN
cord-327697-80msva10	1	27	interaction	interaction	NN
cord-327697-80msva10	1	28	between	between	IN
cord-327697-80msva10	1	29	SARS	SARS	NNP
cord-327697-80msva10	1	30	-	-	HYPH
cord-327697-80msva10	1	31	CoV-2	CoV-2	NNP
cord-327697-80msva10	1	32	and	and	CC
cord-327697-80msva10	1	33	the	the	DT
cord-327697-80msva10	1	34	renin	renin	NN
cord-327697-80msva10	1	35	-	-	HYPH
cord-327697-80msva10	1	36	angiotensin	angiotensin	NN
cord-327697-80msva10	1	37	system	system	NN
cord-327697-80msva10	1	38	on	on	IN
cord-327697-80msva10	1	39	the	the	DT
cord-327697-80msva10	1	40	clinician	clinician	NN
cord-327697-80msva10	1	41	’s	’s	POS
cord-327697-80msva10	1	42	attitudes	attitude	NNS
cord-327697-80msva10	1	43	toward	toward	IN
cord-327697-80msva10	1	44	hypertension	hypertension	NN
cord-327697-80msva10	1	45	treatment	treatment	NN
cord-327697-80msva10	1	46	date	date	NN
cord-327697-80msva10	2	1	:	:	:
cord-327697-80msva10	2	2	2020	2020	CD
cord-327697-80msva10	2	3	-	-	HYPH
cord-327697-80msva10	2	4	11	11	CD
cord-327697-80msva10	2	5	-	-	HYPH
cord-327697-80msva10	2	6	09	09	CD
cord-327697-80msva10	2	7	journal	journal	NN
cord-327697-80msva10	2	8	:	:	:
cord-327697-80msva10	3	1	J	J	NNP
cord-327697-80msva10	3	2	Hum	Hum	NNP
cord-327697-80msva10	3	3	Hypertens	Hypertens	NNP
cord-327697-80msva10	3	4	DOI	doi	NN
cord-327697-80msva10	3	5	:	:	:
cord-327697-80msva10	4	1	10.1038	10.1038	CD
cord-327697-80msva10	4	2	/	/	SYM
cord-327697-80msva10	4	3	s41371	s41371	NNP
cord-327697-80msva10	4	4	-	-	HYPH
cord-327697-80msva10	4	5	020	020	CD
cord-327697-80msva10	4	6	-	-	HYPH
cord-327697-80msva10	4	7	00436-w	00436-w	CD
cord-327697-80msva10	5	1	sha	sha	NNP
cord-327697-80msva10	5	2	:	:	:
cord-327697-80msva10	6	1	83ac00051e6b894b33048477abacd45e6ce9ea78	83ac00051e6b894b33048477abacd45e6ce9ea78	CD
cord-327697-80msva10	6	2	doc_id	doc_id	CD
cord-327697-80msva10	6	3	:	:	:
cord-327697-80msva10	6	4	327697	327697	CD
cord-327697-80msva10	6	5	cord_uid	cord_uid	NNS
cord-327697-80msva10	6	6	:	:	:
cord-327697-80msva10	7	1	80msva10	80msva10	CD
cord-327697-80msva10	7	2	Concern	concern	NN
cord-327697-80msva10	7	3	has	have	VBZ
cord-327697-80msva10	7	4	arisen	arise	VBN
cord-327697-80msva10	7	5	about	about	IN
cord-327697-80msva10	7	6	the	the	DT
cord-327697-80msva10	7	7	role	role	NN
cord-327697-80msva10	7	8	played	play	VBN
cord-327697-80msva10	7	9	in	in	IN
cord-327697-80msva10	7	10	coronavirus	coronavirus	NN
cord-327697-80msva10	7	11	disease	disease	NN
cord-327697-80msva10	7	12	2019	2019	CD
cord-327697-80msva10	7	13	(	(	-LRB-
cord-327697-80msva10	7	14	COVID-19	COVID-19	NNP
cord-327697-80msva10	7	15	)	)	-RRB-
cord-327697-80msva10	7	16	infection	infection	NN
cord-327697-80msva10	7	17	by	by	IN
cord-327697-80msva10	7	18	angiotensin	angiotensin	NN
cord-327697-80msva10	7	19	-	-	HYPH
cord-327697-80msva10	7	20	converting	convert	VBG
cord-327697-80msva10	7	21	enzyme	enzyme	NN
cord-327697-80msva10	7	22	(	(	-LRB-
cord-327697-80msva10	7	23	ACE	ACE	NNP
cord-327697-80msva10	7	24	)	)	-RRB-
cord-327697-80msva10	7	25	inhibitors	inhibitor	NNS
cord-327697-80msva10	7	26	and	and	CC
cord-327697-80msva10	7	27	angiotensin	angiotensin	NN
cord-327697-80msva10	7	28	II	II	NNP
cord-327697-80msva10	7	29	receptor	receptor	NN
cord-327697-80msva10	7	30	blockers	blocker	NNS
cord-327697-80msva10	7	31	(	(	-LRB-
cord-327697-80msva10	7	32	ARBs	arb	NNS
cord-327697-80msva10	7	33	)	)	-RRB-
cord-327697-80msva10	7	34	.	.	.
cord-327697-80msva10	8	1	This	this	DT
cord-327697-80msva10	8	2	study	study	NN
cord-327697-80msva10	8	3	was	be	VBD
cord-327697-80msva10	8	4	designed	design	VBN
cord-327697-80msva10	8	5	to	to	TO
cord-327697-80msva10	8	6	assess	assess	VB
cord-327697-80msva10	8	7	the	the	DT
cord-327697-80msva10	8	8	practice	practice	NN
cord-327697-80msva10	8	9	behaviors	behavior	NNS
cord-327697-80msva10	8	10	of	of	IN
cord-327697-80msva10	8	11	physicians	physician	NNS
cord-327697-80msva10	8	12	toward	toward	IN
cord-327697-80msva10	8	13	hypertension	hypertension	NN
cord-327697-80msva10	8	14	treatment	treatment	NN
cord-327697-80msva10	8	15	with	with	IN
cord-327697-80msva10	8	16	ACE	ACE	NNP
cord-327697-80msva10	8	17	-	-	HYPH
cord-327697-80msva10	8	18	i	i	PRP
cord-327697-80msva10	8	19	or	or	CC
cord-327697-80msva10	8	20	ARBs	arb	NNS
cord-327697-80msva10	8	21	during	during	IN
cord-327697-80msva10	8	22	the	the	DT
cord-327697-80msva10	8	23	COVID-19	COVID-19	NNP
cord-327697-80msva10	8	24	pandemic	pandemic	NN
cord-327697-80msva10	8	25	.	.	.
cord-327697-80msva10	9	1	A	a	DT
cord-327697-80msva10	9	2	self	self	NN
cord-327697-80msva10	9	3	-	-	HYPH
cord-327697-80msva10	9	4	administered	administer	VBN
cord-327697-80msva10	9	5	survey	survey	NN
cord-327697-80msva10	9	6	questionnaire	questionnaire	NN
cord-327697-80msva10	9	7	consisting	consist	VBG
cord-327697-80msva10	9	8	of	of	IN
cord-327697-80msva10	9	9	26	26	CD
cord-327697-80msva10	9	10	questions	question	NNS
cord-327697-80msva10	9	11	about	about	IN
cord-327697-80msva10	9	12	current	current	JJ
cord-327697-80msva10	9	13	hypertension	hypertension	NN
cord-327697-80msva10	9	14	treatment	treatment	NN
cord-327697-80msva10	9	15	with	with	IN
cord-327697-80msva10	9	16	ACE	ACE	NNP
cord-327697-80msva10	9	17	-	-	HYPH
cord-327697-80msva10	9	18	i/	i/	NNP
cord-327697-80msva10	9	19	ARBs	arb	NNS
cord-327697-80msva10	9	20	was	be	VBD
cord-327697-80msva10	9	21	applied	apply	VBN
cord-327697-80msva10	9	22	to	to	IN
cord-327697-80msva10	9	23	cardiologists	cardiologist	NNS
cord-327697-80msva10	9	24	,	,	,
cord-327697-80msva10	9	25	internists	internist	NNS
cord-327697-80msva10	9	26	,	,	,
cord-327697-80msva10	9	27	and	and	CC
cord-327697-80msva10	9	28	family	family	NN
cord-327697-80msva10	9	29	physicians	physician	NNS
cord-327697-80msva10	9	30	in	in	IN
cord-327697-80msva10	9	31	central	central	JJ
cord-327697-80msva10	9	32	and	and	CC
cord-327697-80msva10	9	33	western	western	JJ
cord-327697-80msva10	9	34	Turkey	Turkey	NNP
cord-327697-80msva10	9	35	,	,	,
cord-327697-80msva10	9	36	between	between	IN
cord-327697-80msva10	9	37	01	01	CD
cord-327697-80msva10	9	38	and	and	CC
cord-327697-80msva10	9	39	19	19	CD
cord-327697-80msva10	9	40	May	May	NNP
cord-327697-80msva10	9	41	2020	2020	CD
cord-327697-80msva10	9	42	.	.	.
cord-327697-80msva10	10	1	A	a	DT
cord-327697-80msva10	10	2	total	total	NN
cord-327697-80msva10	10	3	of	of	IN
cord-327697-80msva10	10	4	460	460	CD
cord-327697-80msva10	10	5	physicians	physician	NNS
cord-327697-80msva10	10	6	were	be	VBD
cord-327697-80msva10	10	7	approached	approach	VBN
cord-327697-80msva10	10	8	,	,	,
cord-327697-80msva10	10	9	and	and	CC
cord-327697-80msva10	10	10	220	220	CD
cord-327697-80msva10	10	11	(	(	-LRB-
cord-327697-80msva10	10	12	47.8	47.8	CD
cord-327697-80msva10	10	13	%	%	NN
cord-327697-80msva10	10	14	)	)	-RRB-
cord-327697-80msva10	10	15	participated	participate	VBD
cord-327697-80msva10	10	16	in	in	IN
cord-327697-80msva10	10	17	the	the	DT
cord-327697-80msva10	10	18	study	study	NN
cord-327697-80msva10	10	19	.	.	.
cord-327697-80msva10	11	1	Of	of	IN
cord-327697-80msva10	11	2	the	the	DT
cord-327697-80msva10	11	3	total	total	JJ
cord-327697-80msva10	11	4	respondents	respondent	NNS
cord-327697-80msva10	11	5	,	,	,
cord-327697-80msva10	11	6	78.7	78.7	CD
cord-327697-80msva10	11	7	%	%	NN
cord-327697-80msva10	11	8	reported	report	VBD
cord-327697-80msva10	11	9	that	that	IN
cord-327697-80msva10	11	10	they	-PRON-	PRP
cord-327697-80msva10	11	11	had	have	VBD
cord-327697-80msva10	11	12	not	not	RB
cord-327697-80msva10	11	13	changed	change	VBN
cord-327697-80msva10	11	14	their	-PRON-	PRP$
cord-327697-80msva10	11	15	antihypertensive	antihypertensive	JJ
cord-327697-80msva10	11	16	medication	medication	NN
cord-327697-80msva10	11	17	prescribing	prescribing	NN
cord-327697-80msva10	11	18	pattern	pattern	NN
cord-327697-80msva10	11	19	,	,	,
cord-327697-80msva10	11	20	8.6	8.6	CD
cord-327697-80msva10	11	21	%	%	NN
cord-327697-80msva10	11	22	of	of	IN
cord-327697-80msva10	11	23	clinicians	clinician	NNS
cord-327697-80msva10	11	24	had	have	VBD
cord-327697-80msva10	11	25	changed	change	VBN
cord-327697-80msva10	11	26	ACE	ACE	NNP
cord-327697-80msva10	11	27	-	-	HYPH
cord-327697-80msva10	11	28	i/	i/	NNP
cord-327697-80msva10	11	29	ARBs	arb	NNS
cord-327697-80msva10	11	30	medicine	medicine	NN
cord-327697-80msva10	11	31	of	of	IN
cord-327697-80msva10	11	32	patients	patient	NNS
cord-327697-80msva10	11	33	during	during	IN
cord-327697-80msva10	11	34	the	the	DT
cord-327697-80msva10	11	35	COVID-19	covid-19	JJ
cord-327697-80msva10	11	36	pandemic	pandemic	NN
cord-327697-80msva10	11	37	and	and	CC
cord-327697-80msva10	11	38	12.7	12.7	CD
cord-327697-80msva10	11	39	%	%	NN
cord-327697-80msva10	11	40	of	of	IN
cord-327697-80msva10	11	41	them	-PRON-	PRP
cord-327697-80msva10	11	42	were	be	VBD
cord-327697-80msva10	11	43	undecided	undecided	JJ
cord-327697-80msva10	11	44	.	.	.
cord-327697-80msva10	12	1	The	the	DT
cord-327697-80msva10	12	2	median	median	NN
cord-327697-80msva10	12	3	(	(	-LRB-
cord-327697-80msva10	12	4	±interquartile	±interquartile	JJ
cord-327697-80msva10	12	5	range	range	NN
cord-327697-80msva10	12	6	)	)	-RRB-
cord-327697-80msva10	12	7	score	score	VBP
cord-327697-80msva10	12	8	indicating	indicate	VBG
cord-327697-80msva10	12	9	general	general	JJ
cord-327697-80msva10	12	10	reliance	reliance	NN
cord-327697-80msva10	12	11	level	level	NN
cord-327697-80msva10	12	12	of	of	IN
cord-327697-80msva10	12	13	physicians	physician	NNS
cord-327697-80msva10	12	14	in	in	IN
cord-327697-80msva10	12	15	ACE	ACE	NNP
cord-327697-80msva10	12	16	-	-	HYPH
cord-327697-80msva10	12	17	i	i	NN
cord-327697-80msva10	12	18	/	/	SYM
cord-327697-80msva10	12	19	ARBs	arb	NNS
cord-327697-80msva10	12	20	therapy	therapy	NN
cord-327697-80msva10	12	21	was	be	VBD
cord-327697-80msva10	12	22	8	8	CD
cord-327697-80msva10	12	23	±	±	NNP
cord-327697-80msva10	12	24	4	4	CD
cord-327697-80msva10	12	25	(	(	-LRB-
cord-327697-80msva10	12	26	range	range	NN
cord-327697-80msva10	12	27	,	,	,
cord-327697-80msva10	12	28	1–10	1–10	CD
cord-327697-80msva10	12	29	)	)	-RRB-
cord-327697-80msva10	12	30	.	.	.
cord-327697-80msva10	13	1	In	in	IN
cord-327697-80msva10	13	2	multiple	multiple	JJ
cord-327697-80msva10	13	3	comparison	comparison	NN
cord-327697-80msva10	13	4	analyses	analysis	NNS
cord-327697-80msva10	13	5	,	,	,
cord-327697-80msva10	13	6	the	the	DT
cord-327697-80msva10	13	7	general	general	JJ
cord-327697-80msva10	13	8	reliance	reliance	NN
cord-327697-80msva10	13	9	level	level	NN
cord-327697-80msva10	13	10	in	in	IN
cord-327697-80msva10	13	11	ACE	ACE	NNP
cord-327697-80msva10	13	12	-	-	HYPH
cord-327697-80msva10	13	13	i	i	NN
cord-327697-80msva10	13	14	/	/	SYM
cord-327697-80msva10	13	15	ARBs	arb	NNS
cord-327697-80msva10	13	16	,	,	,
cord-327697-80msva10	13	17	reliance	reliance	NN
cord-327697-80msva10	13	18	level	level	NN
cord-327697-80msva10	13	19	when	when	WRB
cord-327697-80msva10	13	20	starting	start	VBG
cord-327697-80msva10	13	21	a	a	DT
cord-327697-80msva10	13	22	new	new	JJ
cord-327697-80msva10	13	23	ACEi	ACEi	NNS
cord-327697-80msva10	13	24	/	/	SYM
cord-327697-80msva10	13	25	ARBs	arb	NNS
cord-327697-80msva10	13	26	and	and	CC
cord-327697-80msva10	13	27	changing	change	VBG
cord-327697-80msva10	13	28	behavior	behavior	NN
cord-327697-80msva10	13	29	in	in	IN
cord-327697-80msva10	13	30	heart	heart	NN
cord-327697-80msva10	13	31	failure	failure	NN
cord-327697-80msva10	13	32	patients	patient	NNS
cord-327697-80msva10	13	33	were	be	VBD
cord-327697-80msva10	13	34	significantly	significantly	RB
cord-327697-80msva10	13	35	different	different	JJ
cord-327697-80msva10	13	36	with	with	IN
cord-327697-80msva10	13	37	regard	regard	NN
cord-327697-80msva10	13	38	to	to	IN
cord-327697-80msva10	13	39	the	the	DT
cord-327697-80msva10	13	40	specialties	specialty	NNS
cord-327697-80msva10	13	41	(	(	-LRB-
cord-327697-80msva10	13	42	p:0.02	p:0.02	XX
cord-327697-80msva10	13	43	,	,	,
cord-327697-80msva10	13	44	p:0.009	p:0.009	NNP
cord-327697-80msva10	13	45	,	,	,
cord-327697-80msva10	13	46	p:0.005	p:0.005	NNP
cord-327697-80msva10	13	47	respectively	respectively	RB
cord-327697-80msva10	13	48	)	)	-RRB-
cord-327697-80msva10	13	49	.	.	.
cord-327697-80msva10	14	1	Although	although	IN
cord-327697-80msva10	14	2	most	most	JJS
cord-327697-80msva10	14	3	of	of	IN
cord-327697-80msva10	14	4	the	the	DT
cord-327697-80msva10	14	5	physicians	physician	NNS
cord-327697-80msva10	14	6	found	find	VBD
cord-327697-80msva10	14	7	the	the	DT
cord-327697-80msva10	14	8	publications	publication	NNS
cord-327697-80msva10	14	9	about	about	IN
cord-327697-80msva10	14	10	ACE	ACE	NNP
cord-327697-80msva10	14	11	-	-	HYPH
cord-327697-80msva10	14	12	i/	i/	NNP
cord-327697-80msva10	14	13	ARBs	arb	NNS
cord-327697-80msva10	14	14	during	during	IN
cord-327697-80msva10	14	15	the	the	DT
cord-327697-80msva10	14	16	COVID-19	COVID-19	NNP
cord-327697-80msva10	14	17	pandemic	pandemic	NN
cord-327697-80msva10	14	18	untrustworthy	untrustworthy	JJ
cord-327697-80msva10	14	19	,	,	,
cord-327697-80msva10	14	20	there	there	EX
cord-327697-80msva10	14	21	were	be	VBD
cord-327697-80msva10	14	22	variable	variable	JJ
cord-327697-80msva10	14	23	levels	level	NNS
cord-327697-80msva10	14	24	of	of	IN
cord-327697-80msva10	14	25	knowledge	knowledge	NN
cord-327697-80msva10	14	26	and	and	CC
cord-327697-80msva10	14	27	reliance	reliance	NN
cord-327697-80msva10	14	28	among	among	IN
cord-327697-80msva10	14	29	different	different	JJ
cord-327697-80msva10	14	30	physicians	physician	NNS
cord-327697-80msva10	14	31	and	and	CC
cord-327697-80msva10	14	32	specialty	specialty	NN
cord-327697-80msva10	14	33	groups	group	NNS
cord-327697-80msva10	14	34	.	.	.
cord-327697-80msva10	15	1	In	in	IN
cord-327697-80msva10	15	2	general	general	JJ
cord-327697-80msva10	15	3	,	,	,
cord-327697-80msva10	15	4	the	the	DT
cord-327697-80msva10	15	5	ACE	ACE	NNP
cord-327697-80msva10	15	6	-	-	HYPH
cord-327697-80msva10	15	7	i/	i/	NNP
cord-327697-80msva10	15	8	ARBs	arb	NNS
cord-327697-80msva10	15	9	prescribing	prescribe	VBG
cord-327697-80msva10	15	10	habits	habit	NNS
cord-327697-80msva10	15	11	were	be	VBD
cord-327697-80msva10	15	12	not	not	RB
cord-327697-80msva10	15	13	affected	affect	VBN
cord-327697-80msva10	15	14	by	by	IN
cord-327697-80msva10	15	15	safety	safety	NN
cord-327697-80msva10	15	16	concerns	concern	NNS
cord-327697-80msva10	15	17	during	during	IN
cord-327697-80msva10	15	18	the	the	DT
cord-327697-80msva10	15	19	COVID-19	covid-19	JJ
cord-327697-80msva10	15	20	pandemic	pandemic	NN
cord-327697-80msva10	15	21	in	in	IN
cord-327697-80msva10	15	22	Turkey	Turkey	NNP
cord-327697-80msva10	15	23	.	.	.
cord-327697-80msva10	16	1	In	in	IN
cord-327697-80msva10	16	2	the	the	DT
cord-327697-80msva10	16	3	first	first	JJ
cord-327697-80msva10	16	4	half	half	NN
cord-327697-80msva10	16	5	of	of	IN
cord-327697-80msva10	16	6	2020	2020	CD
cord-327697-80msva10	16	7	,	,	,
cord-327697-80msva10	16	8	it	-PRON-	PRP
cord-327697-80msva10	16	9	was	be	VBD
cord-327697-80msva10	16	10	speculated	speculate	VBN
cord-327697-80msva10	16	11	that	that	IN
cord-327697-80msva10	16	12	angiotensinconverting	angiotensinconverte	VBG
cord-327697-80msva10	16	13	enzyme	enzyme	NN
cord-327697-80msva10	16	14	inhibitors	inhibitor	NNS
cord-327697-80msva10	16	15	(	(	-LRB-
cord-327697-80msva10	16	16	ACE	ace	NN
cord-327697-80msva10	16	17	-	-	HYPH
cord-327697-80msva10	16	18	i)/angiotensin	i)/angiotensin	NNP
cord-327697-80msva10	16	19	receptor	receptor	NN
cord-327697-80msva10	16	20	blockers	blocker	NNS
cord-327697-80msva10	16	21	(	(	-LRB-
cord-327697-80msva10	16	22	ARBs	arb	NNS
cord-327697-80msva10	16	23	)	)	-RRB-
cord-327697-80msva10	16	24	may	may	MD
cord-327697-80msva10	16	25	make	make	VB
cord-327697-80msva10	16	26	patients	patient	NNS
cord-327697-80msva10	16	27	more	more	RBR
cord-327697-80msva10	16	28	susceptible	susceptible	JJ
cord-327697-80msva10	16	29	to	to	IN
cord-327697-80msva10	16	30	COVID-19	covid-19	JJ
cord-327697-80msva10	16	31	disease	disease	NN
cord-327697-80msva10	16	32	and	and	CC
cord-327697-80msva10	16	33	lead	lead	VB
cord-327697-80msva10	16	34	to	to	IN
cord-327697-80msva10	16	35	worse	bad	JJR
cord-327697-80msva10	16	36	outcomes	outcome	NNS
cord-327697-80msva10	16	37	.	.	.
cord-327697-80msva10	17	1	This	this	DT
cord-327697-80msva10	17	2	early	early	JJ
cord-327697-80msva10	17	3	hypothesis	hypothesis	NN
cord-327697-80msva10	17	4	led	lead	VBD
cord-327697-80msva10	17	5	to	to	IN
cord-327697-80msva10	17	6	concerns	concern	NNS
cord-327697-80msva10	17	7	among	among	IN
cord-327697-80msva10	17	8	patients	patient	NNS
cord-327697-80msva10	17	9	taking	take	VBG
cord-327697-80msva10	17	10	these	these	DT
cord-327697-80msva10	17	11	medications	medication	NNS
cord-327697-80msva10	17	12	and	and	CC
cord-327697-80msva10	17	13	among	among	IN
cord-327697-80msva10	17	14	physicians	physician	NNS
cord-327697-80msva10	17	15	prescribing	prescribe	VBG
cord-327697-80msva10	17	16	them	-PRON-	PRP
cord-327697-80msva10	17	17	for	for	IN
cord-327697-80msva10	17	18	long	long	JJ
cord-327697-80msva10	17	19	periods	period	NNS
cord-327697-80msva10	17	20	.	.	.
cord-327697-80msva10	18	1	Angiotensin	angiotensin	NN
cord-327697-80msva10	18	2	-	-	HYPH
cord-327697-80msva10	18	3	converting	convert	VBG
cord-327697-80msva10	18	4	enzyme	enzyme	NN
cord-327697-80msva10	18	5	2	2	CD
cord-327697-80msva10	18	6	(	(	-LRB-
cord-327697-80msva10	18	7	ACE2	ACE2	NNP
cord-327697-80msva10	18	8	)	)	-RRB-
cord-327697-80msva10	18	9	is	be	VBZ
cord-327697-80msva10	18	10	a	a	DT
cord-327697-80msva10	18	11	crucial	crucial	JJ
cord-327697-80msva10	18	12	component	component	NN
cord-327697-80msva10	18	13	of	of	IN
cord-327697-80msva10	18	14	the	the	DT
cord-327697-80msva10	18	15	renin	renin	NN
cord-327697-80msva10	18	16	-	-	HYPH
cord-327697-80msva10	18	17	angiotensin	angiotensin	NN
cord-327697-80msva10	18	18	-	-	HYPH
cord-327697-80msva10	18	19	aldosterone	aldosterone	NN
cord-327697-80msva10	18	20	system	system	NN
cord-327697-80msva10	18	21	(	(	-LRB-
cord-327697-80msva10	18	22	RAAS	RAAS	NNP
cord-327697-80msva10	18	23	)	)	-RRB-
cord-327697-80msva10	18	24	,	,	,
cord-327697-80msva10	18	25	which	which	WDT
cord-327697-80msva10	18	26	metabolizes	metabolize	VBZ
cord-327697-80msva10	18	27	a	a	DT
cord-327697-80msva10	18	28	potent	potent	JJ
cord-327697-80msva10	18	29	vasoconstrictor	vasoconstrictor	NN
cord-327697-80msva10	18	30	angiotensin	angiotensin	NN
cord-327697-80msva10	18	31	II	II	NNP
cord-327697-80msva10	18	32	to	to	IN
cord-327697-80msva10	18	33	vasodilator	vasodilator	NN
cord-327697-80msva10	18	34	peptide	peptide	NN
cord-327697-80msva10	18	35	angiotensin	angiotensin	NN
cord-327697-80msva10	18	36	[	[	-LRB-
cord-327697-80msva10	18	37	1	1	CD
cord-327697-80msva10	18	38	]	]	-RRB-
cord-327697-80msva10	18	39	.	.	.
cord-327697-80msva10	19	1	This	this	DT
cord-327697-80msva10	19	2	hypothesis	hypothesis	NN
cord-327697-80msva10	19	3	was	be	VBD
cord-327697-80msva10	19	4	based	base	VBN
cord-327697-80msva10	19	5	on	on	IN
cord-327697-80msva10	19	6	the	the	DT
cord-327697-80msva10	19	7	fact	fact	NN
cord-327697-80msva10	19	8	that	that	IN
cord-327697-80msva10	19	9	coronavirus	coronavirus	NN
cord-327697-80msva10	19	10	2	2	CD
cord-327697-80msva10	19	11	(	(	-LRB-
cord-327697-80msva10	19	12	SARS	SARS	NNP
cord-327697-80msva10	19	13	-	-	HYPH
cord-327697-80msva10	19	14	CoV-2	CoV-2	NNP
cord-327697-80msva10	19	15	)	)	-RRB-
cord-327697-80msva10	19	16	that	that	WDT
cord-327697-80msva10	19	17	causes	cause	VBZ
cord-327697-80msva10	19	18	COVID-19	COVID-19	NNP
cord-327697-80msva10	19	19	disease	disease	NN
cord-327697-80msva10	19	20	gains	gain	VBZ
cord-327697-80msva10	19	21	entry	entry	NN
cord-327697-80msva10	19	22	into	into	IN
cord-327697-80msva10	19	23	cells	cell	NNS
cord-327697-80msva10	19	24	by	by	IN
cord-327697-80msva10	19	25	binding	bind	VBG
cord-327697-80msva10	19	26	to	to	IN
cord-327697-80msva10	19	27	the	the	DT
cord-327697-80msva10	19	28	ACE2	ACE2	NNP
cord-327697-80msva10	19	29	receptor	receptor	NN
cord-327697-80msva10	19	30	[	[	-LRB-
cord-327697-80msva10	19	31	2	2	CD
cord-327697-80msva10	19	32	]	]	-RRB-
cord-327697-80msva10	19	33	[	[	-LRB-
cord-327697-80msva10	19	34	3	3	CD
cord-327697-80msva10	19	35	]	]	-RRB-
cord-327697-80msva10	19	36	[	[	-LRB-
cord-327697-80msva10	19	37	4	4	CD
cord-327697-80msva10	19	38	]	]	-RRB-
cord-327697-80msva10	19	39	.	.	.
cord-327697-80msva10	20	1	Moreover	moreover	RB
cord-327697-80msva10	20	2	,	,	,
cord-327697-80msva10	20	3	some	some	DT
cord-327697-80msva10	20	4	previous	previous	JJ
cord-327697-80msva10	20	5	studies	study	NNS
cord-327697-80msva10	20	6	have	have	VBP
cord-327697-80msva10	20	7	suggested	suggest	VBN
cord-327697-80msva10	20	8	that	that	IN
cord-327697-80msva10	20	9	ACE	ACE	NNP
cord-327697-80msva10	20	10	-	-	HYPH
cord-327697-80msva10	20	11	i	i	NNP
cord-327697-80msva10	20	12	/	/	SYM
cord-327697-80msva10	20	13	ARBs	arb	NNS
cord-327697-80msva10	20	14	blocker	blocker	NN
cord-327697-80msva10	20	15	treatment	treatment	NN
cord-327697-80msva10	20	16	up	up	RB
cord-327697-80msva10	20	17	-	-	HYPH
cord-327697-80msva10	20	18	regulates	regulate	VBZ
cord-327697-80msva10	20	19	ACE	ace	NN
cord-327697-80msva10	20	20	expression	expression	NN
cord-327697-80msva10	20	21	and	and	CC
cord-327697-80msva10	20	22	the	the	DT
cord-327697-80msva10	20	23	use	use	NN
cord-327697-80msva10	20	24	of	of	IN
cord-327697-80msva10	20	25	these	these	DT
cord-327697-80msva10	20	26	drugs	drug	NNS
cord-327697-80msva10	20	27	may	may	MD
cord-327697-80msva10	20	28	increase	increase	VB
cord-327697-80msva10	20	29	susceptibility	susceptibility	NN
cord-327697-80msva10	20	30	to	to	IN
cord-327697-80msva10	20	31	infection	infection	NN
cord-327697-80msva10	20	32	by	by	IN
cord-327697-80msva10	20	33	SARS	SARS	NNP
cord-327697-80msva10	20	34	-	-	HYPH
cord-327697-80msva10	20	35	CoV-2	CoV-2	NNP
cord-327697-80msva10	20	36	[	[	-LRB-
cord-327697-80msva10	20	37	5	5	CD
cord-327697-80msva10	20	38	]	]	-RRB-
cord-327697-80msva10	20	39	[	[	-LRB-
cord-327697-80msva10	20	40	6	6	CD
cord-327697-80msva10	20	41	]	]	-RRB-
cord-327697-80msva10	20	42	[	[	-LRB-
cord-327697-80msva10	20	43	7	7	CD
cord-327697-80msva10	20	44	]	]	-RRB-
cord-327697-80msva10	20	45	[	[	-LRB-
cord-327697-80msva10	20	46	8	8	CD
cord-327697-80msva10	20	47	]	]	-RRB-
cord-327697-80msva10	20	48	.	.	.
cord-327697-80msva10	21	1	Observational	observational	JJ
cord-327697-80msva10	21	2	studies	study	NNS
cord-327697-80msva10	21	3	have	have	VBP
cord-327697-80msva10	21	4	reported	report	VBN
cord-327697-80msva10	21	5	that	that	IN
cord-327697-80msva10	21	6	patients	patient	NNS
cord-327697-80msva10	21	7	taking	take	VBG
cord-327697-80msva10	21	8	ACE	ACE	NNP
cord-327697-80msva10	21	9	-	-	HYPH
cord-327697-80msva10	21	10	i	i	NN
cord-327697-80msva10	21	11	/	/	SYM
cord-327697-80msva10	21	12	ARBs	arb	NNS
cord-327697-80msva10	21	13	treatment	treatment	NN
cord-327697-80msva10	21	14	are	be	VBP
cord-327697-80msva10	21	15	at	at	IN
cord-327697-80msva10	21	16	increased	increase	VBN
cord-327697-80msva10	21	17	risk	risk	NN
cord-327697-80msva10	21	18	of	of	IN
cord-327697-80msva10	21	19	becoming	become	VBG
cord-327697-80msva10	21	20	infected	infect	VBN
cord-327697-80msva10	21	21	with	with	IN
cord-327697-80msva10	21	22	SARS	SARS	NNP
cord-327697-80msva10	21	23	-	-	HYPH
cord-327697-80msva10	21	24	CoV2	CoV2	NNS
cord-327697-80msva10	21	25	and	and	CC
cord-327697-80msva10	21	26	developing	develop	VBG
cord-327697-80msva10	21	27	severe	severe	JJ
cord-327697-80msva10	21	28	forms	form	NNS
cord-327697-80msva10	21	29	of	of	IN
cord-327697-80msva10	21	30	COVID-19	covid-19	JJ
cord-327697-80msva10	21	31	disease	disease	NN
cord-327697-80msva10	21	32	.	.	.
cord-327697-80msva10	22	1	During	during	IN
cord-327697-80msva10	22	2	the	the	DT
cord-327697-80msva10	22	3	pandemic	pandemic	NN
cord-327697-80msva10	22	4	,	,	,
cord-327697-80msva10	22	5	contradictory	contradictory	JJ
cord-327697-80msva10	22	6	studies	study	NNS
cord-327697-80msva10	22	7	and	and	CC
cord-327697-80msva10	22	8	opinions	opinion	NNS
cord-327697-80msva10	22	9	have	have	VBP
cord-327697-80msva10	22	10	suggested	suggest	VBN
cord-327697-80msva10	22	11	that	that	IN
cord-327697-80msva10	22	12	local	local	JJ
cord-327697-80msva10	22	13	inactivation	inactivation	NN
cord-327697-80msva10	22	14	of	of	IN
cord-327697-80msva10	22	15	the	the	DT
cord-327697-80msva10	22	16	reninangiotensin	reninangiotensin	NNP
cord-327697-80msva10	22	17	aldosterone	aldosterone	NNP
cord-327697-80msva10	22	18	system	system	NN
cord-327697-80msva10	22	19	may	may	MD
cord-327697-80msva10	22	20	have	have	VB
cord-327697-80msva10	22	21	protective	protective	JJ
cord-327697-80msva10	22	22	effects	effect	NNS
cord-327697-80msva10	22	23	against	against	IN
cord-327697-80msva10	22	24	the	the	DT
cord-327697-80msva10	22	25	development	development	NN
cord-327697-80msva10	22	26	and	and	CC
cord-327697-80msva10	22	27	progression	progression	NN
cord-327697-80msva10	22	28	of	of	IN
cord-327697-80msva10	22	29	acute	acute	JJ
cord-327697-80msva10	22	30	lung	lung	NN
cord-327697-80msva10	22	31	failure	failure	NN
cord-327697-80msva10	22	32	[	[	-LRB-
cord-327697-80msva10	22	33	3	3	CD
cord-327697-80msva10	22	34	,	,	,
cord-327697-80msva10	22	35	9	9	CD
cord-327697-80msva10	22	36	]	]	-RRB-
cord-327697-80msva10	22	37	.	.	.
cord-327697-80msva10	23	1	Professional	professional	JJ
cord-327697-80msva10	23	2	societies	society	NNS
cord-327697-80msva10	23	3	have	have	VBP
cord-327697-80msva10	23	4	navigated	navigate	VBN
cord-327697-80msva10	23	5	this	this	DT
cord-327697-80msva10	23	6	ambiguity	ambiguity	NN
cord-327697-80msva10	23	7	by	by	IN
cord-327697-80msva10	23	8	recommending	recommend	VBG
cord-327697-80msva10	23	9	that	that	IN
cord-327697-80msva10	23	10	patients	patient	NNS
cord-327697-80msva10	23	11	should	should	MD
cord-327697-80msva10	23	12	continue	continue	VB
cord-327697-80msva10	23	13	to	to	TO
cord-327697-80msva10	23	14	use	use	VB
cord-327697-80msva10	23	15	ACE	ace	NN
cord-327697-80msva10	23	16	inhibitors	inhibitor	NNS
cord-327697-80msva10	23	17	or	or	CC
cord-327697-80msva10	23	18	ARBs	arb	NNS
cord-327697-80msva10	23	19	[	[	-LRB-
cord-327697-80msva10	23	20	10	10	CD
cord-327697-80msva10	23	21	]	]	-RRB-
cord-327697-80msva10	23	22	.	.	.
cord-327697-80msva10	24	1	However	however	RB
cord-327697-80msva10	24	2	,	,	,
cord-327697-80msva10	24	3	these	these	DT
cord-327697-80msva10	24	4	recommendations	recommendation	NNS
cord-327697-80msva10	24	5	have	have	VBP
cord-327697-80msva10	24	6	not	not	RB
cord-327697-80msva10	24	7	been	be	VBN
cord-327697-80msva10	24	8	supported	support	VBN
cord-327697-80msva10	24	9	by	by	IN
cord-327697-80msva10	24	10	medical	medical	JJ
cord-327697-80msva10	24	11	data	datum	NNS
cord-327697-80msva10	24	12	.	.	.
cord-327697-80msva10	25	1	In	in	IN
cord-327697-80msva10	25	2	consequence	consequence	NN
cord-327697-80msva10	25	3	,	,	,
cord-327697-80msva10	25	4	the	the	DT
cord-327697-80msva10	25	5	clinical	clinical	JJ
cord-327697-80msva10	25	6	decision	decision	NN
cord-327697-80msva10	25	7	-	-	HYPH
cord-327697-80msva10	25	8	making	making	NN
cord-327697-80msva10	25	9	process	process	NN
cord-327697-80msva10	25	10	has	have	VBZ
cord-327697-80msva10	25	11	become	become	VBN
cord-327697-80msva10	25	12	even	even	RB
cord-327697-80msva10	25	13	more	more	RBR
cord-327697-80msva10	25	14	difficult	difficult	JJ
cord-327697-80msva10	25	15	for	for	IN
cord-327697-80msva10	25	16	physicians	physician	NNS
cord-327697-80msva10	25	17	until	until	IN
cord-327697-80msva10	25	18	this	this	DT
cord-327697-80msva10	25	19	interaction	interaction	NN
cord-327697-80msva10	25	20	is	be	VBZ
cord-327697-80msva10	25	21	clarified	clarify	VBN
cord-327697-80msva10	25	22	with	with	IN
cord-327697-80msva10	25	23	robust	robust	JJ
cord-327697-80msva10	25	24	clinical	clinical	JJ
cord-327697-80msva10	25	25	data	datum	NNS
cord-327697-80msva10	25	26	.	.	.
cord-327697-80msva10	26	1	The	the	DT
cord-327697-80msva10	26	2	aim	aim	NN
cord-327697-80msva10	26	3	of	of	IN
cord-327697-80msva10	26	4	this	this	DT
cord-327697-80msva10	26	5	study	study	NN
cord-327697-80msva10	26	6	was	be	VBD
cord-327697-80msva10	26	7	to	to	TO
cord-327697-80msva10	26	8	assess	assess	VB
cord-327697-80msva10	26	9	the	the	DT
cord-327697-80msva10	26	10	behaviors	behavior	NNS
cord-327697-80msva10	26	11	of	of	IN
cord-327697-80msva10	26	12	physicians	physician	NNS
cord-327697-80msva10	26	13	toward	toward	IN
cord-327697-80msva10	26	14	prescribing	prescribe	VBG
cord-327697-80msva10	26	15	ACE	ACE	NNP
cord-327697-80msva10	26	16	-	-	HYPH
cord-327697-80msva10	26	17	i	i	NN
cord-327697-80msva10	26	18	/	/	SYM
cord-327697-80msva10	26	19	ARBs	arb	NNS
cord-327697-80msva10	26	20	treatment	treatment	NN
cord-327697-80msva10	26	21	during	during	IN
cord-327697-80msva10	26	22	the	the	DT
cord-327697-80msva10	26	23	COVID-19	covid-19	JJ
cord-327697-80msva10	26	24	pandemic	pandemic	NN
cord-327697-80msva10	26	25	to	to	TO
cord-327697-80msva10	26	26	determine	determine	VB
cord-327697-80msva10	26	27	if	if	IN
cord-327697-80msva10	26	28	physicians	physician	NNS
cord-327697-80msva10	26	29	had	have	VBD
cord-327697-80msva10	26	30	changed	change	VBN
cord-327697-80msva10	26	31	their	-PRON-	PRP$
cord-327697-80msva10	26	32	routine	routine	JJ
cord-327697-80msva10	26	33	treatment	treatment	NN
cord-327697-80msva10	26	34	algorithms	algorithm	NNS
cord-327697-80msva10	26	35	and	and	CC
cord-327697-80msva10	26	36	how	how	WRB
cord-327697-80msva10	26	37	they	-PRON-	PRP
cord-327697-80msva10	26	38	had	have	VBD
cord-327697-80msva10	26	39	been	be	VBN
cord-327697-80msva10	26	40	affected	affect	VBN
cord-327697-80msva10	26	41	by	by	IN
cord-327697-80msva10	26	42	these	these	DT
cord-327697-80msva10	26	43	speculations	speculation	NNS
cord-327697-80msva10	26	44	.	.	.
cord-327697-80msva10	27	1	This	this	DT
cord-327697-80msva10	27	2	cross	cross	JJ
cord-327697-80msva10	27	3	-	-	JJ
cord-327697-80msva10	27	4	sectional	sectional	JJ
cord-327697-80msva10	27	5	survey	survey	NN
cord-327697-80msva10	27	6	included	include	VBD
cord-327697-80msva10	27	7	cardiologists	cardiologist	NNS
cord-327697-80msva10	27	8	,	,	,
cord-327697-80msva10	27	9	internists	internist	NNS
cord-327697-80msva10	27	10	,	,	,
cord-327697-80msva10	27	11	and	and	CC
cord-327697-80msva10	27	12	family	family	NN
cord-327697-80msva10	27	13	physicians	physician	NNS
cord-327697-80msva10	27	14	responsible	responsible	JJ
cord-327697-80msva10	27	15	for	for	IN
cord-327697-80msva10	27	16	the	the	DT
cord-327697-80msva10	27	17	treatment	treatment	NN
cord-327697-80msva10	27	18	of	of	IN
cord-327697-80msva10	27	19	hypertension	hypertension	NN
cord-327697-80msva10	27	20	or	or	CC
cord-327697-80msva10	27	21	prescribing	prescribe	VBG
cord-327697-80msva10	27	22	antihypertensive	antihypertensive	JJ
cord-327697-80msva10	27	23	drugs	drug	NNS
cord-327697-80msva10	27	24	.	.	.
cord-327697-80msva10	28	1	The	the	DT
cord-327697-80msva10	28	2	study	study	NN
cord-327697-80msva10	28	3	was	be	VBD
cord-327697-80msva10	28	4	administered	administer	VBN
cord-327697-80msva10	28	5	in	in	IN
cord-327697-80msva10	28	6	six	six	CD
cord-327697-80msva10	28	7	metropolitan	metropolitan	JJ
cord-327697-80msva10	28	8	areas	area	NNS
cord-327697-80msva10	28	9	located	locate	VBN
cord-327697-80msva10	28	10	in	in	IN
cord-327697-80msva10	28	11	central	central	JJ
cord-327697-80msva10	28	12	and	and	CC
cord-327697-80msva10	28	13	western	western	JJ
cord-327697-80msva10	28	14	Turkey	Turkey	NNP
cord-327697-80msva10	28	15	,	,	,
cord-327697-80msva10	28	16	between	between	IN
cord-327697-80msva10	28	17	1	1	CD
cord-327697-80msva10	28	18	May	May	NNP
cord-327697-80msva10	28	19	and	and	CC
cord-327697-80msva10	28	20	19	19	CD
cord-327697-80msva10	28	21	May	May	NNP
cord-327697-80msva10	28	22	2020	2020	CD
cord-327697-80msva10	28	23	.	.	.
cord-327697-80msva10	29	1	The	the	DT
cord-327697-80msva10	29	2	hospitals	hospital	NNS
cord-327697-80msva10	29	3	and	and	CC
cord-327697-80msva10	29	4	family	family	NN
cord-327697-80msva10	29	5	health	health	NN
cord-327697-80msva10	29	6	centers	center	NNS
cord-327697-80msva10	29	7	from	from	IN
cord-327697-80msva10	29	8	the	the	DT
cord-327697-80msva10	29	9	mentioned	mention	VBN
cord-327697-80msva10	29	10	cities	city	NNS
cord-327697-80msva10	29	11	were	be	VBD
cord-327697-80msva10	29	12	selected	select	VBN
cord-327697-80msva10	29	13	according	accord	VBG
cord-327697-80msva10	29	14	to	to	IN
cord-327697-80msva10	29	15	their	-PRON-	PRP$
cord-327697-80msva10	29	16	COVID-19	covid-19	JJ
cord-327697-80msva10	29	17	patient	patient	NN
cord-327697-80msva10	29	18	loads	load	NNS
cord-327697-80msva10	29	19	.	.	.
cord-327697-80msva10	30	1	The	the	DT
cord-327697-80msva10	30	2	questionnaire	questionnaire	NN
cord-327697-80msva10	30	3	was	be	VBD
cord-327697-80msva10	30	4	developed	develop	VBN
cord-327697-80msva10	30	5	in	in	IN
cord-327697-80msva10	30	6	Turkish	Turkish	NNP
cord-327697-80msva10	30	7	by	by	IN
cord-327697-80msva10	30	8	an	an	DT
cord-327697-80msva10	30	9	expert	expert	NN
cord-327697-80msva10	30	10	committee	committee	NN
cord-327697-80msva10	30	11	including	include	VBG
cord-327697-80msva10	30	12	the	the	DT
cord-327697-80msva10	30	13	manuscript	manuscript	NN
cord-327697-80msva10	30	14	authors	author	NNS
cord-327697-80msva10	30	15	.	.	.
cord-327697-80msva10	31	1	Although	although	IN
cord-327697-80msva10	31	2	the	the	DT
cord-327697-80msva10	31	3	surveys	survey	NNS
cord-327697-80msva10	31	4	were	be	VBD
cord-327697-80msva10	31	5	not	not	RB
cord-327697-80msva10	31	6	formally	formally	RB
cord-327697-80msva10	31	7	validated	validate	VBN
cord-327697-80msva10	31	8	,	,	,
cord-327697-80msva10	31	9	the	the	DT
cord-327697-80msva10	31	10	development	development	NN
cord-327697-80msva10	31	11	process	process	NN
cord-327697-80msva10	31	12	involved	involve	VBD
cord-327697-80msva10	31	13	comprehensive	comprehensive	JJ
cord-327697-80msva10	31	14	reviewing	reviewing	NN
cord-327697-80msva10	31	15	and	and	CC
cord-327697-80msva10	31	16	piloting	piloting	NN
cord-327697-80msva10	31	17	of	of	IN
cord-327697-80msva10	31	18	the	the	DT
cord-327697-80msva10	31	19	surveys	survey	NNS
cord-327697-80msva10	31	20	.	.	.
cord-327697-80msva10	32	1	The	the	DT
cord-327697-80msva10	32	2	survey	survey	NN
cord-327697-80msva10	32	3	consisted	consist	VBD
cord-327697-80msva10	32	4	of	of	IN
cord-327697-80msva10	32	5	26	26	CD
cord-327697-80msva10	32	6	questions	question	NNS
cord-327697-80msva10	32	7	about	about	IN
cord-327697-80msva10	32	8	current	current	JJ
cord-327697-80msva10	32	9	hypertension	hypertension	NN
cord-327697-80msva10	32	10	treatment	treatment	NN
cord-327697-80msva10	32	11	behavior	behavior	NN
cord-327697-80msva10	32	12	with	with	IN
cord-327697-80msva10	32	13	ACE	ACE	NNP
cord-327697-80msva10	32	14	-	-	HYPH
cord-327697-80msva10	32	15	i	i	PRP
cord-327697-80msva10	32	16	and	and	CC
cord-327697-80msva10	32	17	ARBs	arb	NNS
cord-327697-80msva10	32	18	during	during	IN
cord-327697-80msva10	32	19	the	the	DT
cord-327697-80msva10	32	20	COVID-19	COVID-19	NNP
cord-327697-80msva10	32	21	pandemic	pandemic	NN
cord-327697-80msva10	32	22	.	.	.
cord-327697-80msva10	33	1	Physicians	physician	NNS
cord-327697-80msva10	33	2	who	who	WP
cord-327697-80msva10	33	3	were	be	VBD
cord-327697-80msva10	33	4	responsible	responsible	JJ
cord-327697-80msva10	33	5	for	for	IN
cord-327697-80msva10	33	6	the	the	DT
cord-327697-80msva10	33	7	treatment	treatment	NN
cord-327697-80msva10	33	8	of	of	IN
cord-327697-80msva10	33	9	at	at	RB
cord-327697-80msva10	33	10	least	least	RBS
cord-327697-80msva10	33	11	30	30	CD
cord-327697-80msva10	33	12	patients	patient	NNS
cord-327697-80msva10	33	13	with	with	IN
cord-327697-80msva10	33	14	hypertension	hypertension	NN
cord-327697-80msva10	33	15	per	per	IN
cord-327697-80msva10	33	16	month	month	NN
cord-327697-80msva10	33	17	were	be	VBD
cord-327697-80msva10	33	18	invited	invite	VBN
cord-327697-80msva10	33	19	to	to	TO
cord-327697-80msva10	33	20	participate	participate	VB
cord-327697-80msva10	33	21	in	in	IN
cord-327697-80msva10	33	22	the	the	DT
cord-327697-80msva10	33	23	survey	survey	NN
cord-327697-80msva10	33	24	by	by	IN
cord-327697-80msva10	33	25	phone	phone	NN
cord-327697-80msva10	33	26	or	or	CC
cord-327697-80msva10	33	27	e	e	NN
cord-327697-80msva10	33	28	-	-	NN
cord-327697-80msva10	33	29	mail	mail	NN
cord-327697-80msva10	33	30	.	.	.
cord-327697-80msva10	34	1	The	the	DT
cord-327697-80msva10	34	2	survey	survey	NN
cord-327697-80msva10	34	3	was	be	VBD
cord-327697-80msva10	34	4	delivered	deliver	VBN
cord-327697-80msva10	34	5	as	as	IN
cord-327697-80msva10	34	6	an	an	DT
cord-327697-80msva10	34	7	online	online	JJ
cord-327697-80msva10	34	8	form	form	NN
cord-327697-80msva10	34	9	and	and	CC
cord-327697-80msva10	34	10	responses	response	NNS
cord-327697-80msva10	34	11	were	be	VBD
cord-327697-80msva10	34	12	submitted	submit	VBN
cord-327697-80msva10	34	13	online	online	RB
cord-327697-80msva10	34	14	.	.	.
cord-327697-80msva10	35	1	The	the	DT
cord-327697-80msva10	35	2	study	study	NN
cord-327697-80msva10	35	3	was	be	VBD
cord-327697-80msva10	35	4	approved	approve	VBN
cord-327697-80msva10	35	5	by	by	IN
cord-327697-80msva10	35	6	the	the	DT
cord-327697-80msva10	35	7	Ethics	Ethics	NNP
cord-327697-80msva10	35	8	Committee	Committee	NNP
cord-327697-80msva10	35	9	of	of	IN
cord-327697-80msva10	35	10	Izmir	Izmir	NNP
cord-327697-80msva10	35	11	Tepecik	Tepecik	NNP
cord-327697-80msva10	35	12	Training	Training	NNP
cord-327697-80msva10	35	13	and	and	CC
cord-327697-80msva10	35	14	Research	Research	NNP
cord-327697-80msva10	35	15	Hospital	Hospital	NNP
cord-327697-80msva10	35	16	(	(	-LRB-
cord-327697-80msva10	35	17	approval	approval	NN
cord-327697-80msva10	35	18	number	number	NN
cord-327697-80msva10	35	19	2020/	2020/	CD
cord-327697-80msva10	35	20	6	6	CD
cord-327697-80msva10	35	21	-	-	SYM
cord-327697-80msva10	35	22	11	11	CD
cord-327697-80msva10	35	23	)	)	-RRB-
cord-327697-80msva10	35	24	.	.	.
cord-327697-80msva10	36	1	The	the	DT
cord-327697-80msva10	36	2	sample	sample	NN
cord-327697-80msva10	36	3	size	size	NN
cord-327697-80msva10	36	4	was	be	VBD
cord-327697-80msva10	36	5	calculated	calculate	VBN
cord-327697-80msva10	36	6	to	to	TO
cord-327697-80msva10	36	7	be	be	VB
cord-327697-80msva10	36	8	213	213	CD
cord-327697-80msva10	36	9	to	to	TO
cord-327697-80msva10	36	10	provide	provide	VB
cord-327697-80msva10	36	11	80	80	CD
cord-327697-80msva10	36	12	%	%	NN
cord-327697-80msva10	36	13	power	power	NN
cord-327697-80msva10	36	14	with	with	IN
cord-327697-80msva10	36	15	an	an	DT
cord-327697-80msva10	36	16	effect	effect	NN
cord-327697-80msva10	36	17	size	size	NN
cord-327697-80msva10	36	18	of	of	IN
cord-327697-80msva10	36	19	0.5	0.5	CD
cord-327697-80msva10	36	20	at	at	IN
cord-327697-80msva10	36	21	an	an	DT
cord-327697-80msva10	36	22	alpha	alpha	NN
cord-327697-80msva10	36	23	of	of	IN
cord-327697-80msva10	36	24	0.05	0.05	CD
cord-327697-80msva10	36	25	using	use	VBG
cord-327697-80msva10	36	26	open	open	JJ
cord-327697-80msva10	36	27	source	source	NN
cord-327697-80msva10	36	28	software	software	NN
cord-327697-80msva10	36	29	,	,	,
cord-327697-80msva10	36	30	Open	Open	NNP
cord-327697-80msva10	36	31	-	-	HYPH
cord-327697-80msva10	36	32	epi	epi	NNP
cord-327697-80msva10	36	33	Version	Version	NNP
cord-327697-80msva10	36	34	3.01	3.01	CD
cord-327697-80msva10	36	35	.	.	.
cord-327697-80msva10	37	1	A	a	DT
cord-327697-80msva10	37	2	convenience	convenience	NN
cord-327697-80msva10	37	3	sample	sample	NN
cord-327697-80msva10	37	4	of	of	IN
cord-327697-80msva10	37	5	460	460	CD
cord-327697-80msva10	37	6	physicians	physician	NNS
cord-327697-80msva10	37	7	was	be	VBD
cord-327697-80msva10	37	8	approached	approach	VBN
cord-327697-80msva10	37	9	by	by	IN
cord-327697-80msva10	37	10	phone	phone	NN
cord-327697-80msva10	37	11	or	or	CC
cord-327697-80msva10	37	12	e	e	NN
cord-327697-80msva10	37	13	-	-	NN
cord-327697-80msva10	37	14	mail	mail	NN
cord-327697-80msva10	37	15	at	at	IN
cord-327697-80msva10	37	16	hospital	hospital	NN
cord-327697-80msva10	37	17	and	and	CC
cord-327697-80msva10	37	18	family	family	NN
cord-327697-80msva10	37	19	health	health	NN
cord-327697-80msva10	37	20	centers	center	NNS
cord-327697-80msva10	37	21	in	in	IN
cord-327697-80msva10	37	22	central	central	JJ
cord-327697-80msva10	37	23	and	and	CC
cord-327697-80msva10	37	24	western	western	JJ
cord-327697-80msva10	37	25	Turkey	Turkey	NNP
cord-327697-80msva10	37	26	.	.	.
cord-327697-80msva10	38	1	A	a	DT
cord-327697-80msva10	38	2	total	total	NN
cord-327697-80msva10	38	3	of	of	IN
cord-327697-80msva10	38	4	232	232	CD
cord-327697-80msva10	38	5	physicians	physician	NNS
cord-327697-80msva10	38	6	completed	complete	VBD
cord-327697-80msva10	38	7	the	the	DT
cord-327697-80msva10	38	8	survey	survey	NN
cord-327697-80msva10	38	9	,	,	,
cord-327697-80msva10	38	10	presenting	present	VBG
cord-327697-80msva10	38	11	a	a	DT
cord-327697-80msva10	38	12	response	response	NN
cord-327697-80msva10	38	13	rate	rate	NN
cord-327697-80msva10	38	14	of	of	IN
cord-327697-80msva10	38	15	50.4	50.4	CD
cord-327697-80msva10	38	16	%	%	NN
cord-327697-80msva10	38	17	.	.	.
cord-327697-80msva10	39	1	Data	datum	NNS
cord-327697-80msva10	39	2	obtained	obtain	VBN
cord-327697-80msva10	39	3	in	in	IN
cord-327697-80msva10	39	4	the	the	DT
cord-327697-80msva10	39	5	study	study	NN
cord-327697-80msva10	39	6	were	be	VBD
cord-327697-80msva10	39	7	analyzed	analyze	VBN
cord-327697-80msva10	39	8	statistically	statistically	RB
cord-327697-80msva10	39	9	using	use	VBG
cord-327697-80msva10	39	10	SPSS	SPSS	NNP
cord-327697-80msva10	39	11	for	for	IN
cord-327697-80msva10	39	12	Windows	Windows	NNP
cord-327697-80msva10	39	13	Version	Version	NNP
cord-327697-80msva10	39	14	15.0	15.0	CD
cord-327697-80msva10	39	15	software	software	NN
cord-327697-80msva10	39	16	(	(	-LRB-
cord-327697-80msva10	39	17	SPSS	SPSS	NNP
cord-327697-80msva10	39	18	Inc.	Inc.	NNP
cord-327697-80msva10	39	19	,	,	,
cord-327697-80msva10	39	20	Chicago	Chicago	NNP
cord-327697-80msva10	39	21	,	,	,
cord-327697-80msva10	39	22	IL	IL	NNP
cord-327697-80msva10	39	23	,	,	,
cord-327697-80msva10	39	24	USA	USA	NNP
cord-327697-80msva10	39	25	)	)	-RRB-
cord-327697-80msva10	39	26	.	.	.
cord-327697-80msva10	40	1	Descriptive	descriptive	JJ
cord-327697-80msva10	40	2	statistics	statistic	NNS
cord-327697-80msva10	40	3	were	be	VBD
cord-327697-80msva10	40	4	presented	present	VBN
cord-327697-80msva10	40	5	using	use	VBG
cord-327697-80msva10	40	6	tables	table	NNS
cord-327697-80msva10	40	7	of	of	IN
cord-327697-80msva10	40	8	frequencies	frequency	NNS
cord-327697-80msva10	40	9	for	for	IN
cord-327697-80msva10	40	10	the	the	DT
cord-327697-80msva10	40	11	ordinal	ordinal	JJ
cord-327697-80msva10	40	12	variables	variable	NNS
cord-327697-80msva10	40	13	and	and	CC
cord-327697-80msva10	40	14	median	median	NN
cord-327697-80msva10	40	15	and	and	CC
cord-327697-80msva10	40	16	interquartile	interquartile	JJ
cord-327697-80msva10	40	17	range	range	NN
cord-327697-80msva10	40	18	values	value	NNS
cord-327697-80msva10	40	19	for	for	IN
cord-327697-80msva10	40	20	the	the	DT
cord-327697-80msva10	40	21	appropriate	appropriate	JJ
cord-327697-80msva10	40	22	variables	variable	NNS
cord-327697-80msva10	40	23	.	.	.
cord-327697-80msva10	41	1	The	the	DT
cord-327697-80msva10	41	2	primary	primary	JJ
cord-327697-80msva10	41	3	outcome	outcome	NN
cord-327697-80msva10	41	4	was	be	VBD
cord-327697-80msva10	41	5	the	the	DT
cord-327697-80msva10	41	6	proportion	proportion	NN
cord-327697-80msva10	41	7	of	of	IN
cord-327697-80msva10	41	8	subjects	subject	NNS
cord-327697-80msva10	41	9	changing	change	VBG
cord-327697-80msva10	41	10	the	the	DT
cord-327697-80msva10	41	11	prescribing	prescribing	NN
cord-327697-80msva10	41	12	pattern	pattern	NN
cord-327697-80msva10	41	13	of	of	IN
cord-327697-80msva10	41	14	RAAS	RAAS	NNP
cord-327697-80msva10	41	15	blockers	blocker	NNS
cord-327697-80msva10	41	16	.	.	.
cord-327697-80msva10	42	1	The	the	DT
cord-327697-80msva10	42	2	Pearson	Pearson	NNP
cord-327697-80msva10	42	3	χ2	χ2	NNP
cord-327697-80msva10	42	4	test	test	NN
cord-327697-80msva10	42	5	was	be	VBD
cord-327697-80msva10	42	6	used	use	VBN
cord-327697-80msva10	42	7	to	to	TO
cord-327697-80msva10	42	8	identify	identify	VB
cord-327697-80msva10	42	9	significant	significant	JJ
cord-327697-80msva10	42	10	relationships	relationship	NNS
cord-327697-80msva10	42	11	between	between	IN
cord-327697-80msva10	42	12	categorical	categorical	JJ
cord-327697-80msva10	42	13	variables	variable	NNS
cord-327697-80msva10	42	14	.	.	.
cord-327697-80msva10	43	1	To	to	TO
cord-327697-80msva10	43	2	determine	determine	VB
cord-327697-80msva10	43	3	whether	whether	IN
cord-327697-80msva10	43	4	physician	physician	NN
cord-327697-80msva10	43	5	specialist	specialist	NN
cord-327697-80msva10	43	6	training	training	NN
cord-327697-80msva10	43	7	contributed	contribute	VBD
cord-327697-80msva10	43	8	to	to	IN
cord-327697-80msva10	43	9	the	the	DT
cord-327697-80msva10	43	10	behaviors	behavior	NNS
cord-327697-80msva10	43	11	of	of	IN
cord-327697-80msva10	43	12	hypertension	hypertension	NN
cord-327697-80msva10	43	13	treatment	treatment	NN
cord-327697-80msva10	43	14	,	,	,
cord-327697-80msva10	43	15	the	the	DT
cord-327697-80msva10	43	16	physicians	physician	NNS
cord-327697-80msva10	43	17	were	be	VBD
cord-327697-80msva10	43	18	separated	separate	VBN
cord-327697-80msva10	43	19	into	into	IN
cord-327697-80msva10	43	20	three	three	CD
cord-327697-80msva10	43	21	groups	group	NNS
cord-327697-80msva10	43	22	based	base	VBN
cord-327697-80msva10	43	23	on	on	IN
cord-327697-80msva10	43	24	their	-PRON-	PRP$
cord-327697-80msva10	43	25	specialist	specialist	JJ
cord-327697-80msva10	43	26	area	area	NN
cord-327697-80msva10	43	27	(	(	-LRB-
cord-327697-80msva10	43	28	family	family	NN
cord-327697-80msva10	43	29	medicine	medicine	NN
cord-327697-80msva10	43	30	,	,	,
cord-327697-80msva10	43	31	Internal	internal	JJ
cord-327697-80msva10	43	32	medicine	medicine	NN
cord-327697-80msva10	43	33	,	,	,
cord-327697-80msva10	43	34	and	and	CC
cord-327697-80msva10	43	35	cardiology	cardiology	NN
cord-327697-80msva10	43	36	)	)	-RRB-
cord-327697-80msva10	43	37	.	.	.
cord-327697-80msva10	44	1	The	the	DT
cord-327697-80msva10	44	2	Kruskal	Kruskal	NNP
cord-327697-80msva10	44	3	-	-	HYPH
cord-327697-80msva10	44	4	Wallis	Wallis	NNP
cord-327697-80msva10	44	5	test	test	NN
cord-327697-80msva10	44	6	was	be	VBD
cord-327697-80msva10	44	7	used	use	VBN
cord-327697-80msva10	44	8	to	to	TO
cord-327697-80msva10	44	9	assess	assess	VB
cord-327697-80msva10	44	10	differences	difference	NNS
cord-327697-80msva10	44	11	between	between	IN
cord-327697-80msva10	44	12	specialists	specialist	NNS
cord-327697-80msva10	44	13	in	in	IN
cord-327697-80msva10	44	14	attitudes	attitude	NNS
cord-327697-80msva10	44	15	and	and	CC
cord-327697-80msva10	44	16	behaviors	behavior	NNS
cord-327697-80msva10	44	17	about	about	IN
cord-327697-80msva10	44	18	hypertension	hypertension	NN
cord-327697-80msva10	44	19	treatment	treatment	NN
cord-327697-80msva10	44	20	and	and	CC
cord-327697-80msva10	44	21	to	to	TO
cord-327697-80msva10	44	22	assess	assess	VB
cord-327697-80msva10	44	23	multiple	multiple	JJ
cord-327697-80msva10	44	24	group	group	NN
cord-327697-80msva10	44	25	comparisons	comparison	NNS
cord-327697-80msva10	44	26	for	for	IN
cord-327697-80msva10	44	27	ordinal	ordinal	JJ
cord-327697-80msva10	44	28	variables	variable	NNS
cord-327697-80msva10	44	29	.	.	.
cord-327697-80msva10	45	1	Bonferroni	bonferroni	JJ
cord-327697-80msva10	45	2	correction	correction	NN
cord-327697-80msva10	45	3	was	be	VBD
cord-327697-80msva10	45	4	performed	perform	VBN
cord-327697-80msva10	45	5	to	to	TO
cord-327697-80msva10	45	6	adjust	adjust	VB
cord-327697-80msva10	45	7	for	for	IN
cord-327697-80msva10	45	8	multiple	multiple	JJ
cord-327697-80msva10	45	9	group	group	NN
cord-327697-80msva10	45	10	comparisons	comparison	NNS
cord-327697-80msva10	45	11	.	.	.
cord-327697-80msva10	46	1	A	a	DT
cord-327697-80msva10	46	2	value	value	NN
cord-327697-80msva10	46	3	of	of	IN
cord-327697-80msva10	46	4	p	p	NN
cord-327697-80msva10	46	5	<	<	XX
cord-327697-80msva10	46	6	0.05	0.05	CD
cord-327697-80msva10	46	7	was	be	VBD
cord-327697-80msva10	46	8	considered	consider	VBN
cord-327697-80msva10	46	9	statistically	statistically	RB
cord-327697-80msva10	46	10	significant	significant	JJ
cord-327697-80msva10	46	11	.	.	.
cord-327697-80msva10	47	1	A	a	DT
cord-327697-80msva10	47	2	total	total	NN
cord-327697-80msva10	47	3	of	of	IN
cord-327697-80msva10	47	4	232	232	CD
cord-327697-80msva10	47	5	physicians	physician	NNS
cord-327697-80msva10	47	6	completed	complete	VBD
cord-327697-80msva10	47	7	the	the	DT
cord-327697-80msva10	47	8	survey	survey	NN
cord-327697-80msva10	47	9	in	in	IN
cord-327697-80msva10	47	10	the	the	DT
cord-327697-80msva10	47	11	defined	define	VBN
cord-327697-80msva10	47	12	study	study	NN
cord-327697-80msva10	47	13	period	period	NN
cord-327697-80msva10	47	14	and	and	CC
cord-327697-80msva10	47	15	220	220	CD
cord-327697-80msva10	47	16	physicians	physician	NNS
cord-327697-80msva10	47	17	(	(	-LRB-
cord-327697-80msva10	47	18	142	142	CD
cord-327697-80msva10	47	19	male	male	NN
cord-327697-80msva10	47	20	,	,	,
cord-327697-80msva10	47	21	78	78	CD
cord-327697-80msva10	47	22	female	female	NN
cord-327697-80msva10	47	23	)	)	-RRB-
cord-327697-80msva10	47	24	gave	give	VBD
cord-327697-80msva10	47	25	permission	permission	NN
cord-327697-80msva10	47	26	for	for	IN
cord-327697-80msva10	47	27	the	the	DT
cord-327697-80msva10	47	28	data	datum	NNS
cord-327697-80msva10	47	29	retrieved	retrieve	VBN
cord-327697-80msva10	47	30	from	from	IN
cord-327697-80msva10	47	31	the	the	DT
cord-327697-80msva10	47	32	questionnaire	questionnaire	NN
cord-327697-80msva10	47	33	to	to	TO
cord-327697-80msva10	47	34	be	be	VB
cord-327697-80msva10	47	35	analyzed	analyze	VBN
cord-327697-80msva10	47	36	within	within	IN
cord-327697-80msva10	47	37	the	the	DT
cord-327697-80msva10	47	38	framework	framework	NN
cord-327697-80msva10	47	39	of	of	IN
cord-327697-80msva10	47	40	the	the	DT
cord-327697-80msva10	47	41	study	study	NN
cord-327697-80msva10	47	42	.	.	.
cord-327697-80msva10	48	1	A	a	DT
cord-327697-80msva10	48	2	total	total	NN
cord-327697-80msva10	48	3	of	of	IN
cord-327697-80msva10	48	4	12	12	CD
cord-327697-80msva10	48	5	physicians	physician	NNS
cord-327697-80msva10	48	6	were	be	VBD
cord-327697-80msva10	48	7	excluded	exclude	VBN
cord-327697-80msva10	48	8	from	from	IN
cord-327697-80msva10	48	9	the	the	DT
cord-327697-80msva10	48	10	study	study	NN
cord-327697-80msva10	48	11	as	as	IN
cord-327697-80msva10	48	12	they	-PRON-	PRP
cord-327697-80msva10	48	13	managed	manage	VBD
cord-327697-80msva10	48	14	<	<	XX
cord-327697-80msva10	48	15	30	30	CD
cord-327697-80msva10	48	16	patients	patient	NNS
cord-327697-80msva10	48	17	with	with	IN
cord-327697-80msva10	48	18	hypertension	hypertension	NN
cord-327697-80msva10	48	19	per	per	IN
cord-327697-80msva10	48	20	month	month	NN
cord-327697-80msva10	48	21	.	.	.
cord-327697-80msva10	49	1	Most	Most	JJS
cord-327697-80msva10	49	2	of	of	IN
cord-327697-80msva10	49	3	the	the	DT
cord-327697-80msva10	49	4	participants	participant	NNS
cord-327697-80msva10	49	5	(	(	-LRB-
cord-327697-80msva10	49	6	63.2	63.2	CD
cord-327697-80msva10	49	7	%	%	NN
cord-327697-80msva10	49	8	)	)	-RRB-
cord-327697-80msva10	49	9	were	be	VBD
cord-327697-80msva10	49	10	aged	age	VBN
cord-327697-80msva10	49	11	<	<	XX
cord-327697-80msva10	49	12	40	40	CD
cord-327697-80msva10	49	13	years	year	NNS
cord-327697-80msva10	49	14	and	and	CC
cord-327697-80msva10	50	1	12.8	12.8	CD
cord-327697-80msva10	50	2	%	%	NN
cord-327697-80msva10	50	3	of	of	IN
cord-327697-80msva10	50	4	them	-PRON-	PRP
cord-327697-80msva10	50	5	were	be	VBD
cord-327697-80msva10	50	6	>	>	XX
cord-327697-80msva10	50	7	50	50	CD
cord-327697-80msva10	50	8	years	year	NNS
cord-327697-80msva10	50	9	of	of	IN
cord-327697-80msva10	50	10	age	age	NN
cord-327697-80msva10	50	11	.	.	.
cord-327697-80msva10	51	1	Nearly	nearly	RB
cord-327697-80msva10	51	2	half	half	NN
cord-327697-80msva10	51	3	of	of	IN
cord-327697-80msva10	51	4	the	the	DT
cord-327697-80msva10	51	5	physicians	physician	NNS
cord-327697-80msva10	51	6	participating	participate	VBG
cord-327697-80msva10	51	7	in	in	IN
cord-327697-80msva10	51	8	the	the	DT
cord-327697-80msva10	51	9	survey	survey	NN
cord-327697-80msva10	51	10	were	be	VBD
cord-327697-80msva10	52	1	cardiologists	cardiologist	NNS
cord-327697-80msva10	52	2	(	(	-LRB-
cord-327697-80msva10	52	3	n	n	NN
cord-327697-80msva10	52	4	=	=	SYM
cord-327697-80msva10	52	5	88	88	CD
cord-327697-80msva10	52	6	,	,	,
cord-327697-80msva10	52	7	40	40	CD
cord-327697-80msva10	52	8	%	%	NN
cord-327697-80msva10	52	9	)	)	-RRB-
cord-327697-80msva10	52	10	71	71	CD
cord-327697-80msva10	52	11	(	(	-LRB-
cord-327697-80msva10	52	12	32.3	32.3	CD
cord-327697-80msva10	52	13	%	%	NN
cord-327697-80msva10	52	14	)	)	-RRB-
cord-327697-80msva10	52	15	were	be	VBD
cord-327697-80msva10	52	16	family	family	NN
cord-327697-80msva10	52	17	medicine/	medicine/	CD
cord-327697-80msva10	52	18	general	general	JJ
cord-327697-80msva10	52	19	practitioners	practitioner	NNS
cord-327697-80msva10	52	20	and	and	CC
cord-327697-80msva10	52	21	61	61	CD
cord-327697-80msva10	52	22	(	(	-LRB-
cord-327697-80msva10	52	23	27.7	27.7	CD
cord-327697-80msva10	52	24	%	%	NN
cord-327697-80msva10	52	25	)	)	-RRB-
cord-327697-80msva10	52	26	were	be	VBD
cord-327697-80msva10	52	27	internal	internal	JJ
cord-327697-80msva10	52	28	medicine	medicine	NN
cord-327697-80msva10	52	29	specialists	specialist	NNS
cord-327697-80msva10	52	30	.	.	.
cord-327697-80msva10	53	1	Of	of	IN
cord-327697-80msva10	53	2	the	the	DT
cord-327697-80msva10	53	3	physicians	physician	NNS
cord-327697-80msva10	53	4	,	,	,
cord-327697-80msva10	53	5	111	111	CD
cord-327697-80msva10	53	6	(	(	-LRB-
cord-327697-80msva10	53	7	50.4	50.4	CD
cord-327697-80msva10	53	8	%	%	NN
cord-327697-80msva10	53	9	)	)	-RRB-
cord-327697-80msva10	53	10	were	be	VBD
cord-327697-80msva10	53	11	working	work	VBG
cord-327697-80msva10	53	12	in	in	IN
cord-327697-80msva10	53	13	tertiary	tertiary	JJ
cord-327697-80msva10	53	14	level	level	NN
cord-327697-80msva10	53	15	healthcare	healthcare	NN
cord-327697-80msva10	53	16	centers	center	NNS
cord-327697-80msva10	53	17	(	(	-LRB-
cord-327697-80msva10	53	18	University	University	NNP
cord-327697-80msva10	53	19	/	/	SYM
cord-327697-80msva10	53	20	Training	Training	NNP
cord-327697-80msva10	53	21	and	and	CC
cord-327697-80msva10	53	22	research	research	NN
cord-327697-80msva10	53	23	hospital	hospital	NN
cord-327697-80msva10	53	24	)	)	-RRB-
cord-327697-80msva10	53	25	.	.	.
cord-327697-80msva10	54	1	In	in	IN
cord-327697-80msva10	54	2	respect	respect	NN
cord-327697-80msva10	54	3	of	of	IN
cord-327697-80msva10	54	4	experience	experience	NN
cord-327697-80msva10	54	5	,	,	,
cord-327697-80msva10	54	6	half	half	NN
cord-327697-80msva10	54	7	of	of	IN
cord-327697-80msva10	54	8	the	the	DT
cord-327697-80msva10	54	9	participants	participant	NNS
cord-327697-80msva10	54	10	(	(	-LRB-
cord-327697-80msva10	54	11	53	53	CD
cord-327697-80msva10	54	12	%	%	NN
cord-327697-80msva10	54	13	)	)	-RRB-
cord-327697-80msva10	54	14	had	have	VBD
cord-327697-80msva10	54	15	>	>	VBN
cord-327697-80msva10	54	16	10	10	CD
cord-327697-80msva10	54	17	years	year	NNS
cord-327697-80msva10	54	18	of	of	IN
cord-327697-80msva10	54	19	experience	experience	NN
cord-327697-80msva10	54	20	in	in	IN
cord-327697-80msva10	54	21	practice	practice	NN
cord-327697-80msva10	55	1	(	(	-LRB-
cord-327697-80msva10	55	2	Table	table	NN
cord-327697-80msva10	55	3	1	1	CD
cord-327697-80msva10	55	4	)	)	-RRB-
cord-327697-80msva10	55	5	.	.	.
cord-327697-80msva10	56	1	Of	of	IN
cord-327697-80msva10	56	2	the	the	DT
cord-327697-80msva10	56	3	total	total	JJ
cord-327697-80msva10	56	4	physicians	physician	NNS
cord-327697-80msva10	56	5	in	in	IN
cord-327697-80msva10	56	6	the	the	DT
cord-327697-80msva10	56	7	study	study	NN
cord-327697-80msva10	56	8	,	,	,
cord-327697-80msva10	56	9	65	65	CD
cord-327697-80msva10	56	10	%	%	NN
cord-327697-80msva10	56	11	described	describe	VBD
cord-327697-80msva10	56	12	themselves	-PRON-	PRP
cord-327697-80msva10	56	13	as	as	IN
cord-327697-80msva10	56	14	having	have	VBG
cord-327697-80msva10	56	15	a	a	DT
cord-327697-80msva10	56	16	moderate	moderate	JJ
cord-327697-80msva10	56	17	to	to	IN
cord-327697-80msva10	56	18	high	high	JJ
cord-327697-80msva10	56	19	level	level	NN
cord-327697-80msva10	56	20	of	of	IN
cord-327697-80msva10	56	21	knowledge	knowledge	NN
cord-327697-80msva10	56	22	about	about	IN
cord-327697-80msva10	56	23	the	the	DT
cord-327697-80msva10	56	24	relationship	relationship	NN
cord-327697-80msva10	56	25	between	between	IN
cord-327697-80msva10	56	26	COVID-19	covid-19	DT
cord-327697-80msva10	56	27	infection	infection	NN
cord-327697-80msva10	56	28	and	and	CC
cord-327697-80msva10	56	29	ACE	ACE	NNP
cord-327697-80msva10	56	30	-	-	HYPH
cord-327697-80msva10	56	31	i	i	NN
cord-327697-80msva10	56	32	/	/	SYM
cord-327697-80msva10	56	33	ARBs	arb	NNS
cord-327697-80msva10	56	34	treatments	treatment	NNS
cord-327697-80msva10	56	35	and	and	CC
cord-327697-80msva10	56	36	16	16	CD
cord-327697-80msva10	56	37	%	%	NN
cord-327697-80msva10	56	38	of	of	IN
cord-327697-80msva10	56	39	the	the	DT
cord-327697-80msva10	56	40	study	study	NN
cord-327697-80msva10	56	41	population	population	NN
cord-327697-80msva10	56	42	stated	state	VBD
cord-327697-80msva10	56	43	that	that	IN
cord-327697-80msva10	56	44	they	-PRON-	PRP
cord-327697-80msva10	56	45	did	do	VBD
cord-327697-80msva10	56	46	not	not	RB
cord-327697-80msva10	56	47	have	have	VB
cord-327697-80msva10	56	48	enough	enough	JJ
cord-327697-80msva10	56	49	information	information	NN
cord-327697-80msva10	56	50	on	on	IN
cord-327697-80msva10	56	51	this	this	DT
cord-327697-80msva10	56	52	subject	subject	NN
cord-327697-80msva10	56	53	.	.	.
cord-327697-80msva10	57	1	The	the	DT
cord-327697-80msva10	57	2	sources	source	NNS
cord-327697-80msva10	57	3	of	of	IN
cord-327697-80msva10	57	4	information	information	NN
cord-327697-80msva10	57	5	showed	show	VBD
cord-327697-80msva10	57	6	variety	variety	NN
cord-327697-80msva10	57	7	but	but	CC
cord-327697-80msva10	57	8	83.9	83.9	CD
cord-327697-80msva10	57	9	%	%	NN
cord-327697-80msva10	57	10	of	of	IN
cord-327697-80msva10	57	11	the	the	DT
cord-327697-80msva10	57	12	physicians	physician	NNS
cord-327697-80msva10	57	13	were	be	VBD
cord-327697-80msva10	57	14	informed	inform	VBN
cord-327697-80msva10	57	15	from	from	IN
cord-327697-80msva10	57	16	at	at	RB
cord-327697-80msva10	57	17	least	least	RBS
cord-327697-80msva10	57	18	one	one	CD
cord-327697-80msva10	57	19	reliable	reliable	JJ
cord-327697-80msva10	57	20	academic	academic	JJ
cord-327697-80msva10	57	21	document	document	NN
cord-327697-80msva10	57	22	such	such	JJ
cord-327697-80msva10	57	23	as	as	IN
cord-327697-80msva10	57	24	reports	report	NNS
cord-327697-80msva10	57	25	of	of	IN
cord-327697-80msva10	57	26	scientific	scientific	JJ
cord-327697-80msva10	57	27	societies	society	NNS
cord-327697-80msva10	57	28	and	and	CC
cord-327697-80msva10	57	29	articles	article	NNS
cord-327697-80msva10	57	30	of	of	IN
cord-327697-80msva10	57	31	medical	medical	JJ
cord-327697-80msva10	57	32	journals	journal	NNS
cord-327697-80msva10	57	33	.	.	.
cord-327697-80msva10	58	1	When	when	WRB
cord-327697-80msva10	58	2	the	the	DT
cord-327697-80msva10	58	3	respondents	respondent	NNS
cord-327697-80msva10	58	4	were	be	VBD
cord-327697-80msva10	58	5	asked	ask	VBN
cord-327697-80msva10	58	6	to	to	TO
cord-327697-80msva10	58	7	evaluate	evaluate	VB
cord-327697-80msva10	58	8	the	the	DT
cord-327697-80msva10	58	9	reliability	reliability	NN
cord-327697-80msva10	58	10	of	of	IN
cord-327697-80msva10	58	11	the	the	DT
cord-327697-80msva10	58	12	evidence	evidence	NN
cord-327697-80msva10	58	13	of	of	IN
cord-327697-80msva10	58	14	these	these	DT
cord-327697-80msva10	58	15	sources	source	NNS
cord-327697-80msva10	58	16	,	,	,
cord-327697-80msva10	58	17	84	84	CD
cord-327697-80msva10	58	18	%	%	NN
cord-327697-80msva10	58	19	stated	state	VBD
cord-327697-80msva10	58	20	that	that	IN
cord-327697-80msva10	58	21	the	the	DT
cord-327697-80msva10	58	22	reports	report	NNS
cord-327697-80msva10	58	23	were	be	VBD
cord-327697-80msva10	58	24	suspicious	suspicious	JJ
cord-327697-80msva10	58	25	/contradictory	/contradictory	.
cord-327697-80msva10	58	26	and	and	CC
cord-327697-80msva10	58	27	emphasized	emphasize	VBD
cord-327697-80msva10	58	28	that	that	IN
cord-327697-80msva10	58	29	new	new	JJ
cord-327697-80msva10	58	30	studies	study	NNS
cord-327697-80msva10	58	31	are	be	VBP
cord-327697-80msva10	58	32	needed	need	VBN
cord-327697-80msva10	58	33	.	.	.
cord-327697-80msva10	59	1	The	the	DT
cord-327697-80msva10	59	2	opinions	opinion	NNS
cord-327697-80msva10	59	3	of	of	IN
cord-327697-80msva10	59	4	the	the	DT
cord-327697-80msva10	59	5	physicians	physician	NNS
cord-327697-80msva10	59	6	about	about	IN
cord-327697-80msva10	59	7	the	the	DT
cord-327697-80msva10	59	8	relationship	relationship	NN
cord-327697-80msva10	59	9	between	between	IN
cord-327697-80msva10	59	10	COVID-19	covid-19	DT
cord-327697-80msva10	59	11	infection	infection	NN
cord-327697-80msva10	59	12	and	and	CC
cord-327697-80msva10	59	13	ACE	ACE	NNP
cord-327697-80msva10	59	14	-	-	HYPH
cord-327697-80msva10	59	15	i	i	NN
cord-327697-80msva10	59	16	/	/	SYM
cord-327697-80msva10	59	17	ARBs	arb	NNS
cord-327697-80msva10	59	18	treatments	treatment	NNS
cord-327697-80msva10	59	19	are	be	VBP
cord-327697-80msva10	59	20	shown	show	VBN
cord-327697-80msva10	59	21	in	in	IN
cord-327697-80msva10	59	22	Fig	Fig	NNP
cord-327697-80msva10	59	23	.	.	.
cord-327697-80msva10	60	1	1a	1a	LS
cord-327697-80msva10	60	2	.	.	.
cord-327697-80msva10	61	1	Requests	request	NNS
cord-327697-80msva10	61	2	from	from	IN
cord-327697-80msva10	61	3	patients	patient	NNS
cord-327697-80msva10	61	4	to	to	TO
cord-327697-80msva10	61	5	change	change	VB
cord-327697-80msva10	61	6	ACE	ACE	NNP
cord-327697-80msva10	61	7	-	-	HYPH
cord-327697-80msva10	61	8	i	i	NN
cord-327697-80msva10	61	9	/	/	SYM
cord-327697-80msva10	61	10	ARBs	arb	NNS
cord-327697-80msva10	61	11	treatment	treatment	NN
cord-327697-80msva10	61	12	during	during	IN
cord-327697-80msva10	61	13	the	the	DT
cord-327697-80msva10	61	14	pandemic	pandemic	NN
cord-327697-80msva10	61	15	were	be	VBD
cord-327697-80msva10	61	16	reported	report	VBN
cord-327697-80msva10	61	17	to	to	TO
cord-327697-80msva10	61	18	have	have	VB
cord-327697-80msva10	61	19	been	be	VBN
cord-327697-80msva10	61	20	received	receive	VBN
cord-327697-80msva10	61	21	by	by	IN
cord-327697-80msva10	61	22	65	65	CD
cord-327697-80msva10	61	23	%	%	NN
cord-327697-80msva10	61	24	(	(	-LRB-
cord-327697-80msva10	61	25	143/220	143/220	NNP
cord-327697-80msva10	61	26	)	)	-RRB-
cord-327697-80msva10	61	27	of	of	IN
cord-327697-80msva10	61	28	the	the	DT
cord-327697-80msva10	61	29	physicians	physician	NNS
cord-327697-80msva10	61	30	.	.	.
cord-327697-80msva10	62	1	Of	of	IN
cord-327697-80msva10	62	2	the	the	DT
cord-327697-80msva10	62	3	total	total	JJ
cord-327697-80msva10	62	4	physicians	physician	NNS
cord-327697-80msva10	62	5	,	,	,
cord-327697-80msva10	62	6	78.7	78.7	CD
cord-327697-80msva10	62	7	%	%	NN
cord-327697-80msva10	62	8	(	(	-LRB-
cord-327697-80msva10	62	9	173/220	173/220	NNP
cord-327697-80msva10	62	10	)	)	-RRB-
cord-327697-80msva10	62	11	advised	advise	VBD
cord-327697-80msva10	62	12	continuing	continue	VBG
cord-327697-80msva10	62	13	the	the	DT
cord-327697-80msva10	62	14	ACE	ACE	NNP
cord-327697-80msva10	62	15	-	-	HYPH
cord-327697-80msva10	62	16	i	i	NN
cord-327697-80msva10	62	17	/	/	SYM
cord-327697-80msva10	62	18	ARBs	arb	NNS
cord-327697-80msva10	62	19	medications	medication	NNS
cord-327697-80msva10	62	20	,	,	,
cord-327697-80msva10	62	21	12.7	12.7	CD
cord-327697-80msva10	62	22	%	%	NN
cord-327697-80msva10	62	23	(	(	-LRB-
cord-327697-80msva10	62	24	28/220	28/220	CD
cord-327697-80msva10	62	25	)	)	-RRB-
cord-327697-80msva10	62	26	left	leave	VBD
cord-327697-80msva10	62	27	the	the	DT
cord-327697-80msva10	62	28	decision	decision	NN
cord-327697-80msva10	62	29	to	to	IN
cord-327697-80msva10	62	30	the	the	DT
cord-327697-80msva10	62	31	patient	patient	NN
cord-327697-80msva10	62	32	,	,	,
cord-327697-80msva10	62	33	having	have	VBG
cord-327697-80msva10	62	34	explained	explain	VBN
cord-327697-80msva10	62	35	that	that	IN
cord-327697-80msva10	62	36	there	there	EX
cord-327697-80msva10	62	37	were	be	VBD
cord-327697-80msva10	62	38	conflicting	conflict	VBG
cord-327697-80msva10	62	39	views	view	NNS
cord-327697-80msva10	62	40	on	on	IN
cord-327697-80msva10	62	41	this	this	DT
cord-327697-80msva10	62	42	issue	issue	NN
cord-327697-80msva10	62	43	,	,	,
cord-327697-80msva10	62	44	and	and	CC
cord-327697-80msva10	62	45	8.6	8.6	CD
cord-327697-80msva10	62	46	%	%	NN
cord-327697-80msva10	62	47	(	(	-LRB-
cord-327697-80msva10	62	48	19/220	19/220	CD
cord-327697-80msva10	62	49	)	)	-RRB-
cord-327697-80msva10	62	50	discontinued	discontinue	VBD
cord-327697-80msva10	62	51	the	the	DT
cord-327697-80msva10	62	52	treatment	treatment	NN
cord-327697-80msva10	62	53	and	and	CC
cord-327697-80msva10	62	54	switched	switch	VBD
cord-327697-80msva10	62	55	to	to	IN
cord-327697-80msva10	62	56	another	another	DT
cord-327697-80msva10	62	57	drug	drug	NN
cord-327697-80msva10	62	58	.	.	.
cord-327697-80msva10	63	1	The	the	DT
cord-327697-80msva10	63	2	respondents	respondent	NNS
cord-327697-80msva10	63	3	were	be	VBD
cord-327697-80msva10	63	4	asked	ask	VBN
cord-327697-80msva10	63	5	to	to	TO
cord-327697-80msva10	63	6	score	score	VB
cord-327697-80msva10	63	7	their	-PRON-	PRP$
cord-327697-80msva10	63	8	level	level	NN
cord-327697-80msva10	63	9	of	of	IN
cord-327697-80msva10	63	10	reliance	reliance	NN
cord-327697-80msva10	63	11	of	of	IN
cord-327697-80msva10	63	12	ACE	ace	NN
cord-327697-80msva10	63	13	-	-	HYPH
cord-327697-80msva10	63	14	i	i	NN
cord-327697-80msva10	63	15	/	/	SYM
cord-327697-80msva10	63	16	ARBs	arb	NNS
cord-327697-80msva10	63	17	treatments	treatment	NNS
cord-327697-80msva10	63	18	in	in	IN
cord-327697-80msva10	63	19	different	different	JJ
cord-327697-80msva10	63	20	clinical	clinical	JJ
cord-327697-80msva10	63	21	conditions	condition	NNS
cord-327697-80msva10	63	22	on	on	IN
cord-327697-80msva10	63	23	a	a	DT
cord-327697-80msva10	63	24	10-point	10-point	JJ
cord-327697-80msva10	63	25	Likert	Likert	NNP
cord-327697-80msva10	63	26	scale	scale	NN
cord-327697-80msva10	63	27	from	from	IN
cord-327697-80msva10	63	28	1	1	CD
cord-327697-80msva10	63	29	to	to	IN
cord-327697-80msva10	63	30	10	10	CD
cord-327697-80msva10	63	31	.	.	.
cord-327697-80msva10	64	1	Questions	question	NNS
cord-327697-80msva10	64	2	were	be	VBD
cord-327697-80msva10	64	3	then	then	RB
cord-327697-80msva10	64	4	asked	ask	VBN
cord-327697-80msva10	64	5	to	to	TO
cord-327697-80msva10	64	6	ascertain	ascertain	VB
cord-327697-80msva10	64	7	the	the	DT
cord-327697-80msva10	64	8	probability	probability	NN
cord-327697-80msva10	64	9	of	of	IN
cord-327697-80msva10	64	10	the	the	DT
cord-327697-80msva10	64	11	physician	physician	NN
cord-327697-80msva10	64	12	beginning	beginning	NN
cord-327697-80msva10	64	13	and	and	CC
cord-327697-80msva10	64	14	repeating	repeat	VBG
cord-327697-80msva10	64	15	ACE	ace	NN
cord-327697-80msva10	64	16	-	-	HYPH
cord-327697-80msva10	64	17	i	i	NN
cord-327697-80msva10	64	18	/	/	SYM
cord-327697-80msva10	64	19	ARBs	arb	NNS
cord-327697-80msva10	64	20	treatment	treatment	NN
cord-327697-80msva10	64	21	during	during	IN
cord-327697-80msva10	64	22	the	the	DT
cord-327697-80msva10	64	23	COVID-19	COVID-19	NNP
cord-327697-80msva10	64	24	pandemic	pandemic	NN
cord-327697-80msva10	64	25	.	.	.
cord-327697-80msva10	65	1	These	these	DT
cord-327697-80msva10	65	2	items	item	NNS
cord-327697-80msva10	65	3	were	be	VBD
cord-327697-80msva10	65	4	also	also	RB
cord-327697-80msva10	65	5	scored	score	VBN
cord-327697-80msva10	65	6	using	use	VBG
cord-327697-80msva10	65	7	a	a	DT
cord-327697-80msva10	65	8	Likert	Likert	NNP
cord-327697-80msva10	65	9	scale	scale	NN
cord-327697-80msva10	65	10	.	.	.
cord-327697-80msva10	66	1	The	the	DT
cord-327697-80msva10	66	2	median	median	NN
cord-327697-80msva10	66	3	(	(	-LRB-
cord-327697-80msva10	66	4	±interquartile	±interquartile	JJ
cord-327697-80msva10	66	5	range	range	NN
cord-327697-80msva10	66	6	)	)	-RRB-
cord-327697-80msva10	66	7	score	score	NN
cord-327697-80msva10	66	8	indicating	indicate	VBG
cord-327697-80msva10	66	9	the	the	DT
cord-327697-80msva10	66	10	general	general	JJ
cord-327697-80msva10	66	11	reliance	reliance	NN
cord-327697-80msva10	66	12	level	level	NN
cord-327697-80msva10	66	13	of	of	IN
cord-327697-80msva10	66	14	physicians	physician	NNS
cord-327697-80msva10	66	15	in	in	IN
cord-327697-80msva10	66	16	ACE	ACE	NNP
cord-327697-80msva10	66	17	-	-	HYPH
cord-327697-80msva10	66	18	i	i	NN
cord-327697-80msva10	66	19	/	/	SYM
cord-327697-80msva10	66	20	ARBs	arb	NNS
cord-327697-80msva10	66	21	therapy	therapy	NN
cord-327697-80msva10	66	22	was	be	VBD
cord-327697-80msva10	66	23	8	8	CD
cord-327697-80msva10	66	24	±	±	CD
cord-327697-80msva10	66	25	4	4	CD
cord-327697-80msva10	66	26	and	and	CC
cord-327697-80msva10	66	27	for	for	IN
cord-327697-80msva10	66	28	the	the	DT
cord-327697-80msva10	66	29	trend	trend	NN
cord-327697-80msva10	66	30	to	to	TO
cord-327697-80msva10	66	31	start	start	VB
cord-327697-80msva10	66	32	new	new	JJ
cord-327697-80msva10	66	33	ACE	ace	NN
cord-327697-80msva10	66	34	-	-	HYPH
cord-327697-80msva10	66	35	i	i	NN
cord-327697-80msva10	66	36	/	/	SYM
cord-327697-80msva10	66	37	ARBs	arb	NNS
cord-327697-80msva10	66	38	therapy	therapy	NN
cord-327697-80msva10	66	39	was	be	VBD
cord-327697-80msva10	66	40	8	8	CD
cord-327697-80msva10	66	41	±	±	NNP
cord-327697-80msva10	66	42	4	4	CD
cord-327697-80msva10	66	43	.	.	.
cord-327697-80msva10	67	1	The	the	DT
cord-327697-80msva10	67	2	median	median	JJ
cord-327697-80msva10	67	3	score	score	NN
cord-327697-80msva10	67	4	indicating	indicate	VBG
cord-327697-80msva10	67	5	withholding	withhold	VBG
cord-327697-80msva10	67	6	the	the	DT
cord-327697-80msva10	67	7	current	current	JJ
cord-327697-80msva10	67	8	ACEi	ACEi	NNS
cord-327697-80msva10	67	9	/	/	SYM
cord-327697-80msva10	67	10	ARBs	arb	NNS
cord-327697-80msva10	67	11	therapy	therapy	NN
cord-327697-80msva10	67	12	was	be	VBD
cord-327697-80msva10	67	13	1	1	CD
cord-327697-80msva10	67	14	±	±	CD
cord-327697-80msva10	67	15	1	1	CD
cord-327697-80msva10	67	16	and	and	CC
cord-327697-80msva10	67	17	for	for	IN
cord-327697-80msva10	67	18	the	the	DT
cord-327697-80msva10	67	19	continuation	continuation	NN
cord-327697-80msva10	67	20	of	of	IN
cord-327697-80msva10	67	21	the	the	DT
cord-327697-80msva10	67	22	therapy	therapy	NN
cord-327697-80msva10	67	23	was	be	VBD
cord-327697-80msva10	67	24	9	9	CD
cord-327697-80msva10	67	25	±	±	CD
cord-327697-80msva10	67	26	1	1	CD
cord-327697-80msva10	68	1	(	(	-LRB-
cord-327697-80msva10	68	2	Fig	Fig	NNP
cord-327697-80msva10	68	3	.	.	NNP
cord-327697-80msva10	68	4	2	2	CD
cord-327697-80msva10	68	5	)	)	-RRB-
cord-327697-80msva10	68	6	.	.	.
cord-327697-80msva10	69	1	The	the	DT
cord-327697-80msva10	69	2	tendency	tendency	NN
cord-327697-80msva10	69	3	for	for	IN
cord-327697-80msva10	69	4	changing	change	VBG
cord-327697-80msva10	69	5	the	the	DT
cord-327697-80msva10	69	6	prescribing	prescribe	VBG
cord-327697-80msva10	69	7	patterns	pattern	NNS
cord-327697-80msva10	69	8	of	of	IN
cord-327697-80msva10	69	9	ACE	ace	NN
cord-327697-80msva10	69	10	-	-	HYPH
cord-327697-80msva10	69	11	i	i	NN
cord-327697-80msva10	69	12	/	/	SYM
cord-327697-80msva10	69	13	ARBs	arb	NNS
cord-327697-80msva10	69	14	treatment	treatment	NN
cord-327697-80msva10	69	15	in	in	IN
cord-327697-80msva10	69	16	different	different	JJ
cord-327697-80msva10	69	17	clinical	clinical	JJ
cord-327697-80msva10	69	18	conditions	condition	NNS
cord-327697-80msva10	69	19	,	,	,
cord-327697-80msva10	69	20	including	include	VBG
cord-327697-80msva10	69	21	coronary	coronary	JJ
cord-327697-80msva10	69	22	artery	artery	NN
cord-327697-80msva10	69	23	disease	disease	NN
cord-327697-80msva10	69	24	,	,	,
cord-327697-80msva10	69	25	heart	heart	NN
cord-327697-80msva10	69	26	failure	failure	NN
cord-327697-80msva10	69	27	,	,	,
cord-327697-80msva10	69	28	hypertension	hypertension	NN
cord-327697-80msva10	69	29	alone	alone	RB
cord-327697-80msva10	69	30	,	,	,
cord-327697-80msva10	69	31	and	and	CC
cord-327697-80msva10	69	32	multiple	multiple	JJ
cord-327697-80msva10	69	33	comorbidities	comorbiditie	NNS
cord-327697-80msva10	69	34	is	be	VBZ
cord-327697-80msva10	69	35	shown	show	VBN
cord-327697-80msva10	69	36	with	with	IN
cord-327697-80msva10	69	37	box	box	NN
cord-327697-80msva10	69	38	-	-	HYPH
cord-327697-80msva10	69	39	plot	plot	NN
cord-327697-80msva10	69	40	graphs	graph	NNS
cord-327697-80msva10	69	41	in	in	IN
cord-327697-80msva10	69	42	Fig	Fig	NNP
cord-327697-80msva10	69	43	.	.	.
cord-327697-80msva10	70	1	3	3	LS
cord-327697-80msva10	70	2	.	.	.
cord-327697-80msva10	71	1	Although	although	IN
cord-327697-80msva10	71	2	more	more	JJR
cord-327697-80msva10	71	3	than	than	IN
cord-327697-80msva10	71	4	half	half	NN
cord-327697-80msva10	71	5	of	of	IN
cord-327697-80msva10	71	6	the	the	DT
cord-327697-80msva10	71	7	specialists	specialist	NNS
cord-327697-80msva10	71	8	did	do	VBD
cord-327697-80msva10	71	9	not	not	RB
cord-327697-80msva10	71	10	believe	believe	VB
cord-327697-80msva10	71	11	there	there	EX
cord-327697-80msva10	71	12	was	be	VBD
cord-327697-80msva10	71	13	any	any	DT
cord-327697-80msva10	71	14	relationship	relationship	NN
cord-327697-80msva10	71	15	between	between	IN
cord-327697-80msva10	71	16	ACE	ace	NN
cord-327697-80msva10	71	17	-	-	HYPH
cord-327697-80msva10	71	18	i	i	NN
cord-327697-80msva10	71	19	/	/	SYM
cord-327697-80msva10	71	20	ARBs	arb	NNS
cord-327697-80msva10	71	21	use	use	VBP
cord-327697-80msva10	71	22	and	and	CC
cord-327697-80msva10	71	23	risk	risk	NN
cord-327697-80msva10	71	24	of	of	IN
cord-327697-80msva10	71	25	having	have	VBG
cord-327697-80msva10	71	26	COVID-19	COVID-19	NNP
cord-327697-80msva10	71	27	disease	disease	NN
cord-327697-80msva10	71	28	,	,	,
cord-327697-80msva10	71	29	only	only	RB
cord-327697-80msva10	71	30	one	one	CD
cord-327697-80msva10	71	31	-	-	HYPH
cord-327697-80msva10	71	32	third	third	NN
cord-327697-80msva10	71	33	of	of	IN
cord-327697-80msva10	71	34	the	the	DT
cord-327697-80msva10	71	35	assistant	assistant	JJ
cord-327697-80msva10	71	36	doctors	doctor	NNS
cord-327697-80msva10	71	37	/	/	SYM
cord-327697-80msva10	71	38	general	general	JJ
cord-327697-80msva10	71	39	practitioners	practitioner	NNS
cord-327697-80msva10	71	40	held	hold	VBD
cord-327697-80msva10	71	41	these	these	DT
cord-327697-80msva10	71	42	beliefs	belief	NNS
cord-327697-80msva10	71	43	.	.	.
cord-327697-80msva10	72	1	Nearly	nearly	RB
cord-327697-80msva10	72	2	40	40	CD
cord-327697-80msva10	72	3	%	%	NN
cord-327697-80msva10	72	4	of	of	IN
cord-327697-80msva10	72	5	the	the	DT
cord-327697-80msva10	72	6	assistant	assistant	JJ
cord-327697-80msva10	72	7	doctors	doctor	NNS
cord-327697-80msva10	72	8	believed	believe	VBD
cord-327697-80msva10	72	9	that	that	IN
cord-327697-80msva10	72	10	ACE	ACE	NNP
cord-327697-80msva10	72	11	-	-	HYPH
cord-327697-80msva10	72	12	i/	i/	NNP
cord-327697-80msva10	72	13	ARBs	arb	NNS
cord-327697-80msva10	72	14	users	user	NNS
cord-327697-80msva10	72	15	had	have	VBD
cord-327697-80msva10	72	16	more	more	RBR
cord-327697-80msva10	72	17	-	-	HYPH
cord-327697-80msva10	72	18	severe	severe	JJ
cord-327697-80msva10	72	19	COVID-19	covid-19	JJ
cord-327697-80msva10	72	20	disease	disease	NN
cord-327697-80msva10	72	21	.	.	.
cord-327697-80msva10	73	1	The	the	DT
cord-327697-80msva10	73	2	effect	effect	NN
cord-327697-80msva10	73	3	of	of	IN
cord-327697-80msva10	73	4	experience	experience	NN
cord-327697-80msva10	73	5	on	on	IN
cord-327697-80msva10	73	6	knowledge	knowledge	NN
cord-327697-80msva10	73	7	level	level	NN
cord-327697-80msva10	73	8	and	and	CC
cord-327697-80msva10	73	9	on	on	IN
cord-327697-80msva10	73	10	the	the	DT
cord-327697-80msva10	73	11	prescribing	prescribing	NN
cord-327697-80msva10	73	12	pattern	pattern	NN
cord-327697-80msva10	73	13	was	be	VBD
cord-327697-80msva10	73	14	evaluated	evaluate	VBN
cord-327697-80msva10	73	15	.	.	.
cord-327697-80msva10	74	1	There	there	EX
cord-327697-80msva10	74	2	was	be	VBD
cord-327697-80msva10	74	3	determined	determined	JJ
cord-327697-80msva10	74	4	to	to	TO
cord-327697-80msva10	74	5	be	be	VB
cord-327697-80msva10	74	6	a	a	DT
cord-327697-80msva10	74	7	close	close	JJ
cord-327697-80msva10	74	8	interaction	interaction	NN
cord-327697-80msva10	74	9	with	with	IN
cord-327697-80msva10	74	10	every	every	DT
cord-327697-80msva10	74	11	5	5	CD
cord-327697-80msva10	74	12	years	year	NNS
cord-327697-80msva10	74	13	increase	increase	NN
cord-327697-80msva10	74	14	of	of	IN
cord-327697-80msva10	74	15	experience	experience	NN
cord-327697-80msva10	74	16	in	in	IN
cord-327697-80msva10	74	17	practice	practice	NN
cord-327697-80msva10	74	18	showing	show	VBG
cord-327697-80msva10	74	19	a	a	DT
cord-327697-80msva10	74	20	steady	steady	JJ
cord-327697-80msva10	74	21	increase	increase	NN
cord-327697-80msva10	74	22	in	in	IN
cord-327697-80msva10	74	23	the	the	DT
cord-327697-80msva10	74	24	high	high	JJ
cord-327697-80msva10	74	25	level	level	NN
cord-327697-80msva10	74	26	of	of	IN
cord-327697-80msva10	74	27	knowledge	knowledge	NN
cord-327697-80msva10	74	28	ratio	ratio	NN
cord-327697-80msva10	74	29	about	about	IN
cord-327697-80msva10	74	30	ACE	ACE	NNP
cord-327697-80msva10	74	31	/	/	SYM
cord-327697-80msva10	74	32	ARB	ARB	NNP
cord-327697-80msva10	74	33	treatment	treatment	NN
cord-327697-80msva10	74	34	and	and	CC
cord-327697-80msva10	74	35	COVID-19	COVID-19	NNP
cord-327697-80msva10	74	36	disease	disease	NN
cord-327697-80msva10	74	37	.	.	.
cord-327697-80msva10	75	1	(	(	-LRB-
cord-327697-80msva10	75	2	Fig	Fig	NNP
cord-327697-80msva10	75	3	.	.	NNP
cord-327697-80msva10	75	4	4	4	CD
cord-327697-80msva10	75	5	)	)	-RRB-
cord-327697-80msva10	75	6	.	.	.
cord-327697-80msva10	76	1	The	the	DT
cord-327697-80msva10	76	2	percentage	percentage	NN
cord-327697-80msva10	76	3	of	of	IN
cord-327697-80msva10	76	4	physicians	physician	NNS
cord-327697-80msva10	76	5	who	who	WP
cord-327697-80msva10	76	6	thought	think	VBD
cord-327697-80msva10	76	7	they	-PRON-	PRP
cord-327697-80msva10	76	8	had	have	VBD
cord-327697-80msva10	76	9	a	a	DT
cord-327697-80msva10	76	10	high	high	JJ
cord-327697-80msva10	76	11	level	level	NN
cord-327697-80msva10	76	12	of	of	IN
cord-327697-80msva10	76	13	knowledge	knowledge	NN
cord-327697-80msva10	76	14	about	about	IN
cord-327697-80msva10	76	15	ACE	ace	NN
cord-327697-80msva10	76	16	-	-	HYPH
cord-327697-80msva10	76	17	i	i	NNP
cord-327697-80msva10	76	18	/	/	SYM
cord-327697-80msva10	76	19	ARB	ARB	NNP
cord-327697-80msva10	76	20	treatment	treatment	NN
cord-327697-80msva10	76	21	and	and	CC
cord-327697-80msva10	76	22	COVID	COVID	NNP
cord-327697-80msva10	76	23	-19	-19	NN
cord-327697-80msva10	76	24	interaction	interaction	NN
cord-327697-80msva10	76	25	was	be	VBD
cord-327697-80msva10	76	26	48.7	48.7	CD
cord-327697-80msva10	76	27	%	%	NN
cord-327697-80msva10	76	28	in	in	IN
cord-327697-80msva10	76	29	cardiologists	cardiologist	NNS
cord-327697-80msva10	76	30	,	,	,
cord-327697-80msva10	76	31	23.7	23.7	CD
cord-327697-80msva10	76	32	%	%	NN
cord-327697-80msva10	76	33	in	in	IN
cord-327697-80msva10	76	34	internal	internal	JJ
cord-327697-80msva10	76	35	medicine	medicine	NN
cord-327697-80msva10	76	36	,	,	,
cord-327697-80msva10	76	37	and	and	CC
cord-327697-80msva10	76	38	11.5	11.5	CD
cord-327697-80msva10	76	39	%	%	NN
cord-327697-80msva10	76	40	in	in	IN
cord-327697-80msva10	76	41	family	family	NN
cord-327697-80msva10	76	42	medicine	medicine	NN
cord-327697-80msva10	76	43	(	(	-LRB-
cord-327697-80msva10	76	44	Fig	Fig	NNP
cord-327697-80msva10	76	45	.	.	.
cord-327697-80msva10	76	46	5a	5a	CD
cord-327697-80msva10	76	47	)	)	-RRB-
cord-327697-80msva10	76	48	.	.	.
cord-327697-80msva10	77	1	The	the	DT
cord-327697-80msva10	77	2	percentage	percentage	NN
cord-327697-80msva10	77	3	of	of	IN
cord-327697-80msva10	77	4	physicians	physician	NNS
cord-327697-80msva10	77	5	who	who	WP
cord-327697-80msva10	77	6	considered	consider	VBD
cord-327697-80msva10	77	7	that	that	IN
cord-327697-80msva10	77	8	ACE	ace	NN
cord-327697-80msva10	77	9	-	-	HYPH
cord-327697-80msva10	77	10	i	i	NN
cord-327697-80msva10	77	11	/	/	SYM
cord-327697-80msva10	77	12	ARBs	arb	NNS
cord-327697-80msva10	77	13	therapy	therapy	NN
cord-327697-80msva10	77	14	may	may	MD
cord-327697-80msva10	77	15	be	be	VB
cord-327697-80msva10	77	16	harmful	harmful	JJ
cord-327697-80msva10	77	17	during	during	IN
cord-327697-80msva10	77	18	the	the	DT
cord-327697-80msva10	77	19	COVID-19	covid-19	JJ
cord-327697-80msva10	77	20	pandemic	pandemic	NN
cord-327697-80msva10	77	21	was	be	VBD
cord-327697-80msva10	77	22	44.2	44.2	CD
cord-327697-80msva10	77	23	%	%	NN
cord-327697-80msva10	77	24	of	of	IN
cord-327697-80msva10	77	25	the	the	DT
cord-327697-80msva10	77	26	family	family	NN
cord-327697-80msva10	77	27	medicine	medicine	NN
cord-327697-80msva10	77	28	specialists	specialist	NNS
cord-327697-80msva10	77	29	,	,	,
cord-327697-80msva10	77	30	34.8	34.8	CD
cord-327697-80msva10	77	31	%	%	NN
cord-327697-80msva10	77	32	of	of	IN
cord-327697-80msva10	77	33	the	the	DT
cord-327697-80msva10	77	34	internal	internal	JJ
cord-327697-80msva10	77	35	medicine	medicine	NN
cord-327697-80msva10	77	36	specialists	specialist	NNS
cord-327697-80msva10	77	37	,	,	,
cord-327697-80msva10	77	38	33.3	33.3	CD
cord-327697-80msva10	77	39	%	%	NN
cord-327697-80msva10	77	40	of	of	IN
cord-327697-80msva10	77	41	the	the	DT
cord-327697-80msva10	77	42	general	general	JJ
cord-327697-80msva10	77	43	practitioners	practitioner	NNS
cord-327697-80msva10	77	44	,	,	,
cord-327697-80msva10	77	45	and	and	CC
cord-327697-80msva10	77	46	15.4	15.4	CD
cord-327697-80msva10	77	47	%	%	NN
cord-327697-80msva10	77	48	of	of	IN
cord-327697-80msva10	77	49	the	the	DT
cord-327697-80msva10	77	50	cardiologists	cardiologist	NNS
cord-327697-80msva10	77	51	.	.	.
cord-327697-80msva10	78	1	Conversely	conversely	RB
cord-327697-80msva10	78	2	,	,	,
cord-327697-80msva10	78	3	27	27	CD
cord-327697-80msva10	78	4	%	%	NN
cord-327697-80msva10	78	5	of	of	IN
cord-327697-80msva10	78	6	cardiologists	cardiologist	NNS
cord-327697-80msva10	78	7	,	,	,
cord-327697-80msva10	78	8	13	13	CD
cord-327697-80msva10	78	9	%	%	NN
cord-327697-80msva10	78	10	of	of	IN
cord-327697-80msva10	78	11	internal	internal	JJ
cord-327697-80msva10	78	12	medicine	medicine	NN
cord-327697-80msva10	78	13	specialists	specialist	NNS
cord-327697-80msva10	78	14	,	,	,
cord-327697-80msva10	78	15	8	8	CD
cord-327697-80msva10	78	16	%	%	NN
cord-327697-80msva10	78	17	of	of	IN
cord-327697-80msva10	78	18	general	general	JJ
cord-327697-80msva10	78	19	practitioners	practitioner	NNS
cord-327697-80msva10	78	20	,	,	,
cord-327697-80msva10	78	21	and	and	CC
cord-327697-80msva10	78	22	6	6	CD
cord-327697-80msva10	78	23	%	%	NN
cord-327697-80msva10	78	24	of	of	IN
cord-327697-80msva10	78	25	family	family	NN
cord-327697-80msva10	78	26	medicine	medicine	NN
cord-327697-80msva10	78	27	physicians	physician	NNS
cord-327697-80msva10	78	28	had	have	VBD
cord-327697-80msva10	78	29	positive	positive	JJ
cord-327697-80msva10	78	30	opinions	opinion	NNS
cord-327697-80msva10	78	31	that	that	WDT
cord-327697-80msva10	78	32	these	these	DT
cord-327697-80msva10	78	33	medications	medication	NNS
cord-327697-80msva10	78	34	could	could	MD
cord-327697-80msva10	78	35	be	be	VB
cord-327697-80msva10	78	36	associated	associate	VBN
cord-327697-80msva10	78	37	with	with	IN
cord-327697-80msva10	78	38	less	less	RBR
cord-327697-80msva10	78	39	severe	severe	JJ
cord-327697-80msva10	78	40	disease	disease	NN
cord-327697-80msva10	78	41	and	and	CC
cord-327697-80msva10	78	42	could	could	MD
cord-327697-80msva10	78	43	be	be	VB
cord-327697-80msva10	78	44	protective	protective	JJ
cord-327697-80msva10	78	45	against	against	IN
cord-327697-80msva10	78	46	infection	infection	NN
cord-327697-80msva10	78	47	of	of	IN
cord-327697-80msva10	78	48	COVID-19	COVID-19	NNP
cord-327697-80msva10	78	49	disease	disease	NN
cord-327697-80msva10	78	50	(	(	-LRB-
cord-327697-80msva10	78	51	Fig	Fig	NNP
cord-327697-80msva10	78	52	.	.	.
cord-327697-80msva10	78	53	5b	5b	CD
cord-327697-80msva10	78	54	)	)	-RRB-
cord-327697-80msva10	78	55	.	.	.
cord-327697-80msva10	79	1	More	More	JJR
cord-327697-80msva10	79	2	than	than	IN
cord-327697-80msva10	79	3	two	two	CD
cord-327697-80msva10	79	4	-	-	HYPH
cord-327697-80msva10	79	5	thirds	third	NNS
cord-327697-80msva10	79	6	(	(	-LRB-
cord-327697-80msva10	79	7	76.2	76.2	CD
cord-327697-80msva10	79	8	%	%	NN
cord-327697-80msva10	79	9	)	)	-RRB-
cord-327697-80msva10	79	10	of	of	IN
cord-327697-80msva10	79	11	the	the	DT
cord-327697-80msva10	79	12	physicians	physician	NNS
cord-327697-80msva10	79	13	did	do	VBD
cord-327697-80msva10	79	14	not	not	RB
cord-327697-80msva10	79	15	change	change	VB
cord-327697-80msva10	79	16	their	-PRON-	PRP$
cord-327697-80msva10	79	17	mind	mind	NN
cord-327697-80msva10	79	18	,	,	,
cord-327697-80msva10	79	19	27.6	27.6	CD
cord-327697-80msva10	79	20	%	%	NN
cord-327697-80msva10	79	21	of	of	IN
cord-327697-80msva10	79	22	cardiologists	cardiologist	NNS
cord-327697-80msva10	79	23	changed	change	VBD
cord-327697-80msva10	79	24	their	-PRON-	PRP$
cord-327697-80msva10	79	25	opinion	opinion	NN
cord-327697-80msva10	79	26	in	in	IN
cord-327697-80msva10	79	27	favor	favor	NN
cord-327697-80msva10	79	28	of	of	IN
cord-327697-80msva10	79	29	ACE	ACE	NNP
cord-327697-80msva10	79	30	-	-	HYPH
cord-327697-80msva10	79	31	i	i	NN
cord-327697-80msva10	79	32	/	/	SYM
cord-327697-80msva10	79	33	ARBs	arb	NNS
cord-327697-80msva10	79	34	treatment	treatment	NN
cord-327697-80msva10	79	35	and	and	CC
cord-327697-80msva10	79	36	16.6	16.6	CD
cord-327697-80msva10	79	37	%	%	NN
cord-327697-80msva10	79	38	of	of	IN
cord-327697-80msva10	79	39	general	general	JJ
cord-327697-80msva10	79	40	practitioners	practitioner	NNS
cord-327697-80msva10	79	41	were	be	VBD
cord-327697-80msva10	79	42	affected	affect	VBN
cord-327697-80msva10	79	43	negatively	negatively	RB
cord-327697-80msva10	79	44	by	by	IN
cord-327697-80msva10	79	45	the	the	DT
cord-327697-80msva10	79	46	environment	environment	NN
cord-327697-80msva10	79	47	of	of	IN
cord-327697-80msva10	79	48	uncertainty	uncertainty	NN
cord-327697-80msva10	79	49	during	during	IN
cord-327697-80msva10	79	50	the	the	DT
cord-327697-80msva10	79	51	COVID-19	COVID-19	NNP
cord-327697-80msva10	79	52	pandemic	pandemic	NN
cord-327697-80msva10	79	53	.	.	.
cord-327697-80msva10	80	1	Calcium	calcium	NN
cord-327697-80msva10	80	2	channel	channel	NN
cord-327697-80msva10	80	3	blockers	blocker	NNS
cord-327697-80msva10	80	4	(	(	-LRB-
cord-327697-80msva10	80	5	CCB	CCB	NNP
cord-327697-80msva10	80	6	)	)	-RRB-
cord-327697-80msva10	80	7	were	be	VBD
cord-327697-80msva10	80	8	the	the	DT
cord-327697-80msva10	80	9	most	most	RBS
cord-327697-80msva10	80	10	preferred	preferred	JJ
cord-327697-80msva10	80	11	agents	agent	NNS
cord-327697-80msva10	80	12	in	in	IN
cord-327697-80msva10	80	13	the	the	DT
cord-327697-80msva10	80	14	case	case	NN
cord-327697-80msva10	80	15	of	of	IN
cord-327697-80msva10	80	16	ACE	ACE	NNP
cord-327697-80msva10	80	17	-	-	HYPH
cord-327697-80msva10	80	18	i	i	NNP
cord-327697-80msva10	80	19	/	/	SYM
cord-327697-80msva10	80	20	ARBs	arb	NNS
cord-327697-80msva10	80	21	cessation	cessation	NN
cord-327697-80msva10	80	22	(	(	-LRB-
cord-327697-80msva10	80	23	Fig	Fig	NNP
cord-327697-80msva10	80	24	.	.	.
cord-327697-80msva10	80	25	5c	5c	CD
cord-327697-80msva10	80	26	)	)	-RRB-
cord-327697-80msva10	80	27	.	.	.
cord-327697-80msva10	81	1	It	-PRON-	PRP
cord-327697-80msva10	81	2	was	be	VBD
cord-327697-80msva10	81	3	observed	observe	VBN
cord-327697-80msva10	81	4	that	that	IN
cord-327697-80msva10	81	5	14	14	CD
cord-327697-80msva10	81	6	%	%	NN
cord-327697-80msva10	81	7	of	of	IN
cord-327697-80msva10	81	8	all	all	DT
cord-327697-80msva10	81	9	physicians	physician	NNS
cord-327697-80msva10	81	10	,	,	,
cord-327697-80msva10	81	11	19	19	CD
cord-327697-80msva10	81	12	%	%	NN
cord-327697-80msva10	81	13	of	of	IN
cord-327697-80msva10	81	14	cardiologists	cardiologist	NNS
cord-327697-80msva10	81	15	and	and	CC
cord-327697-80msva10	81	16	24	24	CD
cord-327697-80msva10	81	17	%	%	NN
cord-327697-80msva10	81	18	of	of	IN
cord-327697-80msva10	81	19	internal	internal	JJ
cord-327697-80msva10	81	20	medicine	medicine	NN
cord-327697-80msva10	81	21	doctors	doctor	NNS
cord-327697-80msva10	81	22	considered	consider	VBD
cord-327697-80msva10	81	23	changing	change	VBG
cord-327697-80msva10	81	24	the	the	DT
cord-327697-80msva10	81	25	ACE	ACE	NNP
cord-327697-80msva10	81	26	-	-	HYPH
cord-327697-80msva10	81	27	i	i	NN
cord-327697-80msva10	81	28	/	/	SYM
cord-327697-80msva10	81	29	ARBs	arb	NNS
cord-327697-80msva10	81	30	therapy	therapy	NN
cord-327697-80msva10	81	31	in	in	IN
cord-327697-80msva10	81	32	the	the	DT
cord-327697-80msva10	81	33	case	case	NN
cord-327697-80msva10	81	34	of	of	IN
cord-327697-80msva10	81	35	hypertension	hypertension	NN
cord-327697-80msva10	81	36	and	and	CC
cord-327697-80msva10	81	37	multiple	multiple	JJ
cord-327697-80msva10	81	38	comorbidities	comorbiditie	NNS
cord-327697-80msva10	81	39	respectively	respectively	RB
cord-327697-80msva10	81	40	.	.	.
cord-327697-80msva10	82	1	The	the	DT
cord-327697-80msva10	82	2	general	general	JJ
cord-327697-80msva10	82	3	reliance	reliance	NN
cord-327697-80msva10	82	4	level	level	NN
cord-327697-80msva10	82	5	was	be	VBD
cord-327697-80msva10	82	6	highest	high	JJS
cord-327697-80msva10	82	7	among	among	IN
cord-327697-80msva10	82	8	cardiologists	cardiologist	NNS
cord-327697-80msva10	82	9	(	(	-LRB-
cord-327697-80msva10	82	10	8.0	8.0	CD
cord-327697-80msva10	82	11	±	±	CD
cord-327697-80msva10	82	12	4	4	CD
cord-327697-80msva10	82	13	)	)	-RRB-
cord-327697-80msva10	82	14	and	and	CC
cord-327697-80msva10	82	15	lowest	low	JJS
cord-327697-80msva10	82	16	(	(	-LRB-
cord-327697-80msva10	82	17	5.0	5.0	CD
cord-327697-80msva10	82	18	±	±	CD
cord-327697-80msva10	82	19	3	3	CD
cord-327697-80msva10	82	20	)	)	-RRB-
cord-327697-80msva10	82	21	among	among	IN
cord-327697-80msva10	82	22	the	the	DT
cord-327697-80msva10	82	23	family	family	NN
cord-327697-80msva10	82	24	medicine	medicine	NN
cord-327697-80msva10	82	25	/	/	SYM
cord-327697-80msva10	82	26	general	general	JJ
cord-327697-80msva10	82	27	practitioners	practitioner	NNS
cord-327697-80msva10	82	28	(	(	-LRB-
cord-327697-80msva10	82	29	p	p	NN
cord-327697-80msva10	82	30	<	<	XX
cord-327697-80msva10	82	31	0.05	0.05	CD
cord-327697-80msva10	82	32	)	)	-RRB-
cord-327697-80msva10	82	33	.	.	.
cord-327697-80msva10	83	1	The	the	DT
cord-327697-80msva10	83	2	strategy	strategy	NN
cord-327697-80msva10	83	3	for	for	IN
cord-327697-80msva10	83	4	repeating	repeat	VBG
cord-327697-80msva10	83	5	therapy	therapy	NN
cord-327697-80msva10	83	6	was	be	VBD
cord-327697-80msva10	83	7	the	the	DT
cord-327697-80msva10	83	8	same	same	JJ
cord-327697-80msva10	83	9	in	in	IN
cord-327697-80msva10	83	10	all	all	DT
cord-327697-80msva10	83	11	physicians	physician	NNS
cord-327697-80msva10	83	12	,	,	,
cord-327697-80msva10	83	13	and	and	CC
cord-327697-80msva10	83	14	the	the	DT
cord-327697-80msva10	83	15	practice	practice	NN
cord-327697-80msva10	83	16	of	of	IN
cord-327697-80msva10	83	17	starting	start	VBG
cord-327697-80msva10	83	18	new	new	JJ
cord-327697-80msva10	83	19	ACE	ACE	NNP
cord-327697-80msva10	83	20	-	-	HYPH
cord-327697-80msva10	83	21	i	i	NN
cord-327697-80msva10	83	22	/	/	SYM
cord-327697-80msva10	83	23	ARBs	arb	NNS
cord-327697-80msva10	83	24	reported	report	VBN
cord-327697-80msva10	83	25	by	by	IN
cord-327697-80msva10	83	26	the	the	DT
cord-327697-80msva10	83	27	cardiologists	cardiologist	NNS
cord-327697-80msva10	83	28	was	be	VBD
cord-327697-80msva10	83	29	statistically	statistically	RB
cord-327697-80msva10	83	30	different	different	JJ
cord-327697-80msva10	83	31	from	from	IN
cord-327697-80msva10	83	32	that	that	DT
cord-327697-80msva10	83	33	of	of	IN
cord-327697-80msva10	83	34	both	both	DT
cord-327697-80msva10	83	35	internal	internal	JJ
cord-327697-80msva10	83	36	medicine	medicine	NN
cord-327697-80msva10	83	37	and	and	CC
cord-327697-80msva10	83	38	family	family	NN
cord-327697-80msva10	83	39	medicine	medicine	NN
cord-327697-80msva10	83	40	/	/	SYM
cord-327697-80msva10	83	41	general	general	JJ
cord-327697-80msva10	83	42	practitioners	practitioner	NNS
cord-327697-80msva10	83	43	(	(	-LRB-
cord-327697-80msva10	83	44	8.0	8.0	CD
cord-327697-80msva10	83	45	±	±	CD
cord-327697-80msva10	83	46	4	4	CD
cord-327697-80msva10	83	47	vs	vs	IN
cord-327697-80msva10	83	48	8.0	8.0	CD
cord-327697-80msva10	83	49	±	±	CD
cord-327697-80msva10	83	50	4	4	CD
cord-327697-80msva10	83	51	vs	vs	IN
cord-327697-80msva10	83	52	9.0	9.0	CD
cord-327697-80msva10	83	53	±	±	CD
cord-327697-80msva10	83	54	3	3	CD
cord-327697-80msva10	83	55	,	,	,
cord-327697-80msva10	83	56	p	p	NN
cord-327697-80msva10	83	57	<	<	XX
cord-327697-80msva10	83	58	0.05	0.05	CD
cord-327697-80msva10	83	59	)	)	-RRB-
cord-327697-80msva10	84	1	(	(	-LRB-
cord-327697-80msva10	84	2	Table	table	NN
cord-327697-80msva10	84	3	2	2	CD
cord-327697-80msva10	84	4	)	)	-RRB-
cord-327697-80msva10	84	5	.	.	.
cord-327697-80msva10	84	6	 	 	_SP
cord-327697-80msva10	85	1	The	the	DT
cord-327697-80msva10	85	2	institutions	institution	NNS
cord-327697-80msva10	85	3	where	where	WRB
cord-327697-80msva10	85	4	the	the	DT
cord-327697-80msva10	85	5	respondents	respondent	NNS
cord-327697-80msva10	85	6	worked	work	VBD
cord-327697-80msva10	85	7	were	be	VBD
cord-327697-80msva10	85	8	categorized	categorize	VBN
cord-327697-80msva10	85	9	in	in	IN
cord-327697-80msva10	85	10	three	three	CD
cord-327697-80msva10	85	11	levels	level	NNS
cord-327697-80msva10	85	12	as	as	IN
cord-327697-80msva10	85	13	primary	primary	JJ
cord-327697-80msva10	85	14	,	,	,
cord-327697-80msva10	85	15	secondary	secondary	JJ
cord-327697-80msva10	85	16	,	,	,
cord-327697-80msva10	85	17	and	and	CC
cord-327697-80msva10	85	18	tertiary	tertiary	JJ
cord-327697-80msva10	85	19	in	in	IN
cord-327697-80msva10	85	20	order	order	NN
cord-327697-80msva10	85	21	to	to	TO
cord-327697-80msva10	85	22	evaluate	evaluate	VB
cord-327697-80msva10	85	23	the	the	DT
cord-327697-80msva10	85	24	effects	effect	NNS
cord-327697-80msva10	85	25	of	of	IN
cord-327697-80msva10	85	26	the	the	DT
cord-327697-80msva10	85	27	type	type	NN
cord-327697-80msva10	85	28	of	of	IN
cord-327697-80msva10	85	29	healthcare	healthcare	NN
cord-327697-80msva10	85	30	facility	facility	NN
cord-327697-80msva10	85	31	on	on	IN
cord-327697-80msva10	85	32	physician	physician	NN
cord-327697-80msva10	85	33	's	's	POS
cord-327697-80msva10	85	34	behavior	behavior	NN
cord-327697-80msva10	85	35	while	while	IN
cord-327697-80msva10	85	36	starting	start	VBG
cord-327697-80msva10	85	37	or	or	CC
cord-327697-80msva10	85	38	stopping	stop	VBG
cord-327697-80msva10	85	39	ACEI/	ACEI/	NNP
cord-327697-80msva10	85	40	ARB	ARB	NNP
cord-327697-80msva10	85	41	treatments	treatment	NNS
cord-327697-80msva10	85	42	.	.	.
cord-327697-80msva10	86	1	The	the	DT
cord-327697-80msva10	86	2	level	level	NN
cord-327697-80msva10	86	3	of	of	IN
cord-327697-80msva10	86	4	the	the	DT
cord-327697-80msva10	86	5	healthcare	healthcare	NN
cord-327697-80msva10	86	6	institution	institution	NN
cord-327697-80msva10	86	7	and	and	CC
cord-327697-80msva10	86	8	the	the	DT
cord-327697-80msva10	86	9	duration	duration	NN
cord-327697-80msva10	86	10	of	of	IN
cord-327697-80msva10	86	11	working	work	VBG
cord-327697-80msva10	86	12	were	be	VBD
cord-327697-80msva10	86	13	found	find	VBN
cord-327697-80msva10	86	14	to	to	TO
cord-327697-80msva10	86	15	have	have	VB
cord-327697-80msva10	86	16	no	no	DT
cord-327697-80msva10	86	17	impact	impact	NN
cord-327697-80msva10	86	18	on	on	IN
cord-327697-80msva10	86	19	repeating	repeat	VBG
cord-327697-80msva10	86	20	/	/	SYM
cord-327697-80msva10	86	21	starting	start	VBG
cord-327697-80msva10	86	22	/	/	SYM
cord-327697-80msva10	86	23	general	general	JJ
cord-327697-80msva10	86	24	practice	practice	NN
cord-327697-80msva10	86	25	about	about	IN
cord-327697-80msva10	86	26	ACE	ace	NN
cord-327697-80msva10	86	27	-	-	HYPH
cord-327697-80msva10	86	28	i	i	NN
cord-327697-80msva10	86	29	/	/	SYM
cord-327697-80msva10	86	30	ARBs	arb	NNS
cord-327697-80msva10	86	31	(	(	-LRB-
cord-327697-80msva10	86	32	Table	Table	NNP
cord-327697-80msva10	86	33	3	3	CD
cord-327697-80msva10	86	34	)	)	-RRB-
cord-327697-80msva10	86	35	.	.	.
cord-327697-80msva10	87	1	By	by	IN
cord-327697-80msva10	87	2	mid	mid	NNP
cord-327697-80msva10	87	3	-	-	NNP
cord-327697-80msva10	87	4	June	June	NNP
cord-327697-80msva10	87	5	2020	2020	CD
cord-327697-80msva10	87	6	,	,	,
cord-327697-80msva10	87	7	at	at	IN
cord-327697-80msva10	87	8	the	the	DT
cord-327697-80msva10	87	9	time	time	NN
cord-327697-80msva10	87	10	of	of	IN
cord-327697-80msva10	87	11	writing	write	VBG
cord-327697-80msva10	87	12	this	this	DT
cord-327697-80msva10	87	13	study	study	NN
cord-327697-80msva10	87	14	,	,	,
cord-327697-80msva10	87	15	8.5	8.5	CD
cord-327697-80msva10	87	16	million	million	CD
cord-327697-80msva10	87	17	people	people	NNS
cord-327697-80msva10	87	18	have	have	VBP
cord-327697-80msva10	87	19	been	be	VBN
cord-327697-80msva10	87	20	infected	infect	VBN
cord-327697-80msva10	87	21	with	with	IN
cord-327697-80msva10	87	22	SARS	SARS	NNP
cord-327697-80msva10	87	23	-	-	HYPH
cord-327697-80msva10	87	24	CoV-2	CoV-2	NNP
cord-327697-80msva10	87	25	and	and	CC
cord-327697-80msva10	87	26	over	over	IN
cord-327697-80msva10	87	27	470,000	470,000	CD
cord-327697-80msva10	87	28	have	have	VBP
cord-327697-80msva10	87	29	died	die	VBN
cord-327697-80msva10	87	30	worldwide	worldwide	RB
cord-327697-80msva10	87	31	.	.	.
cord-327697-80msva10	88	1	More	More	JJR
cord-327697-80msva10	88	2	and	and	CC
cord-327697-80msva10	88	3	more	more	JJR
cord-327697-80msva10	88	4	patients	patient	NNS
cord-327697-80msva10	88	5	are	be	VBP
cord-327697-80msva10	88	6	still	still	RB
cord-327697-80msva10	88	7	becoming	become	VBG
cord-327697-80msva10	88	8	infected	infect	VBN
cord-327697-80msva10	88	9	every	every	DT
cord-327697-80msva10	88	10	day	day	NN
cord-327697-80msva10	88	11	.	.	.
cord-327697-80msva10	89	1	As	as	IN
cord-327697-80msva10	89	2	COVID-19	COVID-19	NNP
cord-327697-80msva10	89	3	disease	disease	NN
cord-327697-80msva10	89	4	is	be	VBZ
cord-327697-80msva10	89	5	caused	cause	VBN
cord-327697-80msva10	89	6	by	by	IN
cord-327697-80msva10	89	7	the	the	DT
cord-327697-80msva10	89	8	SARS	SARS	NNP
cord-327697-80msva10	89	9	-	-	HYPH
cord-327697-80msva10	89	10	CoV-2	CoV-2	NNP
cord-327697-80msva10	89	11	virus	virus	NN
cord-327697-80msva10	89	12	,	,	,
cord-327697-80msva10	89	13	some	some	DT
cord-327697-80msva10	89	14	speculations	speculation	NNS
cord-327697-80msva10	89	15	have	have	VBP
cord-327697-80msva10	89	16	been	be	VBN
cord-327697-80msva10	89	17	put	put	VBN
cord-327697-80msva10	89	18	forward	forward	RB
cord-327697-80msva10	89	19	linking	link	VBG
cord-327697-80msva10	89	20	aminopeptidase	aminopeptidase	NN
cord-327697-80msva10	89	21	ACE2	ACE2	NNP
cord-327697-80msva10	89	22	with	with	IN
cord-327697-80msva10	89	23	this	this	DT
cord-327697-80msva10	89	24	disease	disease	NN
cord-327697-80msva10	89	25	[	[	-LRB-
cord-327697-80msva10	89	26	11	11	CD
cord-327697-80msva10	89	27	]	]	-RRB-
cord-327697-80msva10	89	28	.	.	.
cord-327697-80msva10	90	1	Based	base	VBN
cord-327697-80msva10	90	2	on	on	IN
cord-327697-80msva10	90	3	these	these	DT
cord-327697-80msva10	90	4	speculations	speculation	NNS
cord-327697-80msva10	90	5	,	,	,
cord-327697-80msva10	90	6	arguments	argument	NNS
cord-327697-80msva10	90	7	and	and	CC
cord-327697-80msva10	90	8	concerns	concern	NNS
cord-327697-80msva10	90	9	about	about	IN
cord-327697-80msva10	90	10	these	these	DT
cord-327697-80msva10	90	11	medications	medication	NNS
cord-327697-80msva10	90	12	have	have	VBP
cord-327697-80msva10	90	13	arisen	arise	VBN
cord-327697-80msva10	90	14	in	in	IN
cord-327697-80msva10	90	15	the	the	DT
cord-327697-80msva10	90	16	community	community	NN
cord-327697-80msva10	90	17	.	.	.
cord-327697-80msva10	91	1	Despite	despite	IN
cord-327697-80msva10	91	2	the	the	DT
cord-327697-80msva10	91	3	supporting	support	VBG
cord-327697-80msva10	91	4	reports	report	NNS
cord-327697-80msva10	91	5	of	of	IN
cord-327697-80msva10	91	6	scientific	scientific	JJ
cord-327697-80msva10	91	7	societies	society	NNS
cord-327697-80msva10	91	8	against	against	IN
cord-327697-80msva10	91	9	discontinuation	discontinuation	NN
cord-327697-80msva10	91	10	of	of	IN
cord-327697-80msva10	91	11	these	these	DT
cord-327697-80msva10	91	12	drugs	drug	NNS
cord-327697-80msva10	91	13	,	,	,
cord-327697-80msva10	91	14	the	the	DT
cord-327697-80msva10	91	15	lack	lack	NN
cord-327697-80msva10	91	16	of	of	IN
cord-327697-80msva10	91	17	information	information	NN
cord-327697-80msva10	91	18	at	at	IN
cord-327697-80msva10	91	19	the	the	DT
cord-327697-80msva10	91	20	beginning	beginning	NN
cord-327697-80msva10	91	21	of	of	IN
cord-327697-80msva10	91	22	the	the	DT
cord-327697-80msva10	91	23	pandemic	pandemic	NN
cord-327697-80msva10	91	24	might	may	MD
cord-327697-80msva10	91	25	have	have	VB
cord-327697-80msva10	91	26	had	have	VBN
cord-327697-80msva10	91	27	an	an	DT
cord-327697-80msva10	91	28	impact	impact	NN
cord-327697-80msva10	91	29	on	on	IN
cord-327697-80msva10	91	30	the	the	DT
cord-327697-80msva10	91	31	behaviors	behavior	NNS
cord-327697-80msva10	91	32	of	of	IN
cord-327697-80msva10	91	33	physicians	physician	NNS
cord-327697-80msva10	91	34	in	in	IN
cord-327697-80msva10	91	35	respect	respect	NN
cord-327697-80msva10	91	36	of	of	IN
cord-327697-80msva10	91	37	whether	whether	IN
cord-327697-80msva10	91	38	or	or	CC
cord-327697-80msva10	91	39	not	not	RB
cord-327697-80msva10	91	40	to	to	TO
cord-327697-80msva10	91	41	prescribe	prescribe	VB
cord-327697-80msva10	91	42	[	[	-LRB-
cord-327697-80msva10	91	43	12	12	CD
cord-327697-80msva10	91	44	]	]	-RRB-
cord-327697-80msva10	91	45	.	.	.
cord-327697-80msva10	92	1	Early	early	JJ
cord-327697-80msva10	92	2	reports	report	NNS
cord-327697-80msva10	92	3	,	,	,
cord-327697-80msva10	92	4	which	which	WDT
cord-327697-80msva10	92	5	mainly	mainly	RB
cord-327697-80msva10	92	6	came	come	VBD
cord-327697-80msva10	92	7	from	from	IN
cord-327697-80msva10	92	8	China	China	NNP
cord-327697-80msva10	92	9	,	,	,
cord-327697-80msva10	92	10	raised	raise	VBD
cord-327697-80msva10	92	11	suspicion	suspicion	NN
cord-327697-80msva10	92	12	and	and	CC
cord-327697-80msva10	92	13	encouraged	encourage	VBD
cord-327697-80msva10	92	14	doctors	doctor	NNS
cord-327697-80msva10	92	15	to	to	TO
cord-327697-80msva10	92	16	stop	stop	VB
cord-327697-80msva10	92	17	prescribing	prescribe	VBG
cord-327697-80msva10	92	18	ACEi	ACEi	NNS
cord-327697-80msva10	92	19	/	/	SYM
cord-327697-80msva10	92	20	ARBs	arb	NNS
cord-327697-80msva10	92	21	[	[	-LRB-
cord-327697-80msva10	92	22	13	13	CD
cord-327697-80msva10	92	23	]	]	-RRB-
cord-327697-80msva10	92	24	.	.	.
cord-327697-80msva10	93	1	These	these	DT
cord-327697-80msva10	93	2	suggestions	suggestion	NNS
cord-327697-80msva10	93	3	come	come	VBP
cord-327697-80msva10	93	4	from	from	IN
cord-327697-80msva10	93	5	observational	observational	JJ
cord-327697-80msva10	93	6	studies	study	NNS
cord-327697-80msva10	93	7	of	of	IN
cord-327697-80msva10	93	8	large	large	JJ
cord-327697-80msva10	93	9	patient	patient	JJ
cord-327697-80msva10	93	10	populations	population	NNS
cord-327697-80msva10	93	11	from	from	IN
cord-327697-80msva10	93	12	different	different	JJ
cord-327697-80msva10	93	13	countries	country	NNS
cord-327697-80msva10	93	14	[	[	-LRB-
cord-327697-80msva10	93	15	14	14	CD
cord-327697-80msva10	93	16	]	]	-RRB-
cord-327697-80msva10	93	17	[	[	-LRB-
cord-327697-80msva10	93	18	15	15	CD
cord-327697-80msva10	93	19	]	]	-RRB-
cord-327697-80msva10	93	20	[	[	-LRB-
cord-327697-80msva10	93	21	16	16	CD
cord-327697-80msva10	93	22	]	]	-RRB-
cord-327697-80msva10	93	23	.	.	.
cord-327697-80msva10	94	1	In	in	IN
cord-327697-80msva10	94	2	these	these	DT
cord-327697-80msva10	94	3	trials	trial	NNS
cord-327697-80msva10	94	4	,	,	,
cord-327697-80msva10	94	5	researchers	researcher	NNS
cord-327697-80msva10	94	6	observed	observe	VBD
cord-327697-80msva10	94	7	that	that	IN
cord-327697-80msva10	94	8	hypertensive	hypertensive	JJ
cord-327697-80msva10	94	9	patients	patient	NNS
cord-327697-80msva10	94	10	had	have	VBD
cord-327697-80msva10	94	11	more	more	RBR
cord-327697-80msva10	94	12	-	-	HYPH
cord-327697-80msva10	94	13	severe	severe	JJ
cord-327697-80msva10	94	14	COVID-19	covid-19	JJ
cord-327697-80msva10	94	15	disease	disease	NN
cord-327697-80msva10	94	16	than	than	IN
cord-327697-80msva10	94	17	other	other	JJ
cord-327697-80msva10	94	18	patients	patient	NNS
cord-327697-80msva10	94	19	,	,	,
cord-327697-80msva10	94	20	so	so	RB
cord-327697-80msva10	94	21	concluded	conclude	VBD
cord-327697-80msva10	94	22	that	that	IN
cord-327697-80msva10	94	23	,	,	,
cord-327697-80msva10	94	24	hypertension	hypertension	NN
cord-327697-80msva10	94	25	could	could	MD
cord-327697-80msva10	94	26	be	be	VB
cord-327697-80msva10	94	27	a	a	DT
cord-327697-80msva10	94	28	risk	risk	NN
cord-327697-80msva10	94	29	factor	factor	NN
cord-327697-80msva10	94	30	for	for	IN
cord-327697-80msva10	94	31	a	a	DT
cord-327697-80msva10	94	32	severe	severe	JJ
cord-327697-80msva10	94	33	disease	disease	NN
cord-327697-80msva10	94	34	course	course	NN
cord-327697-80msva10	94	35	[	[	-LRB-
cord-327697-80msva10	94	36	17	17	CD
cord-327697-80msva10	94	37	]	]	-RRB-
cord-327697-80msva10	94	38	.	.	.
cord-327697-80msva10	95	1	Nevertheless	nevertheless	RB
cord-327697-80msva10	95	2	,	,	,
cord-327697-80msva10	95	3	the	the	DT
cord-327697-80msva10	95	4	hypertensive	hypertensive	JJ
cord-327697-80msva10	95	5	patients	patient	NNS
cord-327697-80msva10	95	6	with	with	IN
cord-327697-80msva10	95	7	severe	severe	JJ
cord-327697-80msva10	95	8	COVID-19	covid-19	NN
cord-327697-80msva10	95	9	in	in	IN
cord-327697-80msva10	95	10	those	those	DT
cord-327697-80msva10	95	11	studies	study	NNS
cord-327697-80msva10	95	12	had	have	VBD
cord-327697-80msva10	95	13	poorer	poor	JJR
cord-327697-80msva10	95	14	general	general	JJ
cord-327697-80msva10	95	15	health	health	NN
cord-327697-80msva10	95	16	as	as	IN
cord-327697-80msva10	95	17	they	-PRON-	PRP
cord-327697-80msva10	95	18	had	have	VBD
cord-327697-80msva10	95	19	additional	additional	JJ
cord-327697-80msva10	95	20	risk	risk	NN
cord-327697-80msva10	95	21	factors	factor	NNS
cord-327697-80msva10	95	22	such	such	JJ
cord-327697-80msva10	95	23	as	as	IN
cord-327697-80msva10	95	24	older	old	JJR
cord-327697-80msva10	95	25	age	age	NN
cord-327697-80msva10	95	26	and	and	CC
cord-327697-80msva10	95	27	comorbidities	comorbiditie	NNS
cord-327697-80msva10	95	28	(	(	-LRB-
cord-327697-80msva10	95	29	heart	heart	NN
cord-327697-80msva10	95	30	failure	failure	NN
cord-327697-80msva10	95	31	,	,	,
cord-327697-80msva10	95	32	diabetes	diabetes	NN
cord-327697-80msva10	95	33	,	,	,
cord-327697-80msva10	96	1	chronic	chronic	JJ
cord-327697-80msva10	96	2	kidney	kidney	NN
cord-327697-80msva10	96	3	disease).These	disease).these	JJ
cord-327697-80msva10	96	4	preliminary	preliminary	JJ
cord-327697-80msva10	96	5	results	result	NNS
cord-327697-80msva10	96	6	not	not	RB
cord-327697-80msva10	96	7	taking	take	VBG
cord-327697-80msva10	96	8	these	these	DT
cord-327697-80msva10	96	9	potential	potential	JJ
cord-327697-80msva10	96	10	confounding	confounding	JJ
cord-327697-80msva10	96	11	factors	factor	NNS
cord-327697-80msva10	96	12	into	into	IN
cord-327697-80msva10	96	13	account	account	NN
cord-327697-80msva10	96	14	may	may	MD
cord-327697-80msva10	96	15	have	have	VB
cord-327697-80msva10	96	16	caused	cause	VBN
cord-327697-80msva10	96	17	cessation	cessation	NN
cord-327697-80msva10	96	18	of	of	IN
cord-327697-80msva10	96	19	these	these	DT
cord-327697-80msva10	96	20	important	important	JJ
cord-327697-80msva10	96	21	beneficial	beneficial	JJ
cord-327697-80msva10	96	22	and	and	CC
cord-327697-80msva10	96	23	More	more	RBR
cord-327697-80msva10	96	24	recently	recently	RB
cord-327697-80msva10	96	25	,	,	,
cord-327697-80msva10	96	26	at	at	IN
cord-327697-80msva10	96	27	later	later	JJ
cord-327697-80msva10	96	28	stages	stage	NNS
cord-327697-80msva10	96	29	of	of	IN
cord-327697-80msva10	96	30	the	the	DT
cord-327697-80msva10	96	31	pandemic	pandemic	NN
cord-327697-80msva10	96	32	,	,	,
cord-327697-80msva10	96	33	more	more	RBR
cord-327697-80msva10	96	34	sophisticated	sophisticated	JJ
cord-327697-80msva10	96	35	studies	study	NNS
cord-327697-80msva10	96	36	were	be	VBD
cord-327697-80msva10	96	37	published	publish	VBN
cord-327697-80msva10	96	38	,	,	,
cord-327697-80msva10	96	39	which	which	WDT
cord-327697-80msva10	96	40	mainly	mainly	RB
cord-327697-80msva10	96	41	aimed	aim	VBD
cord-327697-80msva10	96	42	to	to	TO
cord-327697-80msva10	96	43	clarify	clarify	VB
cord-327697-80msva10	96	44	whether	whether	IN
cord-327697-80msva10	96	45	ACE	ace	NN
cord-327697-80msva10	96	46	-	-	HYPH
cord-327697-80msva10	96	47	i	i	NN
cord-327697-80msva10	96	48	/	/	SYM
cord-327697-80msva10	96	49	ARBs	arb	NNS
cord-327697-80msva10	96	50	were	be	VBD
cord-327697-80msva10	96	51	harmful	harmful	JJ
cord-327697-80msva10	96	52	and	and	CC
cord-327697-80msva10	96	53	to	to	TO
cord-327697-80msva10	96	54	propose	propose	VB
cord-327697-80msva10	96	55	risk	risk	NN
cord-327697-80msva10	96	56	factors	factor	NNS
cord-327697-80msva10	96	57	for	for	IN
cord-327697-80msva10	96	58	severe	severe	JJ
cord-327697-80msva10	96	59	COVID-19	covid-19	JJ
cord-327697-80msva10	96	60	disease	disease	NN
cord-327697-80msva10	96	61	with	with	IN
cord-327697-80msva10	96	62	multivariate	multivariate	JJ
cord-327697-80msva10	96	63	logistic	logistic	JJ
cord-327697-80msva10	96	64	-	-	HYPH
cord-327697-80msva10	96	65	regression	regression	NN
cord-327697-80msva10	96	66	analysis	analysis	NN
cord-327697-80msva10	96	67	.	.	.
cord-327697-80msva10	97	1	However	however	RB
cord-327697-80msva10	97	2	,	,	,
cord-327697-80msva10	97	3	some	some	DT
cord-327697-80msva10	97	4	researchers	researcher	NNS
cord-327697-80msva10	97	5	have	have	VBP
cord-327697-80msva10	97	6	argued	argue	VBN
cord-327697-80msva10	97	7	that	that	IN
cord-327697-80msva10	97	8	ACE	ace	NN
cord-327697-80msva10	97	9	-	-	HYPH
cord-327697-80msva10	97	10	i	i	NNP
cord-327697-80msva10	97	11	/	/	SYM
cord-327697-80msva10	97	12	ARBs	arb	NNS
cord-327697-80msva10	97	13	may	may	MD
cord-327697-80msva10	97	14	have	have	VB
cord-327697-80msva10	97	15	some	some	DT
cord-327697-80msva10	97	16	protective	protective	JJ
cord-327697-80msva10	97	17	effects	effect	NNS
cord-327697-80msva10	97	18	against	against	IN
cord-327697-80msva10	97	19	COVID-19	COVID-19	NNP
cord-327697-80msva10	97	20	disease	disease	NN
cord-327697-80msva10	97	21	.	.	.
cord-327697-80msva10	98	1	It	-PRON-	PRP
cord-327697-80msva10	98	2	has	have	VBZ
cord-327697-80msva10	98	3	been	be	VBN
cord-327697-80msva10	98	4	suggested	suggest	VBN
cord-327697-80msva10	98	5	that	that	IN
cord-327697-80msva10	98	6	ACE2	ACE2	NNP
cord-327697-80msva10	98	7	upregulation	upregulation	NN
cord-327697-80msva10	98	8	by	by	IN
cord-327697-80msva10	98	9	ACE	ace	NN
cord-327697-80msva10	98	10	-	-	HYPH
cord-327697-80msva10	98	11	i	i	NNP
cord-327697-80msva10	98	12	/	/	SYM
cord-327697-80msva10	98	13	ARBs	arb	NNS
cord-327697-80msva10	98	14	inhibitors	inhibitor	NNS
cord-327697-80msva10	98	15	may	may	MD
cord-327697-80msva10	98	16	decrease	decrease	VB
cord-327697-80msva10	98	17	unopposed	unopposed	JJ
cord-327697-80msva10	98	18	angiotensin	angiotensin	NN
cord-327697-80msva10	98	19	II	II	NNP
cord-327697-80msva10	98	20	activity	activity	NN
cord-327697-80msva10	98	21	,	,	,
cord-327697-80msva10	98	22	which	which	WDT
cord-327697-80msva10	98	23	contributes	contribute	VBZ
cord-327697-80msva10	98	24	to	to	IN
cord-327697-80msva10	98	25	facilitating	facilitate	VBG
cord-327697-80msva10	98	26	neutrophil	neutrophil	NN
cord-327697-80msva10	98	27	infiltration	infiltration	NN
cord-327697-80msva10	98	28	and	and	CC
cord-327697-80msva10	98	29	causes	cause	VBZ
cord-327697-80msva10	98	30	organ	organ	NN
cord-327697-80msva10	98	31	injury	injury	NN
cord-327697-80msva10	98	32	in	in	IN
cord-327697-80msva10	98	33	response	response	NN
cord-327697-80msva10	98	34	to	to	IN
cord-327697-80msva10	98	35	bacterial	bacterial	JJ
cord-327697-80msva10	98	36	endotoxin	endotoxin	NN
cord-327697-80msva10	98	37	[	[	-LRB-
cord-327697-80msva10	98	38	18	18	CD
cord-327697-80msva10	98	39	,	,	,
cord-327697-80msva10	98	40	19	19	CD
cord-327697-80msva10	98	41	]	]	-RRB-
cord-327697-80msva10	98	42	.	.	.
cord-327697-80msva10	99	1	In	in	IN
cord-327697-80msva10	99	2	a	a	DT
cord-327697-80msva10	99	3	small	small	JJ
cord-327697-80msva10	99	4	study	study	NN
cord-327697-80msva10	99	5	from	from	IN
cord-327697-80msva10	99	6	China	China	NNP
cord-327697-80msva10	99	7	,	,	,
cord-327697-80msva10	99	8	Liu	Liu	NNP
cord-327697-80msva10	99	9	et	et	NNP
cord-327697-80msva10	99	10	al	al	NNP
cord-327697-80msva10	99	11	.	.	NNP
cord-327697-80msva10	99	12	found	find	VBD
cord-327697-80msva10	99	13	that	that	IN
cord-327697-80msva10	99	14	elevated	elevated	JJ
cord-327697-80msva10	99	15	levels	level	NNS
cord-327697-80msva10	99	16	of	of	IN
cord-327697-80msva10	99	17	plasma	plasma	NN
cord-327697-80msva10	99	18	angiotensin	angiotensin	NN
cord-327697-80msva10	99	19	II	II	NNP
cord-327697-80msva10	99	20	were	be	VBD
cord-327697-80msva10	99	21	correlated	correlate	VBN
cord-327697-80msva10	99	22	with	with	IN
cord-327697-80msva10	99	23	viral	viral	JJ
cord-327697-80msva10	99	24	load	load	NN
cord-327697-80msva10	99	25	and	and	CC
cord-327697-80msva10	99	26	degree	degree	NN
cord-327697-80msva10	99	27	of	of	IN
cord-327697-80msva10	99	28	lung	lung	NN
cord-327697-80msva10	99	29	injury	injury	NN
cord-327697-80msva10	99	30	[	[	-LRB-
cord-327697-80msva10	99	31	20	20	CD
cord-327697-80msva10	99	32	]	]	-RRB-
cord-327697-80msva10	99	33	.	.	.
cord-327697-80msva10	100	1	Prior	prior	RB
cord-327697-80msva10	100	2	to	to	IN
cord-327697-80msva10	100	3	that	that	DT
cord-327697-80msva10	100	4	study	study	NN
cord-327697-80msva10	100	5	,	,	,
cord-327697-80msva10	100	6	there	there	EX
cord-327697-80msva10	100	7	had	have	VBD
cord-327697-80msva10	100	8	been	be	VBN
cord-327697-80msva10	100	9	studies	study	NNS
cord-327697-80msva10	100	10	of	of	IN
cord-327697-80msva10	100	11	other	other	JJ
cord-327697-80msva10	100	12	viruses	virus	NNS
cord-327697-80msva10	100	13	showing	show	VBG
cord-327697-80msva10	100	14	that	that	IN
cord-327697-80msva10	100	15	recombinant	recombinant	JJ
cord-327697-80msva10	100	16	ACE2	ACE2	NNP
cord-327697-80msva10	100	17	administration	administration	NN
cord-327697-80msva10	100	18	reversed	reverse	VBD
cord-327697-80msva10	100	19	lung	lung	NN
cord-327697-80msva10	100	20	injury	injury	NN
cord-327697-80msva10	100	21	[	[	-LRB-
cord-327697-80msva10	100	22	21	21	CD
cord-327697-80msva10	100	23	,	,	,
cord-327697-80msva10	100	24	22	22	CD
cord-327697-80msva10	100	25	]	]	-RRB-
cord-327697-80msva10	100	26	.	.	.
cord-327697-80msva10	101	1	In	in	IN
cord-327697-80msva10	101	2	the	the	DT
cord-327697-80msva10	101	3	current	current	JJ
cord-327697-80msva10	101	4	study	study	NN
cord-327697-80msva10	101	5	,	,	,
cord-327697-80msva10	101	6	16.7	16.7	CD
cord-327697-80msva10	101	7	%	%	NN
cord-327697-80msva10	101	8	of	of	IN
cord-327697-80msva10	101	9	the	the	DT
cord-327697-80msva10	101	10	respondents	respondent	NNS
cord-327697-80msva10	101	11	believed	believe	VBD
cord-327697-80msva10	101	12	that	that	IN
cord-327697-80msva10	101	13	ACEi	ACEi	NNS
cord-327697-80msva10	101	14	/	/	SYM
cord-327697-80msva10	101	15	ARBs	arb	NNS
cord-327697-80msva10	101	16	treatment	treatment	NN
cord-327697-80msva10	101	17	was	be	VBD
cord-327697-80msva10	101	18	associated	associate	VBN
cord-327697-80msva10	101	19	with	with	IN
cord-327697-80msva10	101	20	less	less	RBR
cord-327697-80msva10	101	21	severe	severe	JJ
cord-327697-80msva10	101	22	disease	disease	NN
cord-327697-80msva10	101	23	or	or	CC
cord-327697-80msva10	101	24	a	a	DT
cord-327697-80msva10	101	25	low	low	JJ
cord-327697-80msva10	101	26	likelihood	likelihood	NN
cord-327697-80msva10	101	27	of	of	IN
cord-327697-80msva10	101	28	being	be	VBG
cord-327697-80msva10	101	29	infected	infect	VBN
cord-327697-80msva10	101	30	.	.	.
cord-327697-80msva10	102	1	A	a	DT
cord-327697-80msva10	102	2	recent	recent	JJ
cord-327697-80msva10	102	3	study	study	NN
cord-327697-80msva10	102	4	conducted	conduct	VBN
cord-327697-80msva10	102	5	in	in	IN
cord-327697-80msva10	102	6	Italy	Italy	NNP
cord-327697-80msva10	102	7	clearly	clearly	RB
cord-327697-80msva10	102	8	showed	show	VBD
cord-327697-80msva10	102	9	that	that	IN
cord-327697-80msva10	102	10	neither	neither	CC
cord-327697-80msva10	102	11	ACE	ACE	NNP
cord-327697-80msva10	102	12	inhibitors	inhibitor	NNS
cord-327697-80msva10	102	13	nor	nor	CC
cord-327697-80msva10	102	14	ARBs	arb	NNS
cord-327697-80msva10	102	15	were	be	VBD
cord-327697-80msva10	102	16	harmful	harmful	JJ
cord-327697-80msva10	102	17	during	during	IN
cord-327697-80msva10	102	18	the	the	DT
cord-327697-80msva10	102	19	COVID-19	covid-19	JJ
cord-327697-80msva10	102	20	outbreak	outbreak	NN
cord-327697-80msva10	102	21	[	[	-LRB-
cord-327697-80msva10	102	22	23	23	CD
cord-327697-80msva10	102	23	]	]	-RRB-
cord-327697-80msva10	102	24	.	.	.
cord-327697-80msva10	103	1	In	in	IN
cord-327697-80msva10	103	2	the	the	DT
cord-327697-80msva10	103	3	current	current	JJ
cord-327697-80msva10	103	4	study	study	NN
cord-327697-80msva10	103	5	,	,	,
cord-327697-80msva10	103	6	while	while	IN
cord-327697-80msva10	103	7	physicians	physician	NNS
cord-327697-80msva10	103	8	expressed	express	VBD
cord-327697-80msva10	103	9	many	many	JJ
cord-327697-80msva10	103	10	concerns	concern	NNS
cord-327697-80msva10	103	11	regarding	regard	VBG
cord-327697-80msva10	103	12	ACEi	ACEi	NNS
cord-327697-80msva10	103	13	/	/	SYM
cord-327697-80msva10	103	14	ARBs	arb	NNS
cord-327697-80msva10	103	15	,	,	,
cord-327697-80msva10	103	16	nearly	nearly	RB
cord-327697-80msva10	103	17	half	half	NN
cord-327697-80msva10	103	18	believed	believe	VBD
cord-327697-80msva10	103	19	that	that	IN
cord-327697-80msva10	103	20	ACE	ACE	NNP
cord-327697-80msva10	103	21	-	-	HYPH
cord-327697-80msva10	103	22	i	i	NN
cord-327697-80msva10	103	23	/	/	SYM
cord-327697-80msva10	103	24	ARBs	arb	NNS
cord-327697-80msva10	103	25	treatment	treatment	NN
cord-327697-80msva10	103	26	may	may	MD
cord-327697-80msva10	103	27	worsen	worsen	VB
cord-327697-80msva10	103	28	the	the	DT
cord-327697-80msva10	103	29	clinical	clinical	JJ
cord-327697-80msva10	103	30	scenario	scenario	NN
cord-327697-80msva10	103	31	and	and	CC
cord-327697-80msva10	103	32	increase	increase	VB
cord-327697-80msva10	103	33	the	the	DT
cord-327697-80msva10	103	34	probability	probability	NN
cord-327697-80msva10	103	35	of	of	IN
cord-327697-80msva10	103	36	getting	get	VBG
cord-327697-80msva10	103	37	infected	infect	VBN
cord-327697-80msva10	103	38	.	.	.
cord-327697-80msva10	104	1	However	however	RB
cord-327697-80msva10	104	2	,	,	,
cord-327697-80msva10	104	3	two	two	CD
cord-327697-80msva10	104	4	-	-	HYPH
cord-327697-80msva10	104	5	thirds	third	NNS
cord-327697-80msva10	104	6	of	of	IN
cord-327697-80msva10	104	7	the	the	DT
cord-327697-80msva10	104	8	physicians	physician	NNS
cord-327697-80msva10	104	9	had	have	VBD
cord-327697-80msva10	104	10	not	not	RB
cord-327697-80msva10	104	11	changed	change	VBN
cord-327697-80msva10	104	12	their	-PRON-	PRP$
cord-327697-80msva10	104	13	antihypertensive	antihypertensive	JJ
cord-327697-80msva10	104	14	medication	medication	NN
cord-327697-80msva10	104	15	prescribing	prescribing	NN
cord-327697-80msva10	104	16	pattern	pattern	NN
cord-327697-80msva10	104	17	.	.	.
cord-327697-80msva10	105	1	The	the	DT
cord-327697-80msva10	105	2	results	result	NNS
cord-327697-80msva10	105	3	suggest	suggest	VBP
cord-327697-80msva10	105	4	that	that	IN
cord-327697-80msva10	105	5	the	the	DT
cord-327697-80msva10	105	6	physician	physician	NN
cord-327697-80msva10	105	7	's	's	POS
cord-327697-80msva10	105	8	behavior	behavior	NN
cord-327697-80msva10	105	9	toward	toward	IN
cord-327697-80msva10	105	10	hypertension	hypertension	NN
cord-327697-80msva10	105	11	treatment	treatment	NN
cord-327697-80msva10	105	12	had	have	VBD
cord-327697-80msva10	105	13	not	not	RB
cord-327697-80msva10	105	14	changed	change	VBN
cord-327697-80msva10	105	15	easily	easily	RB
cord-327697-80msva10	105	16	based	base	VBN
cord-327697-80msva10	105	17	on	on	IN
cord-327697-80msva10	105	18	speculations	speculation	NNS
cord-327697-80msva10	105	19	or	or	CC
cord-327697-80msva10	105	20	concerns	concern	NNS
cord-327697-80msva10	105	21	during	during	IN
cord-327697-80msva10	105	22	the	the	DT
cord-327697-80msva10	105	23	pandemic	pandemic	NN
cord-327697-80msva10	105	24	in	in	IN
cord-327697-80msva10	105	25	Turkey	Turkey	NNP
cord-327697-80msva10	105	26	.	.	.
cord-327697-80msva10	106	1	With	with	IN
cord-327697-80msva10	106	2	the	the	DT
cord-327697-80msva10	106	3	argument	argument	NN
cord-327697-80msva10	106	4	regarding	regard	VBG
cord-327697-80msva10	106	5	hypertension	hypertension	NN
cord-327697-80msva10	106	6	as	as	IN
cord-327697-80msva10	106	7	a	a	DT
cord-327697-80msva10	106	8	risk	risk	NN
cord-327697-80msva10	106	9	factor	factor	NN
cord-327697-80msva10	106	10	for	for	IN
cord-327697-80msva10	106	11	COVID-19	COVID-19	NNP
cord-327697-80msva10	106	12	,	,	,
cord-327697-80msva10	106	13	studies	study	NNS
cord-327697-80msva10	106	14	have	have	VBP
cord-327697-80msva10	106	15	been	be	VBN
cord-327697-80msva10	106	16	conducted	conduct	VBN
cord-327697-80msva10	106	17	to	to	TO
cord-327697-80msva10	106	18	determine	determine	VB
cord-327697-80msva10	106	19	which	which	WDT
cord-327697-80msva10	106	20	antihypertensive	antihypertensive	JJ
cord-327697-80msva10	106	21	medications	medication	NNS
cord-327697-80msva10	106	22	are	be	VBP
cord-327697-80msva10	106	23	the	the	DT
cord-327697-80msva10	106	24	safest	safe	JJS
cord-327697-80msva10	106	25	.	.	.
cord-327697-80msva10	107	1	Reynolds	Reynolds	NNP
cord-327697-80msva10	107	2	et	et	NNP
cord-327697-80msva10	107	3	al	al	NNP
cord-327697-80msva10	107	4	.	.	.
cord-327697-80msva10	108	1	assessed	assess	VBD
cord-327697-80msva10	108	2	the	the	DT
cord-327697-80msva10	108	3	relationship	relationship	NN
cord-327697-80msva10	108	4	between	between	IN
cord-327697-80msva10	108	5	five	five	CD
cord-327697-80msva10	108	6	common	common	JJ
cord-327697-80msva10	108	7	classes	class	NNS
cord-327697-80msva10	108	8	of	of	IN
cord-327697-80msva10	108	9	antihypertensive	antihypertensive	JJ
cord-327697-80msva10	108	10	medications	medication	NNS
cord-327697-80msva10	108	11	(	(	-LRB-
cord-327697-80msva10	108	12	ACE	ACE	NNP
cord-327697-80msva10	108	13	-	-	HYPH
cord-327697-80msva10	108	14	i/	i/	NNP
cord-327697-80msva10	108	15	ARBs	arb	NNS
cord-327697-80msva10	108	16	,	,	,
cord-327697-80msva10	108	17	beta	beta	NN
cord-327697-80msva10	108	18	-	-	HYPH
cord-327697-80msva10	108	19	blockers	blocker	NNS
cord-327697-80msva10	108	20	,	,	,
cord-327697-80msva10	108	21	calcium	calcium	NN
cord-327697-80msva10	108	22	-	-	HYPH
cord-327697-80msva10	108	23	channel	channel	NN
cord-327697-80msva10	108	24	blockers	blocker	NNS
cord-327697-80msva10	108	25	,	,	,
cord-327697-80msva10	108	26	thiazide	thiazide	NN
cord-327697-80msva10	108	27	diuretics	diuretic	NNS
cord-327697-80msva10	108	28	)	)	-RRB-
cord-327697-80msva10	108	29	and	and	CC
cord-327697-80msva10	108	30	COVID-19	covid-19	VBP
cord-327697-80msva10	108	31	[	[	-LRB-
cord-327697-80msva10	108	32	24	24	CD
cord-327697-80msva10	108	33	]	]	-RRB-
cord-327697-80msva10	108	34	.	.	.
cord-327697-80msva10	109	1	There	there	EX
cord-327697-80msva10	109	2	was	be	VBD
cord-327697-80msva10	109	3	reported	report	VBN
cord-327697-80msva10	109	4	to	to	TO
cord-327697-80msva10	109	5	be	be	VB
cord-327697-80msva10	109	6	no	no	DT
cord-327697-80msva10	109	7	association	association	NN
cord-327697-80msva10	109	8	for	for	IN
cord-327697-80msva10	109	9	any	any	DT
cord-327697-80msva10	109	10	of	of	IN
cord-327697-80msva10	109	11	the	the	DT
cord-327697-80msva10	109	12	mentioned	mention	VBN
cord-327697-80msva10	109	13	drug	drug	NN
cord-327697-80msva10	109	14	classes	class	NNS
cord-327697-80msva10	109	15	.	.	.
cord-327697-80msva10	110	1	In	in	IN
cord-327697-80msva10	110	2	the	the	DT
cord-327697-80msva10	110	3	current	current	JJ
cord-327697-80msva10	110	4	study	study	NN
cord-327697-80msva10	110	5	,	,	,
cord-327697-80msva10	110	6	majority	majority	NN
cord-327697-80msva10	110	7	of	of	IN
cord-327697-80msva10	110	8	respondents	respondent	NNS
cord-327697-80msva10	110	9	stated	state	VBD
cord-327697-80msva10	110	10	that	that	IN
cord-327697-80msva10	110	11	they	-PRON-	PRP
cord-327697-80msva10	110	12	continued	continue	VBD
cord-327697-80msva10	110	13	as	as	IN
cord-327697-80msva10	110	14	before	before	RB
cord-327697-80msva10	110	15	and	and	CC
cord-327697-80msva10	110	16	had	have	VBD
cord-327697-80msva10	110	17	made	make	VBN
cord-327697-80msva10	110	18	no	no	DT
cord-327697-80msva10	110	19	change	change	NN
cord-327697-80msva10	110	20	in	in	IN
cord-327697-80msva10	110	21	their	-PRON-	PRP$
cord-327697-80msva10	110	22	treatment	treatment	NN
cord-327697-80msva10	110	23	regimen	regimen	NN
cord-327697-80msva10	110	24	,	,	,
cord-327697-80msva10	110	25	and	and	CC
cord-327697-80msva10	110	26	only	only	RB
cord-327697-80msva10	110	27	a	a	DT
cord-327697-80msva10	110	28	small	small	JJ
cord-327697-80msva10	110	29	number	number	NN
cord-327697-80msva10	110	30	of	of	IN
cord-327697-80msva10	110	31	participants	participant	NNS
cord-327697-80msva10	110	32	emitted	emit	VBD
cord-327697-80msva10	110	33	that	that	IN
cord-327697-80msva10	110	34	they	-PRON-	PRP
cord-327697-80msva10	110	35	were	be	VBD
cord-327697-80msva10	110	36	hesitant	hesitant	JJ
cord-327697-80msva10	110	37	to	to	TO
cord-327697-80msva10	110	38	start	start	VB
cord-327697-80msva10	110	39	new	new	JJ
cord-327697-80msva10	110	40	ACE	ace	NN
cord-327697-80msva10	110	41	-	-	HYPH
cord-327697-80msva10	110	42	i	i	NN
cord-327697-80msva10	110	43	/	/	SYM
cord-327697-80msva10	110	44	ARBs	arb	NNS
cord-327697-80msva10	110	45	therapies	therapy	NNS
cord-327697-80msva10	110	46	.	.	.
cord-327697-80msva10	111	1	Ca	Ca	MD
cord-327697-80msva10	111	2	channel	channel	NN
cord-327697-80msva10	111	3	blockers	blocker	NNS
cord-327697-80msva10	111	4	were	be	VBD
cord-327697-80msva10	111	5	considered	consider	VBN
cord-327697-80msva10	111	6	a	a	DT
cord-327697-80msva10	111	7	safe	safe	JJ
cord-327697-80msva10	111	8	alternative	alternative	NN
cord-327697-80msva10	111	9	in	in	IN
cord-327697-80msva10	111	10	cases	case	NNS
cord-327697-80msva10	111	11	where	where	WRB
cord-327697-80msva10	111	12	ACE	ACE	NNP
cord-327697-80msva10	111	13	-	-	HYPH
cord-327697-80msva10	111	14	i	i	NN
cord-327697-80msva10	111	15	/	/	SYM
cord-327697-80msva10	111	16	ARBs	arb	NNS
cord-327697-80msva10	111	17	drugs	drug	NNS
cord-327697-80msva10	111	18	were	be	VBD
cord-327697-80msva10	111	19	discontinued	discontinue	VBN
cord-327697-80msva10	111	20	or	or	CC
cord-327697-80msva10	111	21	changed	change	VBN
cord-327697-80msva10	111	22	,	,	,
cord-327697-80msva10	111	23	and	and	CC
cord-327697-80msva10	111	24	12.9	12.9	CD
cord-327697-80msva10	111	25	%	%	NN
cord-327697-80msva10	111	26	of	of	IN
cord-327697-80msva10	111	27	physicians	physician	NNS
cord-327697-80msva10	111	28	reported	report	VBN
cord-327697-80msva10	111	29	that	that	IN
cord-327697-80msva10	111	30	they	-PRON-	PRP
cord-327697-80msva10	111	31	preferred	prefer	VBD
cord-327697-80msva10	111	32	CCB	CCB	NNP
cord-327697-80msva10	111	33	instead	instead	RB
cord-327697-80msva10	111	34	of	of	IN
cord-327697-80msva10	111	35	ACE	ACE	NNP
cord-327697-80msva10	111	36	-	-	HYPH
cord-327697-80msva10	111	37	i	i	NNP
cord-327697-80msva10	111	38	/	/	SYM
cord-327697-80msva10	111	39	ARBs	arb	NNS
cord-327697-80msva10	111	40	.	.	.
cord-327697-80msva10	112	1	Between	between	IN
cord-327697-80msva10	112	2	Internal	internal	JJ
cord-327697-80msva10	112	3	medicine	medicine	NN
cord-327697-80msva10	112	4	and	and	CC
cord-327697-80msva10	112	5	Cardiologist	cardiologist	NN
cord-327697-80msva10	112	6	p	p	NN
cord-327697-80msva10	112	7	<	<	XX
cord-327697-80msva10	112	8	0.05	0.05	CD
cord-327697-80msva10	112	9	.	.	.
cord-327697-80msva10	113	1	Table	table	NN
cord-327697-80msva10	113	2	3	3	CD
cord-327697-80msva10	113	3	Effect	effect	NN
cord-327697-80msva10	113	4	of	of	IN
cord-327697-80msva10	113	5	duration	duration	NN
cord-327697-80msva10	113	6	on	on	IN
cord-327697-80msva10	113	7	practice	practice	NN
cord-327697-80msva10	113	8	and	and	CC
cord-327697-80msva10	113	9	working	working	NN
cord-327697-80msva10	113	10	center	center	NN
cord-327697-80msva10	113	11	on	on	IN
cord-327697-80msva10	113	12	reliance	reliance	NN
cord-327697-80msva10	113	13	level	level	NN
cord-327697-80msva10	113	14	of	of	IN
cord-327697-80msva10	113	15	ACE	ace	NN
cord-327697-80msva10	113	16	-	-	HYPH
cord-327697-80msva10	113	17	i	i	NN
cord-327697-80msva10	113	18	/	/	SYM
cord-327697-80msva10	113	19	ARBs	arb	NNS
cord-327697-80msva10	113	20	.	.	.
cord-327697-80msva10	114	1	General	general	JJ
cord-327697-80msva10	114	2	reliance	reliance	NN
cord-327697-80msva10	115	1	The	the	DT
cord-327697-80msva10	115	2	data	datum	NNS
cord-327697-80msva10	115	3	are	be	VBP
cord-327697-80msva10	115	4	expressed	express	VBN
cord-327697-80msva10	115	5	as	as	IN
cord-327697-80msva10	115	6	median	median	NN
cord-327697-80msva10	115	7	±	±	NNP
cord-327697-80msva10	115	8	interquartile	interquartile	JJ
cord-327697-80msva10	115	9	range	range	NN
cord-327697-80msva10	115	10	.	.	.
cord-327697-80msva10	116	1	From	from	IN
cord-327697-80msva10	116	2	the	the	DT
cord-327697-80msva10	116	3	results	result	NNS
cord-327697-80msva10	116	4	of	of	IN
cord-327697-80msva10	116	5	this	this	DT
cord-327697-80msva10	116	6	study	study	NN
cord-327697-80msva10	116	7	,	,	,
cord-327697-80msva10	116	8	it	-PRON-	PRP
cord-327697-80msva10	116	9	appears	appear	VBZ
cord-327697-80msva10	116	10	that	that	IN
cord-327697-80msva10	116	11	practicing	practice	VBG
cord-327697-80msva10	116	12	physicians	physician	NNS
cord-327697-80msva10	116	13	found	find	VBD
cord-327697-80msva10	116	14	less	less	JJR
cord-327697-80msva10	116	15	risk	risk	NN
cord-327697-80msva10	116	16	in	in	IN
cord-327697-80msva10	116	17	changing	change	VBG
cord-327697-80msva10	116	18	their	-PRON-	PRP$
cord-327697-80msva10	116	19	prescribing	prescribe	VBG
cord-327697-80msva10	116	20	behavior	behavior	NN
cord-327697-80msva10	116	21	in	in	IN
cord-327697-80msva10	116	22	cases	case	NNS
cord-327697-80msva10	116	23	with	with	IN
cord-327697-80msva10	116	24	hypertension	hypertension	NN
cord-327697-80msva10	116	25	alone	alone	JJ
cord-327697-80msva10	116	26	.	.	.
cord-327697-80msva10	117	1	Nevertheless	nevertheless	RB
cord-327697-80msva10	117	2	,	,	,
cord-327697-80msva10	117	3	they	-PRON-	PRP
cord-327697-80msva10	117	4	considered	consider	VBD
cord-327697-80msva10	117	5	continuing	continue	VBG
cord-327697-80msva10	117	6	with	with	IN
cord-327697-80msva10	117	7	RAAS	RAAS	NNP
cord-327697-80msva10	117	8	inhibitors	inhibitor	NNS
cord-327697-80msva10	117	9	,	,	,
cord-327697-80msva10	117	10	which	which	WDT
cord-327697-80msva10	117	11	are	be	VBP
cord-327697-80msva10	117	12	cornerstone	cornerstone	NN
cord-327697-80msva10	117	13	therapies	therapy	NNS
cord-327697-80msva10	117	14	in	in	IN
cord-327697-80msva10	117	15	heart	heart	NN
cord-327697-80msva10	117	16	failure	failure	NN
cord-327697-80msva10	117	17	patients	patient	NNS
cord-327697-80msva10	117	18	.	.	.
cord-327697-80msva10	118	1	SARS	SARS	NNP
cord-327697-80msva10	118	2	-	-	HYPH
cord-327697-80msva10	118	3	CoV-2	CoV-2	NNP
cord-327697-80msva10	118	4	virus	virus	NN
cord-327697-80msva10	118	5	is	be	VBZ
cord-327697-80msva10	118	6	a	a	DT
cord-327697-80msva10	118	7	cardiotropic	cardiotropic	JJ
cord-327697-80msva10	118	8	virus	virus	NN
cord-327697-80msva10	118	9	than	than	IN
cord-327697-80msva10	118	10	can	can	MD
cord-327697-80msva10	118	11	cause	cause	VB
cord-327697-80msva10	118	12	severe	severe	JJ
cord-327697-80msva10	118	13	myocarditis	myocarditis	NN
cord-327697-80msva10	118	14	in	in	IN
cord-327697-80msva10	118	15	up	up	IN
cord-327697-80msva10	118	16	to	to	TO
cord-327697-80msva10	118	17	40	40	CD
cord-327697-80msva10	118	18	%	%	NN
cord-327697-80msva10	118	19	of	of	IN
cord-327697-80msva10	118	20	critically	critically	RB
cord-327697-80msva10	118	21	ill	ill	JJ
cord-327697-80msva10	118	22	patients	patient	NNS
cord-327697-80msva10	118	23	[	[	-LRB-
cord-327697-80msva10	118	24	25	25	CD
cord-327697-80msva10	118	25	]	]	-RRB-
cord-327697-80msva10	118	26	.	.	.
cord-327697-80msva10	119	1	Cessation	cessation	NN
cord-327697-80msva10	119	2	of	of	IN
cord-327697-80msva10	119	3	ACE	ACE	NNP
cord-327697-80msva10	119	4	-	-	HYPH
cord-327697-80msva10	119	5	i	i	NN
cord-327697-80msva10	119	6	/	/	SYM
cord-327697-80msva10	119	7	ARBs	arb	NNS
cord-327697-80msva10	119	8	treatment	treatment	NN
cord-327697-80msva10	119	9	may	may	MD
cord-327697-80msva10	119	10	lead	lead	VB
cord-327697-80msva10	119	11	to	to	IN
cord-327697-80msva10	119	12	decompensation	decompensation	NN
cord-327697-80msva10	119	13	in	in	IN
cord-327697-80msva10	119	14	those	those	DT
cord-327697-80msva10	119	15	with	with	IN
cord-327697-80msva10	119	16	previous	previous	JJ
cord-327697-80msva10	119	17	heart	heart	NN
cord-327697-80msva10	119	18	failure	failure	NN
cord-327697-80msva10	119	19	and	and	CC
cord-327697-80msva10	119	20	results	result	NNS
cord-327697-80msva10	119	21	in	in	IN
cord-327697-80msva10	119	22	SARS	SARS	NNP
cord-327697-80msva10	119	23	-	-	HYPH
cord-327697-80msva10	119	24	CoV-2	CoV-2	NNP
cord-327697-80msva10	119	25	infected	infect	VBN
cord-327697-80msva10	119	26	patients	patient	NNS
cord-327697-80msva10	119	27	being	be	VBG
cord-327697-80msva10	119	28	more	more	RBR
cord-327697-80msva10	119	29	susceptible	susceptible	JJ
cord-327697-80msva10	119	30	to	to	IN
cord-327697-80msva10	119	31	myocardial	myocardial	JJ
cord-327697-80msva10	119	32	damage	damage	NN
cord-327697-80msva10	119	33	.	.	.
cord-327697-80msva10	120	1	An	an	DT
cord-327697-80msva10	120	2	interesting	interesting	JJ
cord-327697-80msva10	120	3	new	new	JJ
cord-327697-80msva10	120	4	hypothetical	hypothetical	JJ
cord-327697-80msva10	120	5	study	study	NN
cord-327697-80msva10	120	6	from	from	IN
cord-327697-80msva10	120	7	England	England	NNP
cord-327697-80msva10	120	8	investigated	investigate	VBD
cord-327697-80msva10	120	9	the	the	DT
cord-327697-80msva10	120	10	connection	connection	NN
cord-327697-80msva10	120	11	of	of	IN
cord-327697-80msva10	120	12	influenza	influenza	NN
cord-327697-80msva10	120	13	infection	infection	NN
cord-327697-80msva10	120	14	with	with	IN
cord-327697-80msva10	120	15	SARS	SARS	NNP
cord-327697-80msva10	120	16	disease	disease	NN
cord-327697-80msva10	120	17	via	via	IN
cord-327697-80msva10	120	18	the	the	DT
cord-327697-80msva10	120	19	shared	share	VBN
cord-327697-80msva10	120	20	mechanism	mechanism	NN
cord-327697-80msva10	120	21	of	of	IN
cord-327697-80msva10	120	22	both	both	DT
cord-327697-80msva10	120	23	for	for	IN
cord-327697-80msva10	120	24	entering	enter	VBG
cord-327697-80msva10	120	25	the	the	DT
cord-327697-80msva10	120	26	human	human	JJ
cord-327697-80msva10	120	27	cells	cell	NNS
cord-327697-80msva10	120	28	by	by	IN
cord-327697-80msva10	120	29	ACE2	ACE2	NNP
cord-327697-80msva10	120	30	receptors	receptor	NNS
cord-327697-80msva10	120	31	[	[	-LRB-
cord-327697-80msva10	120	32	26	26	CD
cord-327697-80msva10	120	33	]	]	-RRB-
cord-327697-80msva10	120	34	.	.	.
cord-327697-80msva10	121	1	The	the	DT
cord-327697-80msva10	121	2	use	use	NN
cord-327697-80msva10	121	3	of	of	IN
cord-327697-80msva10	121	4	ACE	ace	NN
cord-327697-80msva10	121	5	-	-	HYPH
cord-327697-80msva10	121	6	i	i	NN
cord-327697-80msva10	121	7	/	/	SYM
cord-327697-80msva10	121	8	ARBs	arb	NNS
cord-327697-80msva10	121	9	therapies	therapy	NNS
cord-327697-80msva10	121	10	was	be	VBD
cord-327697-80msva10	121	11	found	find	VBN
cord-327697-80msva10	121	12	to	to	TO
cord-327697-80msva10	121	13	be	be	VB
cord-327697-80msva10	121	14	associated	associate	VBN
cord-327697-80msva10	121	15	with	with	IN
cord-327697-80msva10	121	16	either	either	CC
cord-327697-80msva10	121	17	no	no	DT
cord-327697-80msva10	121	18	effect	effect	NN
cord-327697-80msva10	121	19	on	on	IN
cord-327697-80msva10	121	20	the	the	DT
cord-327697-80msva10	121	21	incidence	incidence	NN
cord-327697-80msva10	121	22	of	of	IN
cord-327697-80msva10	121	23	influenza	influenza	NN
cord-327697-80msva10	121	24	or	or	CC
cord-327697-80msva10	121	25	possibly	possibly	RB
cord-327697-80msva10	121	26	a	a	DT
cord-327697-80msva10	121	27	much	much	RB
cord-327697-80msva10	121	28	lower	low	JJR
cord-327697-80msva10	121	29	incidence	incidence	NN
cord-327697-80msva10	121	30	,	,	,
cord-327697-80msva10	121	31	depending	depend	VBG
cord-327697-80msva10	121	32	on	on	IN
cord-327697-80msva10	121	33	the	the	DT
cord-327697-80msva10	121	34	duration	duration	NN
cord-327697-80msva10	121	35	of	of	IN
cord-327697-80msva10	121	36	use	use	NN
cord-327697-80msva10	121	37	.	.	.
cord-327697-80msva10	122	1	Based	base	VBN
cord-327697-80msva10	122	2	on	on	IN
cord-327697-80msva10	122	3	this	this	DT
cord-327697-80msva10	122	4	trial	trial	NN
cord-327697-80msva10	122	5	,	,	,
cord-327697-80msva10	122	6	it	-PRON-	PRP
cord-327697-80msva10	122	7	was	be	VBD
cord-327697-80msva10	122	8	suggested	suggest	VBN
cord-327697-80msva10	122	9	that	that	IN
cord-327697-80msva10	122	10	the	the	DT
cord-327697-80msva10	122	11	same	same	JJ
cord-327697-80msva10	122	12	relationship	relationship	NN
cord-327697-80msva10	122	13	can	can	MD
cord-327697-80msva10	122	14	be	be	VB
cord-327697-80msva10	122	15	seen	see	VBN
cord-327697-80msva10	122	16	in	in	IN
cord-327697-80msva10	122	17	SARS	SARS	NNP
cord-327697-80msva10	122	18	-	-	HYPH
cord-327697-80msva10	122	19	CoV-2	CoV-2	NNP
cord-327697-80msva10	122	20	.	.	.
cord-327697-80msva10	123	1	This	this	DT
cord-327697-80msva10	123	2	study	study	NN
cord-327697-80msva10	123	3	had	have	VBD
cord-327697-80msva10	123	4	several	several	JJ
cord-327697-80msva10	123	5	limitations	limitation	NNS
cord-327697-80msva10	123	6	.	.	.
cord-327697-80msva10	124	1	The	the	DT
cord-327697-80msva10	124	2	overall	overall	JJ
cord-327697-80msva10	124	3	sample	sample	NN
cord-327697-80msva10	124	4	size	size	NN
cord-327697-80msva10	124	5	was	be	VBD
cord-327697-80msva10	124	6	small	small	JJ
cord-327697-80msva10	124	7	and	and	CC
cord-327697-80msva10	124	8	the	the	DT
cord-327697-80msva10	124	9	subgroups	subgroup	NNS
cord-327697-80msva10	124	10	were	be	VBD
cord-327697-80msva10	124	11	not	not	RB
cord-327697-80msva10	124	12	normalized	normalize	VBN
cord-327697-80msva10	124	13	to	to	IN
cord-327697-80msva10	124	14	the	the	DT
cord-327697-80msva10	124	15	practicing	practice	VBG
cord-327697-80msva10	124	16	population	population	NN
cord-327697-80msva10	124	17	of	of	IN
cord-327697-80msva10	124	18	family	family	NN
cord-327697-80msva10	124	19	medicine	medicine	NN
cord-327697-80msva10	124	20	,	,	,
cord-327697-80msva10	124	21	internal	internal	JJ
cord-327697-80msva10	124	22	medicine	medicine	NN
cord-327697-80msva10	124	23	,	,	,
cord-327697-80msva10	124	24	cardiologist	cardiologist	NN
cord-327697-80msva10	124	25	,	,	,
cord-327697-80msva10	124	26	and	and	CC
cord-327697-80msva10	124	27	general	general	JJ
cord-327697-80msva10	124	28	practitioner	practitioner	NN
cord-327697-80msva10	124	29	.	.	.
cord-327697-80msva10	125	1	In	in	IN
cord-327697-80msva10	125	2	addition	addition	NN
cord-327697-80msva10	125	3	,	,	,
cord-327697-80msva10	125	4	the	the	DT
cord-327697-80msva10	125	5	questionnaire	questionnaire	NN
cord-327697-80msva10	125	6	that	that	WDT
cord-327697-80msva10	125	7	was	be	VBD
cord-327697-80msva10	125	8	used	use	VBN
cord-327697-80msva10	125	9	had	have	VBD
cord-327697-80msva10	125	10	not	not	RB
cord-327697-80msva10	125	11	been	be	VBN
cord-327697-80msva10	125	12	previously	previously	RB
cord-327697-80msva10	125	13	validated	validate	VBN
cord-327697-80msva10	125	14	.	.	.
cord-327697-80msva10	126	1	In	in	IN
cord-327697-80msva10	126	2	the	the	DT
cord-327697-80msva10	126	3	literature	literature	NN
cord-327697-80msva10	126	4	,	,	,
cord-327697-80msva10	126	5	there	there	EX
cord-327697-80msva10	126	6	are	be	VBP
cord-327697-80msva10	126	7	no	no	DT
cord-327697-80msva10	126	8	other	other	JJ
cord-327697-80msva10	126	9	studies	study	NNS
cord-327697-80msva10	126	10	that	that	WDT
cord-327697-80msva10	126	11	have	have	VBP
cord-327697-80msva10	126	12	utilized	utilize	VBN
cord-327697-80msva10	126	13	a	a	DT
cord-327697-80msva10	126	14	questionnaire	questionnaire	NN
cord-327697-80msva10	126	15	to	to	TO
cord-327697-80msva10	126	16	measure	measure	VB
cord-327697-80msva10	126	17	physicians	physician	NNS
cord-327697-80msva10	126	18	'	'	POS
cord-327697-80msva10	126	19	attitudes	attitude	NNS
cord-327697-80msva10	126	20	regarding	regard	VBG
cord-327697-80msva10	126	21	SARS	SARS	NNP
cord-327697-80msva10	126	22	-	-	HYPH
cord-327697-80msva10	126	23	CoV-2	CoV-2	NNP
cord-327697-80msva10	126	24	and	and	CC
cord-327697-80msva10	126	25	hypertension	hypertension	NN
cord-327697-80msva10	126	26	treatment	treatment	NN
cord-327697-80msva10	126	27	interactions	interaction	NNS
cord-327697-80msva10	126	28	.	.	.
cord-327697-80msva10	127	1	The	the	DT
cord-327697-80msva10	127	2	study	study	NN
cord-327697-80msva10	127	3	population	population	NN
cord-327697-80msva10	127	4	was	be	VBD
cord-327697-80msva10	127	5	sampled	sample	VBN
cord-327697-80msva10	127	6	at	at	IN
cord-327697-80msva10	127	7	hospitals	hospital	NNS
cord-327697-80msva10	127	8	and	and	CC
cord-327697-80msva10	127	9	family	family	NN
cord-327697-80msva10	127	10	health	health	NN
cord-327697-80msva10	127	11	centers	center	NNS
cord-327697-80msva10	127	12	in	in	IN
cord-327697-80msva10	127	13	six	six	CD
cord-327697-80msva10	127	14	major	major	JJ
cord-327697-80msva10	127	15	cities	city	NNS
cord-327697-80msva10	127	16	in	in	IN
cord-327697-80msva10	127	17	Turkey	Turkey	NNP
cord-327697-80msva10	127	18	,	,	,
cord-327697-80msva10	127	19	so	so	CC
cord-327697-80msva10	127	20	the	the	DT
cord-327697-80msva10	127	21	results	result	NNS
cord-327697-80msva10	127	22	might	may	MD
cord-327697-80msva10	127	23	not	not	RB
cord-327697-80msva10	127	24	be	be	VB
cord-327697-80msva10	127	25	reflective	reflective	JJ
cord-327697-80msva10	127	26	of	of	IN
cord-327697-80msva10	127	27	physicians	physician	NNS
cord-327697-80msva10	127	28	practicing	practice	VBG
cord-327697-80msva10	127	29	in	in	IN
cord-327697-80msva10	127	30	the	the	DT
cord-327697-80msva10	127	31	whole	whole	NN
cord-327697-80msva10	127	32	of	of	IN
cord-327697-80msva10	127	33	Turkey	Turkey	NNP
cord-327697-80msva10	127	34	.	.	.
cord-327697-80msva10	128	1	The	the	DT
cord-327697-80msva10	128	2	physicians	physician	NNS
cord-327697-80msva10	128	3	interested	interested	JJ
cord-327697-80msva10	128	4	in	in	IN
cord-327697-80msva10	128	5	this	this	DT
cord-327697-80msva10	128	6	issue	issue	NN
cord-327697-80msva10	128	7	might	may	MD
cord-327697-80msva10	128	8	have	have	VB
cord-327697-80msva10	128	9	agreed	agree	VBN
cord-327697-80msva10	128	10	to	to	TO
cord-327697-80msva10	128	11	participate	participate	VB
cord-327697-80msva10	128	12	in	in	IN
cord-327697-80msva10	128	13	the	the	DT
cord-327697-80msva10	128	14	survey	survey	NN
cord-327697-80msva10	128	15	,	,	,
cord-327697-80msva10	128	16	which	which	WDT
cord-327697-80msva10	128	17	could	could	MD
cord-327697-80msva10	128	18	have	have	VB
cord-327697-80msva10	128	19	led	lead	VBN
cord-327697-80msva10	128	20	to	to	IN
cord-327697-80msva10	128	21	the	the	DT
cord-327697-80msva10	128	22	high	high	JJ
cord-327697-80msva10	128	23	rate	rate	NN
cord-327697-80msva10	128	24	of	of	IN
cord-327697-80msva10	128	25	physicians	physician	NNS
cord-327697-80msva10	128	26	who	who	WP
cord-327697-80msva10	128	27	did	do	VBD
cord-327697-80msva10	128	28	not	not	RB
cord-327697-80msva10	128	29	change	change	VB
cord-327697-80msva10	128	30	the	the	DT
cord-327697-80msva10	128	31	treatment	treatment	NN
cord-327697-80msva10	128	32	strategy	strategy	NN
cord-327697-80msva10	128	33	.	.	.
cord-327697-80msva10	129	1	The	the	DT
cord-327697-80msva10	129	2	present	present	JJ
cord-327697-80msva10	129	3	survey	survey	NN
cord-327697-80msva10	129	4	is	be	VBZ
cord-327697-80msva10	129	5	the	the	DT
cord-327697-80msva10	129	6	first	first	JJ
cord-327697-80msva10	129	7	study	study	NN
cord-327697-80msva10	129	8	to	to	TO
cord-327697-80msva10	129	9	have	have	VB
cord-327697-80msva10	129	10	provided	provide	VBN
cord-327697-80msva10	129	11	a	a	DT
cord-327697-80msva10	129	12	snapshot	snapshot	JJ
cord-327697-80msva10	129	13	showing	show	VBG
cord-327697-80msva10	129	14	behaviors	behavior	NNS
cord-327697-80msva10	129	15	of	of	IN
cord-327697-80msva10	129	16	Turkish	turkish	JJ
cord-327697-80msva10	129	17	physicians	physician	NNS
cord-327697-80msva10	129	18	toward	toward	IN
cord-327697-80msva10	129	19	prescribing	prescribe	VBG
cord-327697-80msva10	129	20	ACE	ACE	NNP
cord-327697-80msva10	129	21	-	-	HYPH
cord-327697-80msva10	129	22	i	i	NN
cord-327697-80msva10	129	23	/	/	SYM
cord-327697-80msva10	129	24	ARBs	arb	NNS
cord-327697-80msva10	129	25	treatment	treatment	NN
cord-327697-80msva10	129	26	during	during	IN
cord-327697-80msva10	129	27	the	the	DT
cord-327697-80msva10	129	28	COVID-19	COVID-19	NNP
cord-327697-80msva10	129	29	pandemic	pandemic	NN
cord-327697-80msva10	129	30	.	.	.
cord-327697-80msva10	130	1	An	an	DT
cord-327697-80msva10	130	2	important	important	JJ
cord-327697-80msva10	130	3	finding	finding	NN
cord-327697-80msva10	130	4	of	of	IN
cord-327697-80msva10	130	5	this	this	DT
cord-327697-80msva10	130	6	study	study	NN
cord-327697-80msva10	130	7	is	be	VBZ
cord-327697-80msva10	130	8	that	that	IN
cord-327697-80msva10	130	9	the	the	DT
cord-327697-80msva10	130	10	majority	majority	NN
cord-327697-80msva10	130	11	of	of	IN
cord-327697-80msva10	130	12	physicians	physician	NNS
cord-327697-80msva10	130	13	were	be	VBD
cord-327697-80msva10	130	14	not	not	RB
cord-327697-80msva10	130	15	affected	affect	VBN
cord-327697-80msva10	130	16	by	by	IN
cord-327697-80msva10	130	17	the	the	DT
cord-327697-80msva10	130	18	concerns	concern	NNS
cord-327697-80msva10	130	19	,	,	,
cord-327697-80msva10	130	20	which	which	WDT
cord-327697-80msva10	130	21	had	have	VBD
cord-327697-80msva10	130	22	arisen	arise	VBN
cord-327697-80msva10	130	23	at	at	IN
cord-327697-80msva10	130	24	the	the	DT
cord-327697-80msva10	130	25	beginning	beginning	NN
cord-327697-80msva10	130	26	of	of	IN
cord-327697-80msva10	130	27	the	the	DT
cord-327697-80msva10	130	28	pandemic	pandemic	NN
cord-327697-80msva10	130	29	and	and	CC
cord-327697-80msva10	130	30	continued	continue	VBD
cord-327697-80msva10	130	31	to	to	TO
cord-327697-80msva10	130	32	prescribe	prescribe	VB
cord-327697-80msva10	130	33	ACE	ACE	NNP
cord-327697-80msva10	130	34	-	-	HYPH
cord-327697-80msva10	130	35	i	i	NN
cord-327697-80msva10	130	36	/	/	SYM
cord-327697-80msva10	130	37	ARBs	arb	NNS
cord-327697-80msva10	130	38	treatments	treatment	NNS
cord-327697-80msva10	130	39	.	.	.
cord-327697-80msva10	131	1	However	however	RB
cord-327697-80msva10	131	2	,	,	,
cord-327697-80msva10	131	3	there	there	EX
cord-327697-80msva10	131	4	was	be	VBD
cord-327697-80msva10	131	5	a	a	DT
cord-327697-80msva10	131	6	statistically	statistically	RB
cord-327697-80msva10	131	7	significant	significant	JJ
cord-327697-80msva10	131	8	difference	difference	NN
cord-327697-80msva10	131	9	between	between	IN
cord-327697-80msva10	131	10	different	different	JJ
cord-327697-80msva10	131	11	physician	physician	NN
cord-327697-80msva10	131	12	specialties	specialty	NNS
cord-327697-80msva10	131	13	in	in	IN
cord-327697-80msva10	131	14	the	the	DT
cord-327697-80msva10	131	15	reliance	reliance	NN
cord-327697-80msva10	131	16	level	level	NN
cord-327697-80msva10	131	17	in	in	IN
cord-327697-80msva10	131	18	different	different	JJ
cord-327697-80msva10	131	19	clinical	clinical	JJ
cord-327697-80msva10	131	20	situations	situation	NNS
cord-327697-80msva10	131	21	.	.	.
cord-327697-80msva10	132	1	Given	give	VBN
cord-327697-80msva10	132	2	the	the	DT
cord-327697-80msva10	132	3	probability	probability	NN
cord-327697-80msva10	132	4	of	of	IN
cord-327697-80msva10	132	5	emerging	emerge	VBG
cord-327697-80msva10	132	6	new	new	JJ
cord-327697-80msva10	132	7	evidence	evidence	NN
cord-327697-80msva10	132	8	on	on	IN
cord-327697-80msva10	132	9	this	this	DT
cord-327697-80msva10	132	10	matter	matter	NN
cord-327697-80msva10	132	11	,	,	,
cord-327697-80msva10	132	12	additional	additional	JJ
cord-327697-80msva10	132	13	studies	study	NNS
cord-327697-80msva10	132	14	should	should	MD
cord-327697-80msva10	132	15	be	be	VB
cord-327697-80msva10	132	16	conducted	conduct	VBN
cord-327697-80msva10	132	17	to	to	TO
cord-327697-80msva10	132	18	clarify	clarify	VB
cord-327697-80msva10	132	19	the	the	DT
cord-327697-80msva10	132	20	changes	change	NNS
cord-327697-80msva10	132	21	in	in	IN
cord-327697-80msva10	132	22	prescribing	prescribe	VBG
cord-327697-80msva10	132	23	habits	habit	NNS
cord-327697-80msva10	132	24	of	of	IN
cord-327697-80msva10	132	25	physicians	physician	NNS
cord-327697-80msva10	132	26	of	of	IN
cord-327697-80msva10	132	27	antihypertensive	antihypertensive	JJ
cord-327697-80msva10	132	28	medications	medication	NNS
cord-327697-80msva10	132	29	during	during	IN
cord-327697-80msva10	132	30	the	the	DT
cord-327697-80msva10	132	31	course	course	NN
cord-327697-80msva10	132	32	of	of	IN
cord-327697-80msva10	132	33	the	the	DT
cord-327697-80msva10	132	34	COVID-19	COVID-19	NNP
cord-327697-80msva10	132	35	pandemic	pandemic	NN
cord-327697-80msva10	132	36	.	.	.
cord-327697-80msva10	133	1	What	what	WP
cord-327697-80msva10	133	2	is	be	VBZ
cord-327697-80msva10	133	3	known	know	VBN
cord-327697-80msva10	133	4	about	about	IN
cord-327697-80msva10	133	5	topic	topic	NN
cord-327697-80msva10	134	1	•	•	NNP
cord-327697-80msva10	135	1	In	in	IN
cord-327697-80msva10	135	2	the	the	DT
cord-327697-80msva10	135	3	first	first	JJ
cord-327697-80msva10	135	4	half	half	NN
cord-327697-80msva10	135	5	of	of	IN
cord-327697-80msva10	135	6	2020	2020	CD
cord-327697-80msva10	135	7	COVID-19	covid-19	CD
cord-327697-80msva10	135	8	infection	infection	NN
cord-327697-80msva10	135	9	became	become	VBD
cord-327697-80msva10	135	10	pandemic	pandemic	JJ
cord-327697-80msva10	135	11	.	.	.
cord-327697-80msva10	136	1	SARS	SARS	NNP
cord-327697-80msva10	136	2	-	-	HYPH
cord-327697-80msva10	136	3	CoV-2	CoV-2	NNP
cord-327697-80msva10	136	4	virus	virus	NN
cord-327697-80msva10	136	5	enters	enter	VBZ
cord-327697-80msva10	136	6	into	into	IN
cord-327697-80msva10	136	7	cells	cell	NNS
cord-327697-80msva10	136	8	by	by	IN
cord-327697-80msva10	136	9	binding	bind	VBG
cord-327697-80msva10	136	10	to	to	IN
cord-327697-80msva10	136	11	the	the	DT
cord-327697-80msva10	136	12	ACE2	ACE2	NNP
cord-327697-80msva10	136	13	receptor	receptor	NN
cord-327697-80msva10	136	14	.	.	.
cord-327697-80msva10	137	1	•	•	NNP
cord-327697-80msva10	138	1	Hypertension	hypertension	NN
cord-327697-80msva10	138	2	is	be	VBZ
cord-327697-80msva10	138	3	the	the	DT
cord-327697-80msva10	138	4	most	most	RBS
cord-327697-80msva10	138	5	common	common	JJ
cord-327697-80msva10	138	6	comorbity	comorbity	NN
cord-327697-80msva10	138	7	in	in	IN
cord-327697-80msva10	138	8	COVID-19	COVID-19	NNP
cord-327697-80msva10	138	9	patient	patient	NN
cord-327697-80msva10	138	10	.	.	.
cord-327697-80msva10	139	1	In	in	IN
cord-327697-80msva10	139	2	early	early	JJ
cord-327697-80msva10	139	3	studies	study	NNS
cord-327697-80msva10	139	4	,	,	,
cord-327697-80msva10	139	5	it	-PRON-	PRP
cord-327697-80msva10	139	6	was	be	VBD
cord-327697-80msva10	139	7	speculated	speculate	VBN
cord-327697-80msva10	139	8	that	that	IN
cord-327697-80msva10	139	9	ACE	ACE	NNP
cord-327697-80msva10	139	10	/	/	SYM
cord-327697-80msva10	139	11	ARB	ARB	NNP
cord-327697-80msva10	139	12	users	user	NNS
cord-327697-80msva10	139	13	may	may	MD
cord-327697-80msva10	139	14	be	be	VB
cord-327697-80msva10	139	15	more	more	RBR
cord-327697-80msva10	139	16	susceptible	susceptible	JJ
cord-327697-80msva10	139	17	to	to	IN
cord-327697-80msva10	139	18	COVID-19	covid-19	JJ
cord-327697-80msva10	139	19	disease	disease	NN
cord-327697-80msva10	139	20	and	and	CC
cord-327697-80msva10	139	21	have	have	VBP
cord-327697-80msva10	139	22	worse	bad	JJR
cord-327697-80msva10	139	23	outcomes	outcome	NNS
cord-327697-80msva10	139	24	.	.	.
cord-327697-80msva10	140	1	•	•	NNP
cord-327697-80msva10	141	1	Concerns	concern	NNS
cord-327697-80msva10	141	2	about	about	IN
cord-327697-80msva10	141	3	ACE	ACE	NNP
cord-327697-80msva10	141	4	/	/	SYM
cord-327697-80msva10	141	5	ARB	ARB	NNP
cord-327697-80msva10	141	6	use	use	NN
cord-327697-80msva10	141	7	have	have	VBP
cord-327697-80msva10	141	8	arisen	arise	VBN
cord-327697-80msva10	141	9	among	among	IN
cord-327697-80msva10	141	10	healthcare	healthcare	NN
cord-327697-80msva10	141	11	professionals	professional	NNS
cord-327697-80msva10	141	12	.	.	.
cord-327697-80msva10	142	1	Scientific	scientific	JJ
cord-327697-80msva10	142	2	societies	society	NNS
cord-327697-80msva10	142	3	against	against	IN
cord-327697-80msva10	142	4	discontinuation	discontinuation	NN
cord-327697-80msva10	142	5	of	of	IN
cord-327697-80msva10	142	6	these	these	DT
cord-327697-80msva10	142	7	drugs	drug	NNS
cord-327697-80msva10	142	8	.	.	.
cord-327697-80msva10	143	1	What	what	WP
cord-327697-80msva10	143	2	this	this	DT
cord-327697-80msva10	143	3	study	study	NN
cord-327697-80msva10	143	4	adds	add	VBZ
cord-327697-80msva10	143	5	•	•	NNP
cord-327697-80msva10	144	1	In	in	IN
cord-327697-80msva10	144	2	pandemic	pandemic	NN
cord-327697-80msva10	144	3	era	era	NN
cord-327697-80msva10	144	4	,	,	,
cord-327697-80msva10	144	5	general	general	JJ
cord-327697-80msva10	144	6	reliance	reliance	NN
cord-327697-80msva10	144	7	level	level	NN
cord-327697-80msva10	144	8	of	of	IN
cord-327697-80msva10	144	9	in	in	IN
cord-327697-80msva10	144	10	ACE	ACE	NNP
cord-327697-80msva10	144	11	-	-	HYPH
cord-327697-80msva10	144	12	i/	i/	NNP
cord-327697-80msva10	144	13	ARBs	arb	NNS
cord-327697-80msva10	144	14	therapy	therapy	NN
cord-327697-80msva10	144	15	was	be	VBD
cord-327697-80msva10	144	16	high	high	JJ
cord-327697-80msva10	144	17	.	.	.
cord-327697-80msva10	145	1	78.7	78.7	CD
cord-327697-80msva10	145	2	%	%	NN
cord-327697-80msva10	145	3	of	of	IN
cord-327697-80msva10	145	4	the	the	DT
cord-327697-80msva10	145	5	physicians	physician	NNS
cord-327697-80msva10	145	6	advised	advise	VBD
cord-327697-80msva10	145	7	continuing	continue	VBG
cord-327697-80msva10	145	8	the	the	DT
cord-327697-80msva10	145	9	ACE	ACE	NNP
cord-327697-80msva10	145	10	-	-	HYPH
cord-327697-80msva10	145	11	i	i	NN
cord-327697-80msva10	145	12	/	/	SYM
cord-327697-80msva10	145	13	ARBs	arb	NNS
cord-327697-80msva10	145	14	medications	medication	NNS
cord-327697-80msva10	145	15	.	.	.
cord-327697-80msva10	146	1	•	•	NNP
cord-327697-80msva10	146	2	Calcium	calcium	NN
cord-327697-80msva10	146	3	channel	channel	NN
cord-327697-80msva10	146	4	blockers	blocker	NNS
cord-327697-80msva10	146	5	were	be	VBD
cord-327697-80msva10	146	6	the	the	DT
cord-327697-80msva10	146	7	most	most	RBS
cord-327697-80msva10	146	8	preferred	preferred	JJ
cord-327697-80msva10	146	9	agents	agent	NNS
cord-327697-80msva10	146	10	in	in	IN
cord-327697-80msva10	146	11	the	the	DT
cord-327697-80msva10	146	12	case	case	NN
cord-327697-80msva10	146	13	of	of	IN
cord-327697-80msva10	146	14	ACE	ACE	NNP
cord-327697-80msva10	146	15	-	-	HYPH
cord-327697-80msva10	146	16	i	i	NNP
cord-327697-80msva10	146	17	/	/	SYM
cord-327697-80msva10	146	18	ARBs	arb	NNS
cord-327697-80msva10	146	19	cessation	cessation	NN
cord-327697-80msva10	146	20	due	due	IN
cord-327697-80msva10	146	21	to	to	IN
cord-327697-80msva10	146	22	safety	safety	NN
cord-327697-80msva10	146	23	concerns	concern	NNS
cord-327697-80msva10	146	24	.	.	.
cord-327697-80msva10	147	1	The	the	DT
cord-327697-80msva10	147	2	strategy	strategy	NN
cord-327697-80msva10	147	3	for	for	IN
cord-327697-80msva10	147	4	repeating	repeat	VBG
cord-327697-80msva10	147	5	therapy	therapy	NN
cord-327697-80msva10	147	6	was	be	VBD
cord-327697-80msva10	147	7	the	the	DT
cord-327697-80msva10	147	8	same	same	JJ
cord-327697-80msva10	147	9	in	in	IN
cord-327697-80msva10	147	10	all	all	DT
cord-327697-80msva10	147	11	specialities	speciality	NNS
cord-327697-80msva10	147	12	.	.	.
cord-327697-80msva10	148	1	The	the	DT
cord-327697-80msva10	148	2	practice	practice	NN
cord-327697-80msva10	148	3	of	of	IN
cord-327697-80msva10	148	4	starting	start	VBG
cord-327697-80msva10	148	5	new	new	JJ
cord-327697-80msva10	148	6	ACE	ACE	NNP
cord-327697-80msva10	148	7	-	-	HYPH
cord-327697-80msva10	148	8	i	i	NN
cord-327697-80msva10	148	9	/	/	SYM
cord-327697-80msva10	148	10	ARBs	arb	NNS
cord-327697-80msva10	148	11	and	and	CC
cord-327697-80msva10	148	12	reliance	reliance	NN
cord-327697-80msva10	148	13	level	level	NN
cord-327697-80msva10	148	14	in	in	IN
cord-327697-80msva10	148	15	different	different	JJ
cord-327697-80msva10	148	16	clinical	clinical	JJ
cord-327697-80msva10	148	17	situations	situation	NNS
cord-327697-80msva10	148	18	showed	show	VBD
cord-327697-80msva10	148	19	significant	significant	JJ
cord-327697-80msva10	148	20	difference	difference	NN
cord-327697-80msva10	148	21	between	between	IN
cord-327697-80msva10	148	22	physician	physician	NN
cord-327697-80msva10	148	23	specialties	specialty	NNS
cord-327697-80msva10	148	24	.	.	.
cord-327697-80msva10	149	1	Funding	funding	NN
cord-327697-80msva10	150	1	This	this	DT
cord-327697-80msva10	150	2	research	research	NN
cord-327697-80msva10	150	3	received	receive	VBD
cord-327697-80msva10	150	4	no	no	DT
cord-327697-80msva10	150	5	specific	specific	JJ
cord-327697-80msva10	150	6	grant	grant	NN
cord-327697-80msva10	150	7	from	from	IN
cord-327697-80msva10	150	8	any	any	DT
cord-327697-80msva10	150	9	funding	funding	NN
cord-327697-80msva10	150	10	agency	agency	NN
cord-327697-80msva10	150	11	in	in	IN
cord-327697-80msva10	150	12	the	the	DT
cord-327697-80msva10	150	13	public	public	NN
cord-327697-80msva10	150	14	,	,	,
cord-327697-80msva10	150	15	commercial	commercial	JJ
cord-327697-80msva10	150	16	or	or	CC
cord-327697-80msva10	150	17	not	not	RB
cord-327697-80msva10	150	18	-	-	HYPH
cord-327697-80msva10	150	19	for	for	IN
cord-327697-80msva10	150	20	-	-	HYPH
cord-327697-80msva10	150	21	profit	profit	NN
cord-327697-80msva10	150	22	sectors	sector	NNS
cord-327697-80msva10	150	23	.	.	.
cord-327697-80msva10	151	1	Conflict	conflict	NN
cord-327697-80msva10	151	2	of	of	IN
cord-327697-80msva10	151	3	interest	interest	NN
cord-327697-80msva10	152	1	The	the	DT
cord-327697-80msva10	152	2	authors	author	NNS
cord-327697-80msva10	152	3	declared	declare	VBD
cord-327697-80msva10	152	4	no	no	DT
cord-327697-80msva10	152	5	potential	potential	JJ
cord-327697-80msva10	152	6	conflicts	conflict	NNS
cord-327697-80msva10	152	7	of	of	IN
cord-327697-80msva10	152	8	interest	interest	NN
cord-327697-80msva10	152	9	with	with	IN
cord-327697-80msva10	152	10	respect	respect	NN
cord-327697-80msva10	152	11	to	to	IN
cord-327697-80msva10	152	12	the	the	DT
cord-327697-80msva10	152	13	research	research	NN
cord-327697-80msva10	152	14	,	,	,
cord-327697-80msva10	152	15	authorship	authorship	NN
cord-327697-80msva10	152	16	and/or	and/or	CC
cord-327697-80msva10	152	17	publication	publication	NN
cord-327697-80msva10	152	18	of	of	IN
cord-327697-80msva10	152	19	this	this	DT
cord-327697-80msva10	152	20	article	article	NN
cord-327697-80msva10	152	21	.	.	.
cord-327697-80msva10	153	1	Informed	informed	JJ
cord-327697-80msva10	153	2	consent	consent	NN
cord-327697-80msva10	154	1	All	all	DT
cord-327697-80msva10	154	2	subjects	subject	NNS
cord-327697-80msva10	154	3	gave	give	VBD
cord-327697-80msva10	154	4	informed	informed	JJ
cord-327697-80msva10	154	5	consent	consent	NN
cord-327697-80msva10	154	6	for	for	IN
cord-327697-80msva10	154	7	participation	participation	NN
cord-327697-80msva10	154	8	.	.	.
cord-327697-80msva10	155	1	The	the	DT
cord-327697-80msva10	155	2	vasoprotective	vasoprotective	JJ
cord-327697-80msva10	155	3	axes	axis	NNS
cord-327697-80msva10	155	4	of	of	IN
cord-327697-80msva10	155	5	the	the	DT
cord-327697-80msva10	155	6	reninangiotensin	reninangiotensin	NNP
cord-327697-80msva10	155	7	system	system	NN
cord-327697-80msva10	155	8	:	:	:
cord-327697-80msva10	155	9	physiological	physiological	JJ
cord-327697-80msva10	155	10	relevance	relevance	NN
cord-327697-80msva10	155	11	and	and	CC
cord-327697-80msva10	155	12	therapeutic	therapeutic	JJ
cord-327697-80msva10	155	13	implications	implication	NNS
cord-327697-80msva10	155	14	in	in	IN
cord-327697-80msva10	155	15	cardiovascular	cardiovascular	JJ
cord-327697-80msva10	155	16	,	,	,
cord-327697-80msva10	155	17	hypertensive	hypertensive	JJ
cord-327697-80msva10	155	18	and	and	CC
cord-327697-80msva10	155	19	kidney	kidney	NN
cord-327697-80msva10	155	20	diseases	disease	NNS
cord-327697-80msva10	156	1	COVID-19	covid-19	VB
cord-327697-80msva10	156	2	and	and	CC
cord-327697-80msva10	156	3	the	the	DT
cord-327697-80msva10	156	4	cardiovascular	cardiovascular	JJ
cord-327697-80msva10	156	5	system	system	NN
cord-327697-80msva10	156	6	Renin	Renin	NNP
cord-327697-80msva10	156	7	-	-	HYPH
cord-327697-80msva10	156	8	Angiotensin	Angiotensin	NNP
cord-327697-80msva10	156	9	-	-	HYPH
cord-327697-80msva10	156	10	Aldosterone	Aldosterone	NNP
cord-327697-80msva10	156	11	System	System	NNP
cord-327697-80msva10	156	12	Inhibitors	Inhibitors	NNP
cord-327697-80msva10	156	13	in	in	IN
cord-327697-80msva10	156	14	Patients	patient	NNS
cord-327697-80msva10	156	15	with	with	IN
cord-327697-80msva10	156	16	Covid-19	Covid-19	NNP
cord-327697-80msva10	156	17	Angiotensin	Angiotensin	NNP
cord-327697-80msva10	156	18	-	-	HYPH
cord-327697-80msva10	156	19	converting	convert	VBG
cord-327697-80msva10	156	20	enzyme	enzyme	NN
cord-327697-80msva10	157	1	2	2	CD
cord-327697-80msva10	157	2	is	be	VBZ
cord-327697-80msva10	157	3	a	a	DT
cord-327697-80msva10	157	4	functional	functional	JJ
cord-327697-80msva10	157	5	receptor	receptor	NN
cord-327697-80msva10	157	6	for	for	IN
cord-327697-80msva10	157	7	the	the	DT
cord-327697-80msva10	157	8	SARS	SARS	NNP
cord-327697-80msva10	157	9	coronavirus	coronavirus	NN
cord-327697-80msva10	157	10	Enalapril	Enalapril	NNP
cord-327697-80msva10	157	11	Attenuates	Attenuates	NNP
cord-327697-80msva10	157	12	Downregulation	Downregulation	NNP
cord-327697-80msva10	157	13	of	of	IN
cord-327697-80msva10	157	14	Angiotensin	Angiotensin	NNP
cord-327697-80msva10	157	15	-	-	HYPH
cord-327697-80msva10	157	16	Converting	convert	VBG
cord-327697-80msva10	157	17	Enzyme	Enzyme	NNP
cord-327697-80msva10	157	18	2	2	CD
cord-327697-80msva10	157	19	in	in	IN
cord-327697-80msva10	157	20	the	the	DT
cord-327697-80msva10	157	21	Late	Late	NNP
cord-327697-80msva10	157	22	Phase	Phase	NNP
cord-327697-80msva10	157	23	of	of	IN
cord-327697-80msva10	157	24	Ventricular	Ventricular	NNP
cord-327697-80msva10	157	25	Dysfunction	Dysfunction	NNP
cord-327697-80msva10	157	26	in	in	IN
cord-327697-80msva10	157	27	Myocardial	Myocardial	NNP
cord-327697-80msva10	157	28	Infarcted	Infarcted	NNP
cord-327697-80msva10	157	29	Rat	Rat	NNP
cord-327697-80msva10	157	30	Upregulation	Upregulation	NNP
cord-327697-80msva10	157	31	of	of	IN
cord-327697-80msva10	157	32	angiotensin	angiotensin	NN
cord-327697-80msva10	157	33	-	-	HYPH
cord-327697-80msva10	157	34	converting	convert	VBG
cord-327697-80msva10	157	35	enzyme	enzyme	NN
cord-327697-80msva10	157	36	(	(	-LRB-
cord-327697-80msva10	157	37	ACE	ace	NN
cord-327697-80msva10	157	38	)	)	-RRB-
cord-327697-80msva10	157	39	2	2	CD
cord-327697-80msva10	157	40	in	in	IN
cord-327697-80msva10	157	41	hepatic	hepatic	JJ
cord-327697-80msva10	157	42	fibrosis	fibrosis	NN
cord-327697-80msva10	157	43	by	by	IN
cord-327697-80msva10	157	44	ACE	ACE	NNP
cord-327697-80msva10	157	45	inhibitors	inhibitor	NNS
cord-327697-80msva10	157	46	Upregulation	Upregulation	NNP
cord-327697-80msva10	157	47	of	of	IN
cord-327697-80msva10	157	48	Angiotensin	Angiotensin	NNP
cord-327697-80msva10	157	49	-	-	HYPH
cord-327697-80msva10	157	50	Converting	convert	VBG
cord-327697-80msva10	157	51	Enzyme	Enzyme	NNP
cord-327697-80msva10	158	1	2	2	LS
cord-327697-80msva10	159	1	After	after	IN
cord-327697-80msva10	159	2	Myocardial	Myocardial	NNP
cord-327697-80msva10	159	3	Infarction	Infarction	NNP
cord-327697-80msva10	159	4	by	by	IN
cord-327697-80msva10	159	5	Blockade	Blockade	NNP
cord-327697-80msva10	159	6	of	of	IN
cord-327697-80msva10	159	7	Angiotensin	Angiotensin	NNP
cord-327697-80msva10	159	8	II	II	NNP
cord-327697-80msva10	159	9	Receptors	Receptors	NNPS
cord-327697-80msva10	159	10	Effect	Effect	NNP
cord-327697-80msva10	159	11	of	of	IN
cord-327697-80msva10	159	12	Angiotensin	Angiotensin	NNP
cord-327697-80msva10	159	13	-	-	HYPH
cord-327697-80msva10	159	14	Converting	convert	VBG
cord-327697-80msva10	159	15	Enzyme	Enzyme	NNP
cord-327697-80msva10	159	16	Inhibition	Inhibition	NNP
cord-327697-80msva10	159	17	and	and	CC
cord-327697-80msva10	159	18	Angiotensin	Angiotensin	NNP
cord-327697-80msva10	159	19	II	II	NNP
cord-327697-80msva10	159	20	Receptor	Receptor	NNP
cord-327697-80msva10	159	21	Blockers	Blockers	NNP
cord-327697-80msva10	159	22	on	on	IN
cord-327697-80msva10	159	23	Cardiac	Cardiac	NNP
cord-327697-80msva10	159	24	Angiotensin	Angiotensin	NNP
cord-327697-80msva10	159	25	-	-	HYPH
cord-327697-80msva10	159	26	Converting	convert	VBG
cord-327697-80msva10	159	27	Enzyme	Enzyme	NNP
cord-327697-80msva10	159	28	2	2	CD
cord-327697-80msva10	159	29	RAAS	RAAS	NNP
cord-327697-80msva10	159	30	inhibitors	inhibitor	NNS
cord-327697-80msva10	159	31	do	do	VBP
cord-327697-80msva10	159	32	not	not	RB
cord-327697-80msva10	159	33	increase	increase	VB
cord-327697-80msva10	159	34	the	the	DT
cord-327697-80msva10	159	35	risk	risk	NN
cord-327697-80msva10	159	36	of	of	IN
cord-327697-80msva10	159	37	COVID-19	COVID-19	NNP
cord-327697-80msva10	159	38	Managing	managing	NN
cord-327697-80msva10	159	39	hypertension	hypertension	NN
cord-327697-80msva10	159	40	during	during	IN
cord-327697-80msva10	159	41	the	the	DT
cord-327697-80msva10	159	42	COVID-19	COVID-19	NNP
cord-327697-80msva10	159	43	pandemic	pandemic	NN
cord-327697-80msva10	159	44	COVID19	covid19	NN
cord-327697-80msva10	159	45	and	and	CC
cord-327697-80msva10	159	46	increased	increase	VBN
cord-327697-80msva10	159	47	mortality	mortality	NN
cord-327697-80msva10	159	48	in	in	IN
cord-327697-80msva10	159	49	African	african	JJ
cord-327697-80msva10	159	50	Americans	Americans	NNPS
cord-327697-80msva10	159	51	:	:	:
cord-327697-80msva10	159	52	socioeconomic	socioeconomic	JJ
cord-327697-80msva10	159	53	differences	difference	NNS
cord-327697-80msva10	159	54	or	or	CC
cord-327697-80msva10	159	55	does	do	VBZ
cord-327697-80msva10	159	56	the	the	DT
cord-327697-80msva10	159	57	renin	renin	NN
cord-327697-80msva10	159	58	angiotensin	angiotensin	NNP
cord-327697-80msva10	159	59	system	system	NN
cord-327697-80msva10	159	60	also	also	RB
cord-327697-80msva10	159	61	contribute	contribute	VBP
cord-327697-80msva10	159	62	?	?	.
cord-327697-80msva10	160	1	Joint	Joint	NNP
cord-327697-80msva10	160	2	HFSA	HFSA	NNP
cord-327697-80msva10	160	3	/	/	SYM
cord-327697-80msva10	160	4	ACC	ACC	NNP
cord-327697-80msva10	160	5	/	/	SYM
cord-327697-80msva10	160	6	AHA	AHA	NNP
cord-327697-80msva10	160	7	Statement	Statement	NNP
cord-327697-80msva10	161	1	Addresses	address	NNS
cord-327697-80msva10	161	2	Concerns	concern	NNS
cord-327697-80msva10	161	3	Re	re	IN
cord-327697-80msva10	161	4	:	:	:
cord-327697-80msva10	161	5	using	use	VBG
cord-327697-80msva10	161	6	RAAS	RAAS	NNP
cord-327697-80msva10	161	7	Antagonists	Antagonists	NNPS
cord-327697-80msva10	161	8	in	in	IN
cord-327697-80msva10	161	9	COVID-19	COVID-19	NNP
cord-327697-80msva10	162	1	Are	be	VBP
cord-327697-80msva10	162	2	patients	patient	NNS
cord-327697-80msva10	162	3	with	with	IN
cord-327697-80msva10	162	4	hypertension	hypertension	NN
cord-327697-80msva10	162	5	and	and	CC
cord-327697-80msva10	162	6	diabetes	diabetes	NN
cord-327697-80msva10	162	7	mellitus	mellitus	NN
cord-327697-80msva10	162	8	at	at	IN
cord-327697-80msva10	162	9	increased	increase	VBN
cord-327697-80msva10	162	10	risk	risk	NN
cord-327697-80msva10	162	11	for	for	IN
cord-327697-80msva10	162	12	COVID-19	covid-19	JJ
cord-327697-80msva10	162	13	infection	infection	NN
cord-327697-80msva10	162	14	?	?	.
cord-327697-80msva10	163	1	Lancet	Lancet	NNP
cord-327697-80msva10	163	2	Clinical	clinical	JJ
cord-327697-80msva10	163	3	Characteristics	characteristic	NNS
cord-327697-80msva10	163	4	of	of	IN
cord-327697-80msva10	163	5	Coronavirus	Coronavirus	NNP
cord-327697-80msva10	163	6	Disease	Disease	NNP
cord-327697-80msva10	163	7	2019	2019	CD
cord-327697-80msva10	163	8	in	in	IN
cord-327697-80msva10	163	9	China	China	NNP
cord-327697-80msva10	163	10	Clinical	clinical	JJ
cord-327697-80msva10	163	11	features	feature	NNS
cord-327697-80msva10	163	12	of	of	IN
cord-327697-80msva10	163	13	patients	patient	NNS
cord-327697-80msva10	163	14	infected	infect	VBN
cord-327697-80msva10	163	15	with	with	IN
cord-327697-80msva10	163	16	2019	2019	CD
cord-327697-80msva10	163	17	novel	novel	JJ
cord-327697-80msva10	163	18	coronavirus	coronavirus	NN
cord-327697-80msva10	163	19	in	in	IN
cord-327697-80msva10	163	20	Wuhan	Wuhan	NNP
cord-327697-80msva10	163	21	,	,	,
cord-327697-80msva10	163	22	China	China	NNP
cord-327697-80msva10	163	23	Baseline	Baseline	NNP
cord-327697-80msva10	163	24	Characteristics	Characteristics	NNP
cord-327697-80msva10	163	25	and	and	CC
cord-327697-80msva10	163	26	Outcomes	Outcomes	NNPS
cord-327697-80msva10	163	27	of	of	IN
cord-327697-80msva10	163	28	1591	1591	CD
cord-327697-80msva10	163	29	Patients	patient	NNS
cord-327697-80msva10	163	30	Infected	infect	VBN
cord-327697-80msva10	163	31	With	with	IN
cord-327697-80msva10	163	32	SARS	SARS	NNP
cord-327697-80msva10	163	33	-	-	HYPH
cord-327697-80msva10	163	34	CoV-2	CoV-2	NNP
cord-327697-80msva10	164	1	Admitted	admit	VBN
cord-327697-80msva10	164	2	to	to	IN
cord-327697-80msva10	164	3	ICUs	ICUs	NNP
cord-327697-80msva10	164	4	of	of	IN
cord-327697-80msva10	164	5	the	the	DT
cord-327697-80msva10	164	6	Lombardy	Lombardy	NNP
cord-327697-80msva10	164	7	Region	Region	NNP
cord-327697-80msva10	165	1	COVID-19	covid-19	JJ
cord-327697-80msva10	165	2	patients	patient	NNS
cord-327697-80msva10	165	3	with	with	IN
cord-327697-80msva10	165	4	hypertension	hypertension	NN
cord-327697-80msva10	165	5	have	have	VBP
cord-327697-80msva10	165	6	more	more	JJR
cord-327697-80msva10	165	7	severe	severe	JJ
cord-327697-80msva10	165	8	disease	disease	NN
cord-327697-80msva10	165	9	:	:	:
cord-327697-80msva10	166	1	a	a	DT
cord-327697-80msva10	166	2	multicenter	multicenter	JJ
cord-327697-80msva10	166	3	retrospective	retrospective	JJ
cord-327697-80msva10	166	4	observational	observational	JJ
cord-327697-80msva10	166	5	study	study	NN
cord-327697-80msva10	166	6	Angiotensin	Angiotensin	NNP
cord-327697-80msva10	166	7	receptor	receptor	NN
cord-327697-80msva10	166	8	blockers	blocker	NNS
cord-327697-80msva10	166	9	as	as	IN
cord-327697-80msva10	166	10	tentative	tentative	JJ
cord-327697-80msva10	166	11	SARS	SARS	NNP
cord-327697-80msva10	166	12	-	-	HYPH
cord-327697-80msva10	166	13	CoV-2	CoV-2	NNP
cord-327697-80msva10	166	14	therapeutics	therapeutic	NNS
cord-327697-80msva10	166	15	Attenuation	attenuation	NN
cord-327697-80msva10	166	16	of	of	IN
cord-327697-80msva10	166	17	pulmonary	pulmonary	JJ
cord-327697-80msva10	166	18	ACE2	ACE2	NNP
cord-327697-80msva10	166	19	activity	activity	NN
cord-327697-80msva10	166	20	impairs	impair	VBZ
cord-327697-80msva10	166	21	inactivation	inactivation	NN
cord-327697-80msva10	166	22	of	of	IN
cord-327697-80msva10	166	23	des	des	NNP
cord-327697-80msva10	166	24	-	-	HYPH
cord-327697-80msva10	166	25	Arg9	Arg9	NNP
cord-327697-80msva10	166	26	bradykinin	bradykinin	NN
cord-327697-80msva10	166	27	/	/	SYM
cord-327697-80msva10	166	28	BKB1R	BKB1R	,
cord-327697-80msva10	166	29	axis	axis	NN
cord-327697-80msva10	166	30	and	and	CC
cord-327697-80msva10	166	31	facilitates	facilitate	VBZ
cord-327697-80msva10	166	32	LPS	LPS	NNP
cord-327697-80msva10	166	33	-	-	HYPH
cord-327697-80msva10	166	34	induced	induce	VBN
cord-327697-80msva10	166	35	neutrophil	neutrophil	NN
cord-327697-80msva10	166	36	infiltration	infiltration	NN
cord-327697-80msva10	166	37	Clinical	clinical	JJ
cord-327697-80msva10	166	38	and	and	CC
cord-327697-80msva10	166	39	biochemical	biochemical	JJ
cord-327697-80msva10	166	40	indexes	index	NNS
cord-327697-80msva10	166	41	from	from	IN
cord-327697-80msva10	166	42	2019-nCoV	2019-ncov	CD
cord-327697-80msva10	166	43	infected	infect	VBN
cord-327697-80msva10	166	44	patients	patient	NNS
cord-327697-80msva10	166	45	linked	link	VBN
cord-327697-80msva10	166	46	to	to	IN
cord-327697-80msva10	166	47	viral	viral	JJ
cord-327697-80msva10	166	48	loads	load	NNS
cord-327697-80msva10	166	49	and	and	CC
cord-327697-80msva10	166	50	lung	lung	NN
cord-327697-80msva10	166	51	injury	injury	NN
cord-327697-80msva10	167	1	Angiotensinconverting	angiotensinconverting	NN
cord-327697-80msva10	167	2	enzyme	enzyme	NN
cord-327697-80msva10	167	3	2	2	CD
cord-327697-80msva10	167	4	inhibits	inhibit	VBZ
cord-327697-80msva10	167	5	lung	lung	NN
cord-327697-80msva10	167	6	injury	injury	NN
cord-327697-80msva10	167	7	induced	induce	VBN
cord-327697-80msva10	167	8	by	by	IN
cord-327697-80msva10	167	9	respiratory	respiratory	JJ
cord-327697-80msva10	167	10	syncytial	syncytial	JJ
cord-327697-80msva10	167	11	virus	virus	NN
cord-327697-80msva10	167	12	Angiotensinconverting	Angiotensinconverting	NNP
cord-327697-80msva10	167	13	enzyme	enzyme	NN
cord-327697-80msva10	168	1	2	2	LS
cord-327697-80msva10	168	2	protects	protect	VBZ
cord-327697-80msva10	168	3	from	from	IN
cord-327697-80msva10	168	4	lethal	lethal	JJ
cord-327697-80msva10	168	5	avian	avian	JJ
cord-327697-80msva10	168	6	influenza	influenza	NN
cord-327697-80msva10	168	7	A	a	DT
cord-327697-80msva10	168	8	H5N1	H5N1	NNP
cord-327697-80msva10	168	9	infections	infection	NNS
cord-327697-80msva10	168	10	Renin	renin	NN
cord-327697-80msva10	168	11	-	-	HYPH
cord-327697-80msva10	168	12	Angiotensin	Angiotensin	NNP
cord-327697-80msva10	168	13	-	-	HYPH
cord-327697-80msva10	168	14	Aldosterone	Aldosterone	NNP
cord-327697-80msva10	168	15	System	System	NNP
cord-327697-80msva10	168	16	Blockers	Blockers	NNP
cord-327697-80msva10	168	17	and	and	CC
cord-327697-80msva10	168	18	the	the	DT
cord-327697-80msva10	168	19	Risk	Risk	NNP
cord-327697-80msva10	168	20	of	of	IN
cord-327697-80msva10	168	21	Covid-19	Covid-19	NNP
cord-327697-80msva10	168	22	Renin	Renin	NNP
cord-327697-80msva10	168	23	-	-	HYPH
cord-327697-80msva10	168	24	Angiotensin	Angiotensin	NNP
cord-327697-80msva10	168	25	-	-	HYPH
cord-327697-80msva10	168	26	Aldosterone	Aldosterone	NNP
cord-327697-80msva10	168	27	System	System	NNP
cord-327697-80msva10	168	28	Inhibitors	Inhibitors	NNP
cord-327697-80msva10	168	29	and	and	CC
cord-327697-80msva10	168	30	Risk	Risk	NNP
cord-327697-80msva10	168	31	of	of	IN
cord-327697-80msva10	168	32	Covid-19	Covid-19	NNP
cord-327697-80msva10	168	33	Characteristics	Characteristics	NNPS
cord-327697-80msva10	168	34	and	and	CC
cord-327697-80msva10	168	35	Outcomes	Outcomes	NNPS
cord-327697-80msva10	168	36	of	of	IN
cord-327697-80msva10	168	37	21	21	CD
cord-327697-80msva10	168	38	Critically	critically	RB
cord-327697-80msva10	168	39	Ill	Ill	NNP
cord-327697-80msva10	168	40	Patients	Patients	NNPS
cord-327697-80msva10	168	41	With	with	IN
cord-327697-80msva10	168	42	COVID-19	COVID-19	NNP
cord-327697-80msva10	168	43	in	in	IN
cord-327697-80msva10	168	44	Washington	Washington	NNP
cord-327697-80msva10	168	45	State	State	NNP
cord-327697-80msva10	168	46	Association	Association	NNP
cord-327697-80msva10	168	47	between	between	IN
cord-327697-80msva10	168	48	Angiotensin	Angiotensin	NNP
cord-327697-80msva10	168	49	Blockade	Blockade	NNP
cord-327697-80msva10	168	50	and	and	CC
cord-327697-80msva10	168	51	Incidence	Incidence	NNP
cord-327697-80msva10	168	52	of	of	IN
cord-327697-80msva10	168	53	Influenza	Influenza	NNP
cord-327697-80msva10	168	54	in	in	IN
cord-327697-80msva10	168	55	the	the	DT
cord-327697-80msva10	168	56	United	United	NNP
cord-327697-80msva10	168	57	Kingdom	Kingdom	NNP